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Thesis abstract 
 
There are a number of surgical methods for treating glaucoma, including 
trabeculectomy and the insertion of drainage devices. At the current time, these procedures 
are still associated with post-operative problems for a significant number of patients, 
particularly with the control of aqueous humour flow and pressure e.g. hypotony. The main 
aim of this work was to look at ways of improving the outcomes of the procedures. 
The usual approach in assessing surgical techniques is to test them on live human or 
animal eyes. This is inherently complex, with a significant challenge to keep some of the 
major parameters e.g. aqueous humour inflow and wound healing consistent throughout a 
series of tests, and with this the problem of reproducibility. The approach used in this work 
includes a review and analysis of the different surgical methods and devices from an 
engineering perspective, the use of scaling analysis and a large-scale physical model coupled 
with image processing to study trabeculectomy scleral flap characteristics and its effect on 
flow and pressure, and also the use of model drainage devices in ex vivo settings to look at 
flow and pressure. For each experiment, implications for clinical practice are discussed. 
Applying engineering principles to glaucoma procedures and devices provided novel 
insight into their functions. It was found that the trabeculectomy scleral flap acts as a valve to 
guard from excessive aqueous humour outflow and low pressures, and parameters such as the 
number and position of sutures and scleral flap geometry can be tailored to alter aqueous 
humour outflow. Additionally, 50 μm internal diameter tubes show promise for controlled 
aqueous humour flow into the subconjunctival space with avoidance of low pressures. 
Engineering methodology can be used in the development of new treatments and devices. 
However, some results may not translate exactly into the more complex living eye. 
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Chapter 1 
1 Introduction 
 
Glaucoma can be regarded as a group of diseases that have as a common end point a 
characteristic optic neuropathy which is determined by both structural change and functional 
deficit (World Health Organisation, 2013). It is the commonest cause of irreversible blindness 
in the world. The estimate for 2010 is more than 60 million people worldwide are afflicted 
with this disease and this number will increase to nearly 80 million by 2020 (Quigley & 
Broman, 2006). Those blind in both eyes amount to more than 8 million people and this will 
increase to more than 10 million. Glaucoma is classified according to the mechanism of 
damage and described as either open angle or angle closure types (Foster, Buhrmann, 
Quigley, & Johnson, 2002). Both of these can be further subdivided into primary (unknown 
cause) or secondary (due to another ocular pathology) subtypes. The most common type is 
open angle glaucoma, which accounts for more than 75% of cases globally. Angle closure 
glaucoma accounts for the remainder but is more common (87% of the total) in Asians, 
particularly the Chinese (48% of the total). Of the two types, angle closure glaucoma has a 
greater morbidity, accounting for a nearly equal number of blindness as the more common 
open angle glaucoma. 
The pathogenesis of glaucoma is not fully understood (Weinreb & Khaw, 2004; Kwon, 
Fingert, Kuehn, & Alward, 2009; Quigley, 2011). The biomechanical theory of glaucoma 
suggests that raised intraocular pressure (IOP) leads to stress and outward deformation of the 
weakest part of the scleral shell which is at the lamina cribrosa (Sigal & Ethier, 2009; Downs, 
Roberts, & Sigal, 2011). Blood flow and nutrient supply to the optic nerve head, which is 
made up of axons of retinal ganglion cells, become compromised. Additionally, there is also 
obstruction of retrograde axoplasmic flow carrying essential neurotrophic factors to the 
21 
 
retinal ganglion cell bodies in the retina, thus leading to apoptosis. In the long-term, neural 
tissue thinning and connective tissue re-modelling through activated astrocytes and lamina 
cribrosa cells occur, which result in the characteristic cupping appearance of the optic nerve 
head and functional visual field defects. Independently or in addition is the effect of altered 
blood flow to the eye and retinal ganglion cells (Grieshaber & Flammer, 2005). Studies 
which showed progression of glaucoma despite ‘normal’ IOP readings have challenged the 
pathophysiological concept of glaucoma based only on raised IOP. Low ocular perfusion 
pressure, defined by ocular arterial blood pressure minus IOP, is associated with an increased 
risk of glaucoma, and is likely to be due to disturbed autoregulation and perfusion instability 
(Caprioli & Coleman, 2010; Cherecheanu, Garhofer, Schmidl, Werkmeister, & Schmetterer, 
2013). It may be that ischemia increases susceptibility to pressure-mediated damage. 
However, at the moment there is no evidence to support the value of increasing a patient’s 
blood pressure as therapy for glaucoma, especially with the potentially serious cardiovascular 
side effects such as myocardial infarction and cerebrovascular accidents (Quaranta, Katsanos, 
Russo, & Riva, 2013). 
What has been proven in large trials such as the Early Manifest Glaucoma Trial, Ocular 
Hypertension Treatment Study, Collaborative Normal Tension Glaucoma Study and 
Advanced Glaucoma Intervention Study is that reducing IOP by 20-30% reduces the potential 
for disease progression by at least 40% (Heijl et al., 2002; Kass et al., 2002; Collaborative 
Normal-Tension Glaucoma Study Group, 1998a; Advanced Glaucoma Intervention Study 
Investigators, 2000). There are many different strategies for reducing IOP, but in advanced 
cases the form of intervention is usually surgical (Quigley, 2011; Weinreb & Khaw, 2004). 
The general aim of this thesis is to analyse the effect of surgical intervention in terms of 
reducing IOP, and engineering methodology is applied to aid this understanding. 
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The usual approach in assessing surgical techniques and devices is to test them on 
living eyes. This is inherently complex; along with issues such as medical ethics and cost, 
there is a significant challenge from biological variability to keep some of the major 
parameters e.g. aqueous humour inflow and wound healing consistent throughout a series of 
tests, and with this the problem of reproducibility. There are a number of other research 
methodologies that can be applied to answer the research question, including ex vivo 
biological tissue models, physical analogue models and computational fluid dynamics (CFD). 
These different methodologies have distinct advantages and disadvantages. Ex vivo biological 
models such as enucleated eyes are less costly and enable the control or fixation of certain 
variables such as ‘aqueous humour’ composition and flow rate but they cannot completely 
replicate the intact in vivo biological conditions and reactions (Weinreb & Lindsey, 2005). 
Experimental outcomes with these models may also be different, due to tissue disorganisation 
or the variability of post-mortem tissue samples. Physical analogue and CFD experiments 
enable even more control of variables and more efficient testing but have less relevance than 
in vivo or ex vivo experiments as they lack many biological features and require more 
assumptions. Additionally, with these experiments there is the difficulty in ensuring the 
correct specification of the material properties or geometry to ensure realistic conditions. 
Overall, these latter techniques simplify and standardise conditions to tell us general 
principles to guide the evolution of surgical procedures. The experimental approach used in 
this thesis includes the use of a large-scale physical analogue model coupled with an image 
processing technique to study scleral flap characteristics and its effect on aqueous humour 
flow and pressure control, and also the use of actual and newly developed devices in ex vivo 
experimental settings to look at flow and pressure control which are important in determining 
the outcome of glaucoma surgery. 
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In chapter 2, the trabeculectomy and glaucoma drainage devices are described and 
reviewed. This is followed by a fluid mechanical analysis of the procedure and devices to 
provide the research questions of this thesis. The analysis using an electrical circuit analogy 
identifies how the optimal resistance/ permeability characteristics depend on which route the 
aqueous humour drains by. Another analysis shows the relationship between pressure drop 
and aqueous humour flow across the device depends on whether it operates in the manner of 
a valve or a fixed resistor. These provide the impetus for the subsequent experiments. 
In chapter 3, a mathematical analysis of the trabeculectomy scleral flap is described, 
followed by a supporting experiment with a physical model of the trabeculectomy scleral 
flap. A related piece of work on rectangular flaps (applied to understand Ahmed Glaucoma 
Valves) is described in Appendix A. The physical model of the trabeculectomy scleral flap is 
then used to look at the effect of scleral flap geometry and sutures on pressure change and 
aqueous humour flow direction. This was to look at methods of altering surgical parameters 
which could help towards achieving desired outcomes. 
In chapter 4, a small ex vivo study was performed in the process of devising and 
refining the porcine eye model, to provide confidence in the experimental methodology that 
is applied in chapter 5, which looked at using smaller diameter tubes to drain aqueous 
humour out of the anterior chamber. The performances of these tubes were also compared 
with those of the Express devices. 
Another related piece of work is presented in Appendix B. This describes an 
experiment to look at the effect of a specific intervention (injection of air bubbles into the 
anterior chamber) during glaucoma surgery. 
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In this thesis, there is an emphasis on the fluid mechanics in glaucoma surgery but 
implications for surgical practice are made within each chapter. The general conclusion is 
stated in chapter 6, along with suggestions for future work that can be done following this 
one. 
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Chapter 2 
2 Review and analysis of glaucoma surgery 
 
The aim of this review is to describe the trabeculectomy procedure and devices used in 
glaucoma surgery and analyse them from an engineering perspective. We start off by 
introducing the concept of IOP and its treatment and follow that up with a description of the 
technique and devices, organised according to their drainage pathways. Finally, a fluid 
mechanical analysis is presented that enables the techniques and devices to be classified in a 
useful conceptual framework, before concluding in section 2.7. 
 
2.1 Aqueous humour and IOP 
Aqueous humour provides nutrients to the cornea and surrounding tissue while also 
removing their metabolic products (Allingham, Damji, Freedman, Moroi, & Shafranov, 
2005). In humans, it is produced by ciliary processes on the ciliary body at a secretion rate 
which varies with a circadian rhythm. Fluorophotometry measurements have shown the rate 
to be between 1.5 µl/min at night and 3.0 µl/min in the morning (Brubaker, 1991). From the 
ciliary body in the posterior chamber, aqueous humour flows anterior to the lens and through 
the pupil into the anterior chamber (Figure 2.1a). It then flows peripherally towards the 
trabecular meshwork at the anterior chamber angle. Up to 90% of outflow occurs through this 
trabecular or conventional outflow pathway. The trabecular meshwork consists of uveal, 
corneoscleral and juxtacanalicular layers (Figure 2.1b). After the juxtacanalicular layer, 
aqueous humour enters the Schlemm’s canal through vacuoles and both intra-cellular and 
para-cellular pores in the inner wall endothelium of the canal, and then exits via collector 
channels to the aqueous and episcleral veins to rejoin the circulation (Johnson, 2006; Tamm, 
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a) 
 
b) 
 
Figure 2.1 (a) Aqueous humour movement (blue arrow) from the ciliary body to the 
trabecular meshwork and Schlemm’s canal. (b) Structure of trabecular meshwork and 
Schlemm’s canal (from Allingham et al., 2005). 
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2009). The remaining aqueous humour outflow drains out of the eye via the uveoscleral 
pathway. This pathway starts with aqueous humour entry via the iris root and then through 
spaces within the ciliary muscle. From the spaces, it enters the supraciliary and 
suprachoroidal spaces and then finally into the choroidal, scleral and episcleral vessels (Alm 
& Nilsson, 2009). 
IOP is generated by aqueous humour circulation in the anterior chamber of the eye 
and the resistance to its outflow. Regarding this outflow, the juxtacanalicular trabecular 
meshwork and inner wall of Schlemm’s canal contribute the highest resistance (McEwen, 
1958; Grant, 1963; Rosenquist, 1989; Maepea & Bill, 1989). McEwen calculated flow 
resistance based on dimensions of flow passages in the uveal and corneoscleral trabecular 
meshwork and found that both did not generate significant resistance. In Grant’s study, 
incision of the uveal and corneoscleral trabecular meshwork in enucleated human eyes 
resulted in minimal change in outflow facility (or the inverse of resistance). However, when 
the juxtacanalicular meshwork was excised, the resistance reduced by 75%. In Maepea et 
al.’s study, micropipettes were inserted in the trabecular meshwork, Schlemm’s canal and 
episcleral veins to look at pressures within them. The bulk of the pressure drop was localised 
to the vicinity of the juxtacanalicular trabecular meshwork and inner wall of Schlemm’s 
canal. The relationship between IOP,   and aqueous humour flow,   is shown by the 
Goldmann equation (Goldmann, 1951; Brubaker, 2004). For an intact conventional aqueous 
humour outflow pathway, 
    
     
 
      ,        (2.1) 
where   = uveoscleral outflow,   = outflow facility and     = episcleral venous pressure. 
Typical values for humans are shown in Table 2.1. In particular, episcleral venous pressure 
has been reported to be between 7 mmHg to 10 mmHg (Zeimer et al., 1983; Toris & Camras, 
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2008). From here, we can see that this would be the minimum for IOP as long as the 
conventional outflow pathway is intact. 
 
Table 2.1 Typical values for Goldmann equation variables for humans. 
 Range References 
IOP,   (mmHg) 10-21 (Leydhecker, Akiyama, & Neumann, 
1958; Klein et al., 1992; Mitchell, 
Smith, Attebo, & Healey, 1996; 
Dandona et al., 2000; Czudowska et 
al., 2010) 
 
Aqueous humour flow 
rate,   (µl/min) 
 
1.5-3.0 (Brubaker, 1991) 
Uveoscleral outflow,   
(µl/min) 
 
0.08-0.28  (direct 
measurement), 
1.1-1.5 (indirect 
calculation) 
 
(Bill & Phillips, 1971), 
(Toris, Yablonski, Wang, & Camras, 
1999) 
Outflow facility,   
(µl/min/mmHg) 
0.2-0.4 (Toris & Camras, 2008; Gulati, Ghate, 
Camras, & Toris, 2011; Liu et al., 
2011) 
 
Episcleral venous pressure, 
    (mmHg) 
7-10 (Zeimer et al., 1983; Toris et al., 2008) 
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Population studies have shown that IOP lies between 10-21 mmHg in ≥ 95% of the 
subjects examined (Table 2.1; for example, mean IOP 15.5 +/- 2.6 mmHg in the study by 
Leydhecker et al., 1958). This range has limited functional significance. Glaucoma can occur 
in patients with IOP values within this range (Collaborative Normal-Tension Glaucoma 
Study Group, 1998a; Collaborative Normal-Tension Glaucoma Study Group, 1998b). On the 
other hand, patients with ocular hypertension are able to tolerate pressures higher than 21 
mmHg without developing the physical or functional changes of glaucoma (Kass et al., 
2002). However, what has been shown convincingly by the large randomised controlled trials 
looking at IOP reduction and control of glaucoma is that IOP reduction can prevent the 
progression of glaucoma, and their summaries are presented below. 
 
2.2 Large trials looking at IOP reduction and control of glaucoma 
The Early Manifest Glaucoma Trial (EMGT) was a randomised controlled trial 
involving 255 patients with early visual field loss and median IOP of 20 mmHg, and showed 
that IOP reductions of 5.1 mmHg or 25% with trabeculoplasty and topical betaxolol reduced 
disease progression at 6 years (45% in the treated group versus 62% in the non-treated group, 
a 27.4% difference in disease progression) (Heijl et al., 2002; Leske et al., 2003). Disease 
progression in the treated group was delayed by a median of 18 months when compared to 
controls (median time to progression 48 months in the non-treated group and 64 months in 
the treated group). There was a dose-response effect to treatment, the study estimated that 
each 1 mmHg reduction in IOP from baseline could decrease the risk of glaucoma 
progression by 10%. However, it is also important to note that 45% of the treated group still 
showed disease progression while 38% of the control group were stable, highlighting that 
IOP is not the only factor involved in disease progression (Wishart, 2009). 
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In the randomised controlled Collaborative Normal Tension Glaucoma Study 
(CNTGS), the influence of IOP on normal tension glaucoma was examined (Collaborative 
Normal-Tension Glaucoma Study Group, 1998a).  140 patients with progressing disease were 
randomised to IOP reduction of 30% within 6 months by medical, laser and surgical means 
with subsequent maintenance for 4 years, or untreated. The mean IOP in the treatment group 
was 10.6 mmHg and in the untreated group was 16.0 mmHg, and disease progression 
occurred less in the treatment group (14% versus 35%) when examining for specifically 
defined end-point criteria of glaucomatous optic disc progression or visual field loss. 
However, the incidence of cataracts was higher with treatment (38% versus 14%), 
contributed mainly by filtration surgery, which could have influenced the visual field 
analysis. When an intention-to-treat analysis was performed, the results failed to show any 
beneficial effect of treatment despite the 30% reduction in IOP (Collaborative Normal-
Tension Glaucoma Study Group, 1998b). 
The Ocular Hypertension Treatment Study (OHTS) was a randomised controlled trial 
which demonstrated that medical therapy could reduce IOP by 22.5%  and lowering IOP by 
20% using topical medication reduced the cumulative probability of glaucomatous visual 
field loss and/or optic disc changes in patients with ocular hypertension (IOP between 24 
mmHg and 32 mmHg) from 9.5% in the observation group to 4.4% in the treatment group at 
5 years (Kass et al., 2002). In the second phase report (Kass et al., 2010), when the original 
observation group received treatment after 7.5 years and then followed-up for another 5.5 
years, its IOP reduction was also more than 20% and the cumulative proportion developing 
glaucoma after the total 13 years of follow-up was 0.16 in the original treated group and 0.22 
in the original observation group. One limitation of this study was that if patients who 
developed only glaucomatous visual field loss were considered, then the difference between 
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the treatment arm (8.3%) and the non-treatment arm (10.1%) was not statistically significant 
(Wishart, 2009). 
The Advanced Glaucoma Intervention Study (AGIS) was a randomised controlled trial 
which analysed IOP control and visual field loss progression in patients diagnosed with open-
angle glaucoma non-responsive to medical treatment (Advanced Glaucoma Intervention 
Study Investigators, 2000). 789 eyes in 591 patients were involved, receiving either primary 
ALT or primary trabeculectomy, supplemented by topical medication and followed by 
planned additional treatment as necessary to reduce IOP to < 18 mmHg. After 6 years, results 
showed that patients with average IOP > 17.5 mmHg in the first 18 months had greater visual 
field defects (by 1.00 units of score), as opposed to patients with IOP < 14 mmHg. The group 
of eyes with IOP < 18 mmHg in 100% of follow-ups (mean IOP 12.3 mmHg) had 
no deterioration of the mean visual field defect score compared to those with IOP > 18 
mmHg in > 50% of visits who showed progression by 0.78 units. However, in one 
subsequent report where data from this study was reanalysed using a point-wise linear 
regression rather than the original scoring system, there was no relationship between mean 
IOP and visual field loss, although greater fluctuations in IOP and older age increased the 
odds of visual field progression (Nouri-Mahdavi et al., 2004). 
The Collaborative Initial Glaucoma Treatment Study (CIGTS) was a prospective, 
randomised controlled trial that compared medical treatment with surgical trabeculectomy as 
initial therapy for 607 patients with early primary open angle glaucoma (POAG), 
pseudoexfoliative glaucoma and pigmentary glaucoma (Lichter et al., 2001; Feiner & Piltz-
Seymour, 2003). Patients in the surgical group underwent trabeculectomy, with argon laser 
trabeculoplasty (ALT) if further treatment was needed, followed by a sequence of 
medications and repeat trabeculectomy. In the medical group, patients received a sequence of 
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medications which usually began with a topical beta-blocker followed by an alternate, single 
topical therapeutic agent, and alternate combination medications. Follow-up was at least 6-
monthly for a minimum of 4 years. The study found that surgery reduced IOP greater and to a 
lower number (46% reduction, to 14-15 mmHg) compared to medical treatment (38% 
reduction, to 17-18 mmHg). However, at the end of the study, the visual field defect scores 
were similar between the groups and the trabeculectomy group also developed more cataracts 
(17.3% versus 3.2%). The authors concluded that the results did not support altering 
treatment paradigms at the time for the initial therapy of newly diagnosed glaucoma patients. 
The Glaucoma Laser Trial (GLT) was a prospective, randomised controlled trial to 
compare Argon Laser Trabeculoplasty (ALT) with topical medication (timolol maleate, a 
beta-blocker) for patients with newly-diagnosed POAG (Glaucoma Laser Trial Research 
Group, 1990). 271 patients were enrolled, with each eye randomly assigned to ALT or topical 
medication and followed-up every 3 months for a period of at least 2 years with IOP, optic 
disc and visual field checks. The Glaucoma Laser Trial Follow-up Study followed-up 203 of 
the initial 271 patients in the GLT over median 7 years (Glaucoma Laser Trial Research 
Group, 1995). If IOP was still elevated (> 21 mmHg or > 80% of the reference) after the 
initial intervention, another topical medication (dipivefrin, an alpha- and beta-agonist) was 
added or drops were started on the laser eye. If intraocular pressure was still not successfully 
reduced, surgery or further laser treatment was performed according to standardised 
procedures. When compared with eyes initially treated with topical medication, eyes initially 
treated with ALT had 1.2 mmHg greater reduction in IOP and 0.6 dB greater improvement in 
the visual field. The ALT group optic discs also maintained better optic cup area to optic disc 
area ratios by -0.01 units. The authors concluded that ALT was at least as efficacious as 
topical medication with regard to IOP lowering in POAG. 
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2.3 Current treatment of raised IOP 
As yet, there is no treatment to restore the visual field loss due to glaucoma. Current 
treatment modalities aim at the prevention of glaucoma or its progression by reducing IOP, 
which is still the only modifiable risk factor for this disease. The typical treatment strategy 
for raised IOP is largely based on the results of the studies described in the preceding section 
and is generally first with topical medication or laser treatment, followed by surgery 
(Quigley, 2011; Weinreb & Khaw, 2004). 
Topical medication offers the least invasive and least risk option, and up to 30% IOP 
reduction as seen from the previously described studies. It functions to reduce the production 
of aqueous humour or increase its outflow. Drugs in the former category include beta-
blockers, alpha-adrenergic agonists and carbonic anhydrase inhibitors. Prostaglandin 
analogues, on the other hand increase the outflow of aqueous humour by the uveoscleral 
pathway. Laser treatment in open angle glaucoma aims to reduce IOP by enhancing aqueous 
humour drainage through the trabecular meshwork. ALT and the equally effective selective 
laser trabeculoplasty (SLT) can reduce IOP by around 30% and have been described as 
alternatives to regular medication for glaucoma (Juzych et al., 2004; Damji et al., 2006; 
Glaucoma Laser Trial Research Group, 1990; Glaucoma Laser Trial Research Group, 1995). 
There are other laser applications for allowing passage of aqueous humour to the trabecular 
meshwork in angle closure glaucoma such as laser peripheral iridotomy and laser peripheral 
iridoplasty (Boey, Singhal, Perera, & Aung, 2012) which will not be discussed in this review 
as they are beyond the scope of this thesis. 
Surgical procedures can offer the largest reductions in IOP (40-50%) and are usually 
reserved for more advanced cases which are not controlled by medical or laser treatment 
(Quigley, 2011; Weinreb & Khaw, 2004). Additionally, the cost of long-term medical therapy 
and lack of access to regular medical review and supplies may make surgery the most 
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suitable first line of treatment in some countries. In these cases, surgeons may only get one 
attempt at controlling IOP without the ability to follow-up patients frequently (Thomas, 
Sekhar, & Kumar, 2004). 
Glaucoma surgery is aimed at increasing aqueous humour outflow by either shunting it 
into an alternative drainage location or increasing its flow through the normal pathway, and 
classified as either penetrating or non-penetrating. Penetrating procedures include 
trabeculectomy and the insertion of most glaucoma drainage devices (GDD). They involve 
making a direct connection between the anterior chamber and the subconjunctival space, 
Schlemm’s canal or suprachoroidal space (Figure 2.2). Additionally, with drainage into the 
subconjunctival space, an overlying conjunctival bleb is formed. The non-penetrating surgical 
procedures include deep sclerectomy, viscocanalostomy and viscocanaloplasty. With these 
procedures, the Schlemm’s canal is un-roofed to bypass the juxtacanalicular trabecular 
meshwork and inner wall of Schlemm’s canal (Mendrinos & Shaarawy, 2008). There is no 
direct connection between the anterior chamber and the Schlemm’s canal. Instead, they are 
separated by a thin remaining trabeculo-Descemet's membrane which provides enough 
outflow resistance to prevent post-operative hypotony. Additionally, no peripheral iridotomy 
is performed and there is no significant conjunctival bleb formation. Clinical studies have 
shown that, compared to trabeculectomy, these procedures are associated with lower risks of 
hypotony, shallow anterior chambers, hyphaema and cataract formation but the reduction in 
IOP is less, with IOP usually settling in the high teens (Chai & Loon, 2010; Cheng, Xi, Wei, 
Cai, & Li, 2010; Hondur, 2008). In the meta-analysis by Chai et al. (2010), IOP reduction 
was 3.6 mmHg less at 1 year and 3.4 mmHg less at 2 years than with trabeculectomies. 
Relative risks of hypotony, shallow anterior chambers, hyphaema and cataract formation 
were 0.29, 0.50, 0.19 and 0.31 respectively in relation to trabeculectomy. Additionally, the 
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procedures also have higher learning curves, particularly to avoid perforating the trabeculo-
Descemet’s membrane. 
Angle surgery is another category of procedures which is non-penetrating and includes 
trabeculotomy, goniotomy and the Trabectome procedure. The trabeculotomy and goniotomy 
procedures are less successful for adults but effective in congenital glaucoma cases (Luntz & 
Livingston, 1977; Mendicino et al., 2000; Alodhayb, Morales, Edward, & Abu-Amero, 
2013). The IOP reduction with the Trabectome is modest, with most settling in the mid to 
high teens (Maeda, Watanabe, & Ichikawa, 2013; Mosaed, Dustin, & Minckler, 2009). 
In this review, the emphasis is on penetrating surgery procedures due to their greater 
potential for IOP reductions. We classify these interventions in terms of the target site for 
drainage, whether into the subconjunctival space, Schlemm’s canal or suprachoroidal space. 
This classification is used because these target sites essentially control the resistance 
characteristics of the operation or device, as will be discussed in section 2.6. 
  
36 
 
 
Figure 2.2 Schematic diagram showing the subconjunctival (grey), Schlemm’s canal 
(yellow) and suprachoroidal (red) spaces for alternative aqueous humour drainage. 
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Ciliary body and muscle 
Schlemm’s canal 
Cornea 
Lens 
Choroid 
Iris 
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2.4 Subconjunctival space drainage 
The subconjunctival space is located between the outer sclera and overlying 
conjunctiva (Figure 2.2). During surgery, a passage is created for aqueous humour to drain 
from the anterior chamber into this space. This leads to the formation of a subconjunctival 
bleb. In the following discussion, we describe the trabeculectomy and glaucoma drainage 
devices separately, as one involves the creation of a biological valve from eye tissue and the 
other an implantation of a mechanical device. 
 
2.4.1 Trabeculectomy 
A trabeculectomy involves the creation of a guarded drainage channel in the sclera, 
through which aqueous humour can flow out of the eye into a subconjunctival bleb in a 
controlled manner, thereby reducing the IOP (Figure 2.3). This procedure was developed 
because previous procedures such as iridencleisis, trephination and Scheie’s procedure were 
full thickness (non-guarded) and nearly always led to post-operative hypotony and cataract 
(Elliot, 1909; Scheie, 1958; Spaeth, Joseph, & Fernandes, 1975; Razeghinejad & Spaeth, 
2011). Since its description in 1968 (Cairns, 1968; Watson & Barnett, 1975), small variations 
in technique have been described, including different conjunctival incision sites (Shuster, 
Krupin, Kolker, & Becker, 1984; Jones, Clarke, & Khaw, 2005), scleral flap shapes and sizes 
(Clemente, 1980; Vernon, Gorman, & Zambarakji, 1998; Edmunds, Thompson, Salmon, & 
Wormald, 2001; Dhingra & Khaw, 2009), methods to create sclerostomies (Dellaporta, 1975; 
Dhingra et al., 2009), the use of anti-fibrotic agents (Khaw et al., 2001; Wong et al., 2009c) 
and the use of adjustable or releasable suture techniques (Wells, Bunce, & Khaw, 2004; de 
Barros, Gheith, Siam, & Katz, 2008). The effect of some of these variables will be tested and 
described in more detail in Chapters 3 and 4. A typical technique, the Moorfields Safer 
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a) 
 
b) 
 
c) 
 
Figure 2.3 a) Schematic diagram of trabeculectomy showing the direction of aqueous 
humour outflow (broken arrow). b) Schematic diagram of trabeculectomy scleral flap. The 
conjunctival layer and bleb are not shown. Black arrows show aqueous humour outflow 
under the conjunctival bleb. c) Intra-operative photograph of trabeculectomy scleral flap. 
Scleral flap 
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Surgery System (Jones et al., 2005; Dhingra et al., 2009; Khaw et al., 2012) is described in 
more detail below. 
In this system, a corneal traction suture is inserted with a spatulated 7/0 silk suture on a 
curved needle. This is better than placing a superior rectus suture which may cause superior 
rectus haematoma, globe perforation, subconjunctival haemorrhage, post-operative ptosis, 
and lesser treatment success (Edmunds, Bunce, Thompson, Salmon, & Wormald, 2004; 
Grehn et al., 2007). A conjunctival incision between 6-8 mm long is then made, preferably in 
the superior half to reduce the risk of subconjunctival haemorrhage, dysaesthesia, 
inflammation and endophthalmitis (Wells, Marks, & Khaw, 2005; Budenz, Hoffman, & 
Zacchei, 2001; Wolner et al., 1991). A fornix-based conjunctival incision is preferred as it is 
easier and faster to perform, allows good exposure of the surgical site, easier for re-operations 
when there is extensive scarring, and leads to more diffuse and less cystic blebs (Wells, 
Cordeiro, Bunce, & Khaw, 2003; Alwitry, Patel, & King, 2005; Fukuchi et al., 2006). 
However, there may be a higher risk of wound leakage with this type of incision and it is 
important to handle tissue gently, such as with the use of non-crushing conjunctival clamps. 
Following a generous dissection of Tenon’s capsule with blunt scissors, haemostasis needs to 
be achieved with the minimum amount of wet-field diathermy. The correct creation of a 
partial-thickness (around 0.25 mm thick) scleral flap measuring 3-4 mm long and 4-5 mm 
wide is important as the flap provides the main resistance to aqueous humour outflow and 
hypotony in the early post-operative period (Birchall, Wakely, & Wells, 2006; Birchall, 
Bedggood, & Wells, 2007; Tse et al., 2012). The sides are not extended to the limbus as this 
helps to promote more posterior aqueous humour flow which is associated with larger and 
more diffuse blebs, less scarring and inflammation, and less hypotony (Birchall et al., 2006). 
Thinner flaps are avoided as they may lead to tears, dehiscence and cheese-wiring, all of 
which lead to reduced flap resistance and hypotony. Anti-fibrotics such as 5-fluorouracil 
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(5FU) 5% or Mitomycin C (MMC) 0.02-0.05% are applied under the conjunctiva and scleral 
flap with polyvinyl alcohol (PVA) sponges for 3 minutes in patients with high-risk of 
scarring and complications such as neovascular or inflammatory glaucoma, previous failed 
surgery, aphakia, and Afro-Caribbean descent. It is important to note that anti-metabolite 
application improve trabeculectomy outcomes but may also increase the risks of bleb 
leakage, hypotony and infection (Fluorouracil Filtering Surgery Study Group, 1996; Cheung, 
Wright, Murali, & Pederson, 1997; Khaw, 2001; Wilkins, Indar, & Wormald, 2005). 
Irrigation with at least 20 ml of Balanced Salt Solution (BSS) is needed to remove excess 
5FU or MMC after the 3 minutes. A cannula is inserted into the anterior chamber via a 
paracentesis, and a balanced salt solution (BSS) infusion is started to prevent fluctuation in 
anterior chamber pressure and reduce the risk of suprachoroidal haemorrhage and further 
optic nerve compromise (Stalmans, 2006). The infusion rate is varied by positioning the 
infusion bottle at different levels above the patient’s eye. A small part of the sclera and 
trabecular meshwork is then excised with a punch to make a standardised opening of 0.5 mm 
diameter for aqueous humour to flow under the scleral flap and into the subconjunctival 
space. Using a blade and scissors to create this sclerostomy is also possible but this may 
create a larger and irregular ostium with higher attendant risk of hypotony. A peripheral 
iridectomy is created to prevent pupillary block by incising a section of presenting iris 
horizontally. This iridectomy is placed at the 12 o’clock position so that it is hidden under the 
upper lid to prevent glare and diplopia. The partial-thickness scleral flap is preferably sutured 
down with adjustable or releasable sutures (Wells et al., 2004; de Barros et al., 2008), or 
alternatively with interrupted sutures which can be removed by laser lysis post-operatively 
(Melamed, Ashkenazi, Glovinski, & Blumenthal, 1990). Tight sutures are preferable as they 
prevent overfiltration from the scleral flap in the early post-operative period. The tightness of 
these sutures is adjusted according to the fluid flow from the infusion into the anterior 
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chamber. Finally, watertight closure of the conjunctival layer is performed with either purse-
string or mattress sutures, with the knots tucked into corneal grooves. Round-bodied needles 
assist in the prevention of conjunctival tears and wound leaks. Post-operatively, suture 
adjustment can be performed from two weeks to a few months to titrate aqueous humour flow 
and IOP as needed. 
 
2.4.1.1  Changes to the trabecular aqueous humour outflow pathway after 
trabeculectomy surgery 
These changes include accumulation of extracellular material in the trabecular 
meshwork adjacent to the inner wall of Schlemm’s canal (Lutjen-Drecoll & Barany, 1974) 
and decrease in diameter of Schlemm’s canal (Johnson & Matsumoto, 2000), both seen from 
electron microscopy. As these changes were more obvious with clinically successful surgery 
(high facility of flow or presence of blebs and low IOP in the clinical history), the findings 
were attributed to lower aqueous humour flow through the trabecular meshwork as a result of 
the bypass. Changes to the uveoscleral pathway after trabeculectomy surgery have not been 
reported. However, uveoscleral outflow may increase if there is inflammation (Toris & 
Pederson, 1987), cyclodialysis (Toris & Pederson, 1985) or choroidal detachment (Joo, Ko, 
& Choe, 1989; Pederson, Gaasterland, & MacLellan, 1979). 
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2.4.1.2 Post-operative hypotony 
There are many varied definitions of hypotony (Seah et al., 1995; Schubert, 1996; 
Rahman, Mendonca, Simmons, & Simmons, 2000; Costa & Arcieri, 2007), and one is low 
pressure (+/- 5 mmHg) [whether acute, transient, chronic or permanent] in an individual eye, 
leading to functional [whether asymptomatic or symptomatic] and structural changes 
[whether reversible or irreversible] (Schubert, 1996). The associated structural and functional 
changes include corneal oedema, shallow anterior chambers, cataracts, choroidal effusion, 
chorioretinal folds, papilloedema, maculopathy, visual loss and metamorphopsia (Costa et al., 
2007). Additionally, hypotony may result in around 20% lower 5-year survival rates (Benson, 
Mandal, Bunce, & Fraser, 2005), thought to be due to reduced aqueous humour flow into the 
bleb and a relative increase in inflammatory mediators thus causing increased fibrosis. The 
occurrence rate of hypotony was higher when full thickness surgery was performed (17-74%) 
but reduced after the introduction of the guarded trabeculectomy procedure (10-23%) (Spaeth 
et al., 1975; Lamping, Bellows, Hutchinson, & Afran, 1986; Blondeau & Phelps, 1981). 
Younger age and myopia are risk factors for this condition, attributed to the reduced scleral 
rigidity in these conditions (Seah et al., 1995). 
The possible causes of hypotony can be separated into early and late ones (Rahman et 
al., 2000; Benson et al., 2005). In the early stage, these are decreased aqueous humour 
production, increased uveoscleral outflow, overfiltration and wound leakage. Decreased 
aqueous humour production may be caused by post-operative ciliary body shutdown, which 
is associated with ocular inflammation (Toris et al., 1987) and the use of MMC (Nuyts et al., 
1994; Gandolfi, Vecchi, & Braccio, 1995). Increased uveoscleral flow is caused by 
inflammation (Toris et al., 1987) cyclodialysis (Toris et al., 1985) and choroidal detachment 
(Joo et al., 1989; Pederson et al., 1979). Cyclodialysis is closely related to choroidal 
detachment, it occurs when the ciliary body detaches from the scleral spur after inadvertent 
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trauma during surgery, allowing aqueous humour into the suprachoroidal space. Early 
overfiltration occurs when there is too much aqueous humour flow passing under the scleral 
flap into the subconjunctival space, usually a result of inadequate or loose suture closure. 
Wound leakage occurs when there is inadequate closure or holes in the conjunctival layer. 
Other causes of early hypotony also include retinal detachment and globe perforation. In the 
late stage, cyclitic membranes can occur with inflammation and cover the ciliary body, which 
results in reduced aqueous humour production (Rahman et al., 2000). Overfiltration from an 
over-functioning bleb and leakage either through the bleb or wound dehiscence may also 
occur, particularly with the use of intra-operative MMC and 5FU (Shields, Scroggs, Sloop, & 
Simmons, 1993; Seah et al., 1995; Sihota et al., 2000). 
Prevention of reduced aqueous humour production can be done by pre-operative steroid 
treatment in inflammatory cases (Rahman et al., 2000). For prevention of early overfiltration, 
placing tight scleral flap sutures which can be either adjusted, released, or removed by laser 
can limit the initial flow of aqueous humour (Wells et al., 2004; de Barros et al., 2008; 
Melamed et al., 1990). Meticulous suturing of the conjunctiva reduces the risk of wound 
leakage (Jones et al., 2005). Some cases of hypotony may be transient and need no treatment, 
but treatment may be necessary if it persists for more than 4-8 weeks to avoid permanent 
vision loss, particularly if maculopathy is present (Seah et al., 1995; Costa et al., 2007). To 
increase aqueous humour production, steroids may be needed to suppress inflammation of the 
ciliary body (Rahman et al., 2000). Cyclodialysis may need cycloplegia (whilst avoiding 
steroids), diathermy or laser treatment (Burchfield & Kolker, 1995), or cyclopexy (Spiegel, 
Katz, & McNamara, 1990) for it to close although choroidal detachment on its own is usually 
self-limiting (Pederson et al., 1979). Overfiltration can be treated with scleral flap re-suturing 
(Schwartz et al., 1996), a Simmons scleral shell (Simmons & Kimbrough, 1979), argon laser 
to shrink overly large blebs (Fink, Boys-Smith, & Brear, 1986) and injection of autologous 
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blood into blebs (Wise, 1993). Bleb leakage can be treated by using aqueous humour 
suppressants to reduce flow through the bleb (Costa et al., 2007), a Simmons scleral shell or 
symblepharon ring (Ruderman & Allen, 1985; Melamed, Hersh, Kersten, Lee, & Epstein, 
1986; Hill, Aminlari, Sassani, & Michalski, 1990), a contact lens or shield (Blok, Kok, van 
Mil, Greve, & Kijlstra, 1990; Fourman & Wiley, 1989), topical gentamycin to stimulate 
wound healing (Tomlinson, Belcher, III, Smith, & Simmons, 1987), fibrin glue (Kajiwara, 
1990), autologous blood injections (Wise, 1993; Smith, Magauran, III, Betchkal, & Doyle, 
1995), conjunctival compression sutures to reduce leakage (Palmberg, 1996) or suturing 
donor scleral patches over areas of scleral maceration (Harizman, Ben Cnaan, Goldenfeld, 
Levkovitch-Verbin, & Melamed, 2005). 
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2.4.1.3 IOP outcomes and complications of trabeculectomy 
Table 2.2 lists the IOP outcomes in recent trabeculectomy studies. The final reduction 
in IOP is 40-51% of the pre-operative value and it settles around 10-15 mmHg. Note that the 
majority of the studies involved the use of 5FU and MMC. Table 2.3 lists the commonest 
complications in the studies. It can be seen that most of the early complications are related to 
hypotony, including shallow anterior chambers (AC), choroidal effusion or detachment, 
maculopathy and cataracts, while bleb-related complications such as bleb leakage, infection 
and encapsulation are more common in the later period. Other reports also support this 
observation (Kangas, Greenfield, Flynn, Jr., Parrish, & Palmberg, 1997; DeBry, Perkins, 
Heatley, Kaufman, & Brumback, 2002). Overall, the findings highlight the fact that 
trabeculectomies still have only moderate long term results and a high risk profile, especially 
with the increased usage of anti-fibrotics. One main challenge is to eliminate early post-
operative hypotony but yet still maintain enough aqueous humour drainage for satisfactory 
IOP reduction. It is here that the knowledge of pressure and flow control becomes important 
in trying to achieve the desired outcomes of this challenge. 
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Table 2.2 IOP outcomes after trabeculectomy in recent studies. 
Authors Follow-up 
(months) 
Anti-fibrotic Baseline mean 
IOP (mmHg) 
Final mean IOP 
(mmHg) 
Reduction 
in IOP (%) 
Notes 
(Wong et al., 2013) 96 5FU 24.4 13.7 43.9 Singapore 5FU trial, RCT 
 
(Gedde et al., 2012b) 60 MMC 25.6 12.6 50.8 Tube vs Trabeculectomy Study, RCT 
 
(Shah, Agrawal, Khaw, 
Shafi, & Sii, 2012) 
48.6 MMC 33.7 13.1 41.1 ReGAE, Afro-Caribbean, prospective 
(Lusthaus, Kubay, Karim, 
Wechsler, & Booth, 2010) 
24 MMC 25.3 14.0 44.7  
(Tran et al., 2009) 60 MMC 22.0 11.1 49.5 Trabeculectomy vs Ahmed Glaucoma 
Valve, retrospective 
(Law, Shih, Tran, Coleman, 
& Caprioli, 2009) 
36 MMC 18.8 10.3 45.2 Initial vs repeat trabeculectomy study, 
retrospective 
(Bevin, Molteno, & 
Herbison, 2008) 
> 60 MMC/ 5FU 
(in 2% of 
cases) 
24.9 14.8 (60 months) 40.6 Otago Glaucoma Surgery Outcome Study, 
prospective 
(Stalmans, 2006) 16  21.2 12.8 39.6 Moorfields Safer Surgery System, 
retrospective 
(Edmunds et al., 2001) 12 5FU, MMC 26.2 14.4 45.0 UK National Survey of Trabeculectomy 
(Lichter et al., 2001) 60 MMC, 5FU 27 14-15 46.3 CIGTS, RCT 
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Table 2.3 List of common complications after trabeculectomy surgery in recent studies (early - < 4-6 weeks, late - > 4-6 weeks). 
Authors Anti-fibrotic Hypotony Shallow AC Choroidal effusion/ 
detachment 
Wound 
leakage 
Hypotony 
maculopathy 
(Gedde et al., 
2012a) 
MMC  10% (early), 0% 
(late) 
13% (early), 4% (late) 11% (early) 5%  (late) 
(Jampel et al., 
2012) 
MMC/ 5FU 20% (total), 10% 
(late) 
    
(Shah et al., 2012) MMC 10.6% (early), 0% 
(late) 
 14.9% (early) 8.5% (early) 0% 
(Lusthaus et al., 
2010) 
MMC 55% (early), 3.3% 
(late) 
56.7% (early), 1.7% 
(late) 
   
(Wong et al., 
2009) 
5FU  7% 
 
9% (early)  0% 
(Tran et al., 2009) MMC 59% (early), 16% 
(late) 
 10% (early)   
(Law et al., 2009) MMC 40% (early), 21% 
(late) 
5% 
 
1% 1% 4% 
(Bevin et al., 2008) MMC/ 5FU (in 2% of 
cases) 
39% (early) 14% (early) 12% (early)   
(Stalmans, 2006)    8.9% (early)   
(Jampel et al., 
2005) 
MMC, 5FU 0.9% (early) 13% (early) 11% (early) 6% (early)  
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(Continued) Table 2.3 List of common complications after trabeculectomy surgery in recent studies (early - < 4-6 weeks, late - > 6 weeks). 
Authors Anti-fibrotic Cataract 
progression 
Bleb 
leakage 
Blebitis/ 
endophthalmitis 
Other 
(Gedde et al., 
2012a) 
 
MMC  6% (late) 5% (late) Hyphaema 8% (early), suprachoroidal haemorrhage 3%, 
malignant glaucoma 1% (early), bleb encapsulation 6% (late) 
(Jampel et al., 
2012) 
 
MMC/ 5FU 55% 5.2% (late) 0.4% (early), 3.5% 
(late) 
Oversized bleb 3.5% 
(Shah et al., 
2012) 
 
MMC  2.1% 0% Hyphaema 4.3% (early), suprachoroidal haemorrhage 0% 
(Lusthaus et al., 
2010) 
 
MMC 1.7% (early), 1.7% 
(late) 
1.7% 
(early) 
0%  
(Wong et al., 
2009) 
5FU 50% 13% 0% Oversized bleb 5%, uveitis 14% 
(Tran et al., 
2009) 
 
MMC 13%   Hyphaema 4.5% (early) 
(Law et al., 
2009) 
MMC   3% Hyphaema 25% 
(Bevin et al., 
2008) 
 
MMC/ 5FU (in 2% 
of cases) 
   Hyphaema 27% (early) 
(Stalmans, 2006) 
 
   1.5% (early) Hyphaema 5.4%, malignant glaucoma 1.5%, bleb encapsulation 
14.3% 
(Jampel et al., 
2005) 
MMC, 5FU   0% Hyphaema 10% (early), suprachoroidal haemorrhage 0.7%, 
bleb encapsulation 12% 
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2.4.2 Subconjunctival space GDD 
More recently, glaucoma drainage devices have evolved from being a second or 
third line surgical treatment for glaucoma to being proposed as first line surgical 
treatment. The Tube Versus Trabeculectomy (TVT) study is a randomised controlled 
trial to look at the differences between trabeculectomy with MMC (0.4 mg/ml for 4 
minutes) and a Baerveldt 350 mm
2
 device (Gedde et al., 2012b; Gedde et al., 2012a). 
Patients 18 to 85 years of age who had previous trabeculectomy and/or cataract 
extraction with intraocular lens implantation and uncontrolled glaucoma with IOP ≥ 18 
mmHg and ≤ 40 mmHg on maximum tolerated medical therapy were included. From 
the total of 212 eyes, 107 were in the tube group and 105 were in the trabeculectomy 
group. At 5 years, IOP was 14.4 mmHg in the tube group and 12.6 mmHg in the 
trabeculectomy group, although this difference was not statistically significant. The 
number of glaucoma medications was 1.4 in the tube group and 1.2 in the 
trabeculectomy group, again the difference was not statistically significant. The 
cumulative probability of failure (IOP > 21 mmHg or not reduced by 20%, IOP ≤ 5 
mmHg, reoperation for glaucoma, or loss of light perception vision) was significantly 
higher in the trabeculectomy group (46.9% versus 29.8%; mainly due to inadequate IOP 
control but persistent hypotony was a larger component in the trabeculectomy group). 
The rate of re-operation for glaucoma (including suture lysis and post-operative 5FU 
injections) was significantly higher in the trabeculectomy group (29% versus 9%). Early 
post-operative complications were more common in the trabeculectomy group (37% 
versus 21%), mainly due to hyphaema and wound leaks in this group; hypotony related 
complications were similar between the groups. Late post-operative complications were 
similar in both groups (34% in the tube group, 36% in the trabeculectomy group; 
although choroidal effusion and hypotony maculopathy were more common in the 
trabeculectomy group), as was the rate of re-operation for complications (22% in the 
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tube group, 18% in the trabeculectomy group) and the rate of cataract extraction (54% 
in the tube group, 43% in the trabeculectomy group). The authors concluded that tube 
shunt surgery had a higher success rate compared to trabeculectomy with MMC. Both 
procedures were associated with similar IOP reduction and use of supplemental medical 
therapy but additional glaucoma surgery was needed more frequently after 
trabeculectomy with MMC. Surgical complications were common but most were 
transient and self-limiting. Although the rate of early post-operative complications was 
higher following trabeculectomy, the rates of late post-operative complications, re-
operation for complications, and cataract extraction were similar with both surgical 
procedures. 
The results of this study have attracted much discussion about its limitations 
(Caprioli, 2011; Singh & Gedde, 2011; Gross, 2012). Among them include that when 
the success rate was defined as < 14 mm Hg, there was no statistically significant 
difference between the groups. MMC dosage with trabeculectomy evolved during the 
time of the study, and lower dosages and durations used currently may result in less 
failure due to hypotony. The larger number of early post-operative complications in the 
trabeculectomy group comprised mainly of hyphaema and wound leaks, which were 
transient and self-limiting; serious complications requiring re-operation or loss of ≥ 2 
lines of vision were similar between the groups. The findings are also limited to the 
Baerveldt device and not others like the Ahmed or Molteno ones. Comparison between 
Baerveldt and Ahmed devices will be discussed subsequently. Finally, this TVT study 
involved treatment of eyes with previous operations, in which device insertions are 
relatively well-established; results of trabeculectomy in un-operated eyes may be better. 
To conclude, the findings of the TVT study cannot be extrapolated to all 
trabeculectomies, all tubes, and all glaucoma patients. The relative merits of 
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trabeculectomy and glaucoma drainage device surgery should be considered 
individually for each patient in selecting the optimal glaucoma operation. 
 
The first glaucoma drainage devices were reported in the early 1900s and 
employed horse hair and silk thread to drain the anterior chamber (Rollett & Moreau, 
1907; Zorab, 1912; Lim, 1998). Subsequent attempts used various other materials, such 
as gold, platinum, tantalum and polyethylene but their long-term success was also 
limited (Stefansson, 1925; Row, 1934; Bick, 1949; Bietti, 1955). Most failed due to scar 
formation or seton migration and exposure. In 1969, Molteno described using a 1.0 mm 
long translimbal acrylic tube attached to an acrylic plate 8.5 mm in diameter and 
suturing the device to the sclera just beyond the limbus (Molteno, 1969). This device 
was intended to promote the formation of a juxtalimbal bleb and was then removed after 
a few months. The complications resulting from this procedure included uveitis, corneal 
irritation and discomfort due to the close proximity to the limbus. It was later modified 
to have a longer tube and its explant positioned at the equatorial region of the eye 
(Molteno, Straughan, & Ancker, 1976). Many of the currently available glaucoma 
drainage devices are still based on this concept of a long silicone tube of around 300 µm 
inner diameter connecting the anterior chamber (or vitreous cavity in the case of pars 
plana insertion) to a large explant or end-plate placed 9-10 mm posterior to the limbus. 
The explant would prevent conjunctival adhesion and develop an overlying 
fibrovascular capsule after 4-6 weeks. Once formed, all aqueous humour flow will be 
into this capsule before being absorbed by capillaries and lymphatic vessels in the 
lining. This capsule would provide the primary resistance to aqueous humour flow after 
its completion (Minckler, Shammas, Wilcox, & Ogden, 1987). 
The earliest devices did not offer resistance to aqueous humour outflow, which 
resulted in a significant number of cases developing early post-operative hypotony, flat 
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anterior chambers and choroidal effusions. Subsequently, valved designs were 
introduced to reduce their occurrences. The first to offer a valve to limit overdrainage 
was the Krupin device (Krupin, 1976). This was followed later, among others, by the 
Ahmed Glaucoma Valve in 1993 (Lim, 1998). With the current non-valved devices, 
surgeons routinely restrict flow through them for 3-4 weeks after insertion, using 
external absorbable ligatures (Molteno, Polkinghorne, & Bowbyes, 1986) or internal 
removable suture stents (Egbert & Lieberman, 1989). Some early flow of aqueous 
humour to the outside of the eye is permitted by fenestrating the silicone tubes with a 
suture needle proximal to the ligation or occlusion site (Sherwood & Smith, 1993). 
Alternatively, some surgeons perform a 2-stage insertion where the device is sutured at 
its equatorial position but not connected to the anterior chamber. After about 6 weeks, 
when the fibrous capsule has developed then only is the tube inserted into the anterior 
chamber. During the time between both stages, either medical therapy or an ‘orphan’ 
trabeculectomy is used for IOP control (Molteno et al., 1986; Shaarawy, Sherwood, 
Hitchings, & Crowston, 2009). 
Another major design modification was the increase in surface area of the explant 
to enhance the reduction in IOP. The double-plate Molteno implant was introduced in 
1981 and this was followed by the Baerveldt device in 1992 which initially came in 
sizes of up to 500 mm
2
. One study found that double-plate Molteno implants lowered 
IOP more than single-plate ones (Heuer et al., 1992). However, one Baerveldt study 
later showed that the 350 mm
2 
device had a higher success rate when compared to the 
500 mm
2
 one (Britt et al., 1999). The current belief is that beyond an optimal size, any 
further increase in surface area might only be disadvantageous. Sizes between 250-350 
mm
2
 appear to offer the best trade-offs between IOP control and hypotony. In Table 2.4, 
we list the dimensions and materials of glaucoma drainage devices. 
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Table 2.4 Summary of glaucoma drainage devices and trabeculectomy. 
Device Drainage 
site 
External dimensions Explant surface 
area (mm
2
) 
Explant 
material 
Valve Tube material 
(inner/ outer diameter) 
Trabeculectomy A Width 4 mm, length 3 mm (typical 
values but highly variable) 
 
Variable bleb 
size 
NA Y (scleral 
flap) 
NA 
Ahmed Glaucoma 
Valve 
A Width 13 mm (184 mm
2
), length 16 mm 
(184 mm
2
), plate thickness 0.9 mm 
(silicone), 1.9 mm (polypropylene) 
 
96, 184, 364 Silicone/ 
Polypropylene 
Y Silicone (300 µm, 640 µm) 
Molteno A Circumferential diameter 13 mm (135 
mm
2
), plate thickness 1.65 mm 
 
135, 270 Polypropylene N Silicone (340 µm, 640 µm) 
Molteno 3 A Width 15 mm, length 16 mm (175 
mm
2
), plate thickness 1.5 mm 
 
175, 230 Silicone N Silicone (340 µm, 640 µm) 
Baerveldt A Width 22 mm (250 mm
2
), 32 mm (350 
mm
2
), length 13 mm, plate thickness 
0.84 mm 
 
250, 350 Silicone 
(barium-
impregnated) 
N Silicone (300 µm, 640 µm) 
ExPress A Length 2.64 mm (P50, P200), 2.96 mm 
(R50) 
 
NA NA N Stainless steel (50 µm [P50, R50] 
or 200 µm [P200], 380 µm) 
MIDI-Arrow 
 
A Length 8.5 mm NA NA N SIBS (70 μm inner diameter) 
AqueSys A Length 6 mm NA NA N Gelatine (50 µm inner diameter) 
A – subconjunctival space, B – Schlemm’s canal, C – suprachoroidal space, NA – not applicable/ not available, Y – yes, N – no 
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(Continued) Table 2.4 Summary of glaucoma drainage devices and trabeculectomy. 
Device Drainage 
site 
External dimensions Explant surface 
area (mm
2
) 
Explant 
material 
Valve Tube material 
(inner/ outer diameter) 
Schocket A Width 4 mm (#20 band), 6 mm (#220 
band), circumferential diameter 24 
mm (at equator) 
 
300 (#20 band), 
450 (#220 band) 
Silicone N Silicone (NA) 
Krupin A Width 18 mm, length 13 mm, plate 
thickness 1.75 mm 
 
180 Silicone Y Silicone (300 µm, 640 µm) 
Optimed A Width 10 mm, length 14 mm, plate 
thickness 1.3 mm 
 
140 PMMA Y Silicone (380 µm, 760 µm) 
iStent B Length 1 mm (body), 250 µm 
(snorkel) [GTS100], length 360 μm 
[GTS400] 
 
NA Titanium N (120 µm, 180 µm) [GTS100] 
(230 μm outer diameter) 
[GTS400] 
Hydrus 
 
B Length 15 mm NA Nitinol N NA 
Gold Micro Shunt C Width 3.2 mm, length 5.2 mm, plate 
thickness 44 or 68 µm 
 
NA Gold (24-karat) N (9-19 × 24-40 µm high, 50 µm 
wide microchannels) 
CyPass 
 
C Length 6.35 mm NA Polyimide N (300 µm, 510 µm) 
Aquashunt C Width 4 mm, length 10 mm, plate 
thickness 0.75 mm 
NA Polypropylene N NA 
A – subconjunctival space, B – Schlemm’s canal, C – suprachoroidal space, NA – not applicable/ not available, Y – yes, N - no
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The Ahmed Glaucoma Valve consists of an explant with a trapezoid-shaped 
chamber which encloses a folded silastic sheet valve (Figure 2.4). The explants were 
first made of polypropylene but lower profile silicone ones were later introduced. These 
have been shown to provide better IOP reduction and fewer Tenon's cysts, attributed to 
the change in material and height (Ishida et al., 2006; Mackenzie, Schertzer, & Isbister, 
2007). The manufacturer claims that the valve chamber design creates a Bernoulli’s 
principle effect, although this has been refuted and the effect considered negligible (Lee, 
1998). The valve is said to open at 8 mmHg or higher to prevent hypotony and works on 
the principle that pressure exerted by viscous forces controls its opening. However, 
there is variability in valve performance between individual devices, with each having 
different sensitivities of their response (Prata, Jr., Mermoud, LaBree, & Minckler, 1995; 
Moss, 2008) and this is likely to be due to the lack of consistency in manufacture. 
Finally, this valve was also claimed to become superfluous after a fibrovascular capsule 
had formed over the explant. However, subsequent studies showed that it added to the 
total resistance to aqueous humour flow and could get obstructed in the presence of 
excess anterior chamber inflammation and fibrin formation (Pan, 2002; Brown, Pan, & 
Ziaie, 2003). 
Latest developments to the device include encasing in a polyethylene shell with 
pores to allow tissue integration and vascular ingrowth that gives resistance to infection, 
exposure, extrusion, and mechanical deformation (Kim et al., 2013). The 1-year report 
showed similar reductions in IOP and success rates compared to silicone and 
polypropylene devices. The long term results have not been reported however. 
Preliminary work is also being done on biodegradable sheets for the valve, designed to 
degrade at around 6 weeks when the hypertensive phase, which signifies device 
encapsulation, develops (Luong et al., 2013). Implantation in a small number of rabbits 
showed a more stable IOP profile during the first 12 weeks (signifying avoidance of the 
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hypertensive phase) after surgery and less collagen deposition around the device as 
compared to a ‘normal’ silicone Ahmed Glaucoma Valve. 
 
a) 
 
b) 
 
Figure 2.4 a) Photograph of Ahmed Glaucoma Valve (scale bar = 5 mm). b) Schematic 
cross-section diagram of the resistance mechanism (adapted from Lim (1998)). The 
valve sheets are said to separate at 8 mmHg or higher. 
  
Valve chamber 
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Conjunctiva 
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The Molteno devices include the single plate, double plate and Molteno 3 (Figure 
2.5a). The double plate Molteno increases the effective surface area of a single plate 
from 135 mm
2
 to 270 mm
2
. The single and double plate devices are available with a 
pressure ridge design intended to reduce post-operative hypotony (Freedman, 1992). 
Aqueous humour would flow into the explant which is constrained by overlying 
conjunctival apposition. When IOP is sufficiently high, the conjunctiva will be lifted 
and then only can aqueous humour enter the surrounding bleb. However, one study 
reported that this effect was unpredictable (Gerber, Cantor, & Sponsel, 1997). 
In a randomised controlled trial that compared the single-plate Molteno device 
with the silicone Ahmed Glaucoma Valve in 92 patients with refractory glaucoma 
(Nassiri et al., 2010), the decrease in IOP at two years was significantly higher with the 
Molteno (49.7%) than with the Ahmed devices (41.9%), but the number of glaucoma 
medications were not significantly different (1.41 for Molteno, 1.03 for Ahmed). Visual 
field deterioration was also similar between the groups. The rate of surgical failure (IOP 
> 21 mmHg, IOP < 5 mmHg, phthisis bulbi, loss of light perception vision, removal of 
the implant, reoperation for glaucoma, or any devastating intra-operative or post-
operative complication) was similar at 16% for the Molteno and 18% for the Ahmed 
devices, all due to inadequate IOP reduction. Post-operative complications were 
comparable between the groups, with no reported cases of hypotony. However, one 
limitation of this study was that patients were removed from analysis at the time of 
failure, and mean IOP considering all the cases in each group was not reported (Gedde, 
Panarelli, Banitt, & Lee, 2013). 
The Molteno 3, introduced in 2007, is made of silicone, more flexible, has a lower 
profile and comes in larger 175 mm
2
 and 230 mm
2
 single plate surface area sizes. It is 
also claimed to have an improved flow-restricting mechanism, aqueous humour flows 
into the primary drainage area but is prevented from flowing into the secondary 
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drainage area by conjunctival apposition (Figure 2.5b) until the IOP is sufficiently high. 
In a recent study comparing 175 mm
2 
Molteno 3 and double plate Molteno (270 mm
2
) 
devices, the IOP and medication outcomes were similar at three years (13.9 mmHg with 
0.9 medications for the Molteno 3 versus 14. 5 mmHg with 0.7 medications for the 
double plate Molteno) (Thompson, Molteno, Bevin, & Herbison, 2013). Success rates 
were also similar between them at 79% each. Finally, post-operative hypotony rates 
were again similar at 35.6% with the Molteno 3 and 31.3% with the double plate 
Molteno, contributed mainly by cases which did not have initial tube restrictions. This 
final finding may also indicate a weakness in the claimed flow-restricting mechanism of 
the Molteno 3 device. 
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a) 
 
b) 
 
Figure 2.5 a) Photograph of Molteno 3 device (scale bar = 5 mm). b) Schematic cross-
section diagram of the device (adapted from Lim (1998)). Aqueous humour flow from 
the primary drainage area to the secondary drainage area is limited by overlying 
conjunctiva to prevent continuous drainage leading to hypotony. 
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The Baerveldt device (Figure 2.6) has a wing-shaped explant made of radio-
opaque barium-impregnated silicone and comes in 250 mm
2
 and 350 mm
2
 sizes. The 
larger surface area means that this device needs to be placed underneath 2 rectus 
muscles, leading to a higher profile of the bleb. An earlier 500 mm
2
 size was 
discontinued due to a higher risk of diplopia and a lower success rate (Lloyd et al., 
1994; Britt et al., 1999). The manufacturers subsequently improved on the original 
design by including fenestrations in the explant which enable fibrous tissue growth into 
the plate to reduce its height profile. 
The Ahmed Baerveldt Comparison (ABC) study is a randomised controlled trial 
comparing the silicone Ahmed Glaucoma Valve and Baerveldt 350 mm
2 
devices 
(Barton, Gedde, Budenz, Feuer, & Schiffman, 2011; Budenz et al., 2011; Gedde et al., 
2013). 276 patients with refractory glaucoma requiring tube shunt implantation were 
enrolled. At the end of 1 year, mean IOP was lower in the Baerveldt group (13.2 mmHg 
versus 15.4 mmHg) but the use of number of glaucoma medications was similar (1.5 for 
the Baerveldt versus 1.8 for the Ahmed devices). Failure (IOP > 21 mmHg or not 
reduced > 20% from baseline, IOP < 5 mmHg, additional glaucoma surgery, removal of 
the implant, or loss of light perception vision) rates were similar between the two 
groups (14% for the Baerveldt versus 16% for the Ahmed devices). Post-operative 
complications during the first 3 months after surgery, such as tube occlusion and 
corneal oedema, were more common with the Baerveldt device (58% versus 43%), as 
was the rate of serious complications leading to reoperation and/ or vision loss of two or 
more Snellen lines (34% for Baerveldt versus 20% for Ahmed devices). There was no 
statistically significant difference in the rate of late post-operative complications 
observed between the two devices (37% for Baerveldt versus 29% for Ahmed devices). 
The Ahmed Versus Baerveldt (AVB) Study group has reported longer term 
similarities and differences between the silicone Ahmed Glaucoma Valve and Baerveldt 
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350 mm
2 
devices (Christakis et al., 2013; Gedde et al., 2013). From the 238 patients 
with refractory glaucoma, half of them had secondary glaucoma and 37% had a 
previously failed trabeculectomy. The mean pre-operative IOP was 31.4 mmHg on 3.1 
glaucoma medications. At 3 years, the mean IOP was 15.7 mmHg in the Ahmed group 
and 14.4 mmHg in the Baerveldt group (reductions of 49% and 55% respectively) 
although the difference was not statistically significant. The use of medications was 
significantly higher in the Ahmed group (1.8) than in the Baerveldt group (1.1). The 
cumulative probability of failure (IOP > 18 mmHg or not reduced > 20% from baseline, 
IOP < 5 mmHg, vision-threatening complications, additional glaucoma procedures, or 
loss of light perception vision) was significantly higher in the Ahmed group (51% 
versus 34%). They had similar complication rates (52% for Ahmed group versus 62% 
for Baerveldt group) but the Baerveldt group had a higher rate of hypotony-related 
complications (6% versus 0%). The number of interventions was also not significantly 
different between them (38% for Ahmed group versus 50% for Baerveldt group). The 
authors concluded that both devices were effective in reducing IOP and glaucoma 
medications. The Baerveldt group had a lower failure rate and required fewer 
medications than the Ahmed group after 3 years, but it experienced more hypotony-
related vision-threatening complications. 
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a) 
 
b) 
 
Figure 2.6 a) Photograph of Baerveldt device (scale bar = 5 mm). b) Schematic cross-
section diagram of the device (adapted from Lim (1998)). 
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Table 2.5 lists the IOP outcomes in recent studies involving the above glaucoma 
drainage devices. The final IOP reduction with the majority of the devices is between 
40-50% of the pre-operative value, and it settles between 13-17 mmHg. The overall IOP 
control between devices appears similar. The complications related to hypotony and 
bleb formation are listed in Table 2.6. It is evident that with these glaucoma drainage 
devices, hypotony also occurs in significant numbers despite the incorporation of valve 
mechanisms and preventative measures such as initial restriction of the tubes. 
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Table 2.5 IOP outcomes after GDD surgery in recent studies. 
Authors Device Follow-up 
(months) 
Baseline mean 
IOP (mmHg) 
Final mean IOP 
(mmHg) 
Reduction 
in IOP (%) 
Notes 
(Budenz et al., 2011) Ahmed 12 31.2 15.4 50.6 Ahmed Baerveldt Comparison Study, RCT 
(Nassiri et al., 2010) Ahmed 24 33.0 15.4 53.3 Comparison between Ahmed Glaucoma 
Valve and single plate Molteno, RCT 
(Souza et al., 2007) Ahmed 60 30.4 15.9 47.7 Mixed glaucoma cases, retrospective 
(Wilson, Mendis, Smith, & 
Paliwal, 2000) 
Ahmed 10 25.7 17.2 33.1 Comparison between Ahmed Glaucoma 
Valve and trabeculectomy, RCT 
(Gedde et al., 2012b) Baerveldt 60 25.1 14.4 42.6 Tube vs Trabeculectomy Study, RCT 
(Budenz et al., 2011) Baerveldt 12 31.8 13.2 58.5 Ahmed Baerveldt Comparison Study, RCT 
(Thompson, Molteno, Bevin, & 
Herbison, 2013) 
Molteno 3 36 25.6 13.9 45.7 Comparison between Molteno 3 and 
double plate Molteno, retrospective 
(Nassiri et al., 2010) Molteno 24 30.8 17.0 44.8 Comparison between Ahmed Glaucoma 
Valve and single plate Molteno, RCT 
(Every, Molteno, Bevin, & 
Herbison, 2006) 
Molteno 36 40.1 21.9 45.4 Neovascular glaucoma, prospective 
(Molteno, Bevin, Herbison, & 
Houliston, 2001) 
Molteno 24 23.7 14.4 39.2 Prospective case series 
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Table 2.6 Incidences of hypotony and bleb-related complications after GDD surgery in recent studies (early - < 4-6 weeks, late - > 6 weeks). 
Authors Device Hypotony Shallow AC Choroidal effusion/ 
detachment 
Wound 
leakage 
Hypotony 
maculopathy 
(Budenz et al., 2011) 
 
 
Ahmed  19% (early), 3% 
(late) 
15% (early), 1% (late)  3% (early), 1% (late) 
(Nassiri et al., 2010) 
 
 
Ahmed  2.2% 4.3% 4.3% 0% 
(Souza et al., 2007) 
 
 
Ahmed 29% (early) 5% (early) 
 
5% (early)   
(Wilson, Mendis, Smith, & Paliwal, 
2000) 
 
Ahmed 36% (early) 20% (early) 10.9% (early) 1.8% (early)  
(Gedde et al., 2012a) 
 
 
Baerveldt  10% (early), 1% 
(late) 
14% (early), 2% (late) 1% (early) 1% (late) 
(Budenz et al., 2011) 
 
 
Baerveldt  20% (early), 4% 
(late) 
10% (early), 2% (late)  2% (early), 1% (late) 
(Thompson, Molteno, Bevin, & 
Herbison, 2013) 
 
Molteno 
3 
35.6% 
(early) 
6.9% (early) 
 
18.4% (early)   
(Nassiri et al., 2010) 
 
 
Molteno  4.3% 8.7% 4.3% 2.2% 
(Every et al., 2006) 
 
Molteno  31% (early) 
 
3% (early)   
(Molteno, Bevin, Herbison, & 
Houliston, 2001) 
Molteno  8% (early) 
 
15% (early)   
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(Continued) Table 2.6 Incidences of hypotony and bleb-related complications after GDD surgery in recent studies (early - < 4-6 weeks, late - > 6 
weeks). 
Authors Device Cataract 
progression 
Bleb 
leakage 
Endophthalmitis Other 
(Budenz et al., 2011) Ahmed 13%  0% Hyphaema 9% (early) 1% (late), suprachoroidal haemorrhage 
0% 
(Nassiri et al., 2010) 
 
Ahmed 10.9%   Hyphaema 6.5%, bleb encapsulation 28.3% 
(Souza et al., 2007) 
 
Ahmed 22% (late)   Hyphaema 12% (early) 
(Wilson, Mendis, Smith, & 
Paliwal, 2000) 
 
Ahmed 0%  0% Hyphaema 15% (early), suprachoroidal haemorrhage 0% 
(Gedde et al., 2012a) Baerveldt  0% 1% (late) Hyphaema 2% (early), suprachoroidal haemorrhage 2% 
(early), malignant glaucoma 3% (early), bleb encapsulation 
2% 
(Budenz et al., 2011) Baerveldt 20%  1% (early), 2% (late) Hyphaema 17% (early) 2% (late), suprachoroidal 
haemorrhage 2% (early) 0% (late) 
(Thompson, Molteno, Bevin, & 
Herbison, 2013) 
 
Molteno 3    Hyphaema 17% (early) 
(Nassiri et al., 2010) 
 
Molteno 17.4%   Hyphaema 4.3%, bleb encapsulation 23.9% 
(Every et al., 2006) 
 
Molteno    Hyphaema 65% (early) 
(Molteno, Bevin, Herbison, & 
Houliston, 2001) 
Molteno 17% (late)  0% Hyphaema 6% (early), suprachoroidal haemorrhage 0% 
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2.4.3 Other subconjunctival space GDD 
The ExPress (Figure 2.7) is a stainless steel, non-valved device that was first 
approved by the FDA in 2002 (Gandolfi et al., 2002). It has a different design concept to 
the previously described devices, being a straight tube with a disc-like flange at the 
subconjunctival space end and a spur-like projection at the anterior chamber end to prevent 
extrusion. There are currently 2 versions, the P50 and P200, the numbers signifying their 
internal diameters in μm. Both are 2.64 mm in length. A previous R50 model has been 
discontinued, and it had a 50 μm internal diameter and 2.96 mm length. This device was 
designed for ease of insertion and the elimination of a sclerostomy and iridectomy, thus 
reducing post-operative inflammation and fibrosis when compared to a trabeculectomy. 
In early cases, this device was implanted underneath bare conjunctiva but this 
resulted in complications such as hypotony, conjunctival erosion and endophthalmitis 
(Wamsley, Moster, Rai, Alvim, & Fontanarosa, 2004; Stewart, Diamond, Ashmore, & 
Ayyala, 2005; Rivier, Roy, & Mermoud, 2007). This implantation method was then 
changed to that under a trabeculectomy-style partial-thickness scleral flap (Dahan & 
Carmichael, 2005). In a subsequent retrospective study comparing 50 eyes with ExPress 
R50 devices and 50 eyes with trabeculectomies, IOP reduced from 26.2 mmHg to 13.7 
mmHg after 11 months in the ExPress group and from 25.5 mmHg to 12.9 mmHg in the 
trabeculectomy group (Maris, Ishida, & Netland, 2007). Early postoperative hypotony rates 
were significantly lower in the ExPress group (4% vs 32%). In another comparative study 
of 15 eyes each, mean IOP reduced from 28.1 mmHg to 15.7 mmHg after a mean of 23.6 
months in the ExPress P200 group and from 31.1 mmHg to 16.2 mmHg in the 
trabeculectomy group (Dahan, Ben Simon, & Lafuma, 2012). Complete success rates were 
significantly higher with the ExPress devices. Hypotony rates were also lower in this group 
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(7% vs 33%). One meta-analysis combined eight clinical trials and 605 eyes, and found the 
IOP reduction and success rates to be similar between the ExPress device and 
trabeculectomy (Wang, Zhou, Huang, & Zhang, 2013). However, the device was associated 
with significantly less hypotony and choroidal effusion than trabeculectomies, with pooled 
odds ratios of 0.29 and 0.65 respectively. Overall, current evidence does not support either 
superiority, equality or inferiority of this device over trabeculectomy surgery; however, the 
additional cost of the device itself should also be considered (Francis et al., 2011; Buys, 
2013). 
 
 
Figure 2.7 Scanning electron micrograph of ExPress P200 device (scale bar = 500 µm). 
The disc-like flange lies under the scleral flap in the subconjunctival space while the spur 
and labelled orifices lie in the anterior chamber. 
 
The AqueSys tube (or Aquecentesis procedure, Figure 2.8) has dimensions of 50 
μm internal diameter, 150 μm external diameter and 6 mm length. Made of cross-linked 
gelatine, it is claimed by the manufacturer to be soft, non-inflammatory and well-tolerated 
by the eye. This non-valved device is inserted using a specialised inserter via an ab interno 
(from the inside) approach to connect the anterior chamber and the subconjunctival space 
Main orifice 
Spur 
Flange Side orifice 
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without dissection or conjunctival disruption (Varma, Flynn, Marquis, Craven, & 
Bacharach, 2012). In a small study involving 15 patients, the mean pre-operative IOP of 
21.3 mmHg reduced to 12.2 mmHg at 1 week. It was subsequently maintained at 15.0 
mmHg at 1 month, 15.2 mmHg at 6 months and 15.3 mmHg at 12 months. The mean 
reduction in IOP was 9.1 mmHg at 1 week, 6.3 mmHg at 1 month, 6.5 mmHg at 6 months 
and 6.3 mmHg at 12 months (Kersten-Gomez & Dick, 2012). 
The Miami InnFocus Drainage Implant (MIDI)-Arrow device is a 8.5 mm long, 70 
μm internal diameter, 350 μm outer diameter, flexible non-valved tube made of 
poly(styrene-b-isobutylene-b-styrene) [SIBS]. This material is reported to be biostable and 
biocompatible, and can also be loaded with other pharmaceutical agents; it is also used to 
make coronary stents which can elute the anti-proliferative agent paclitaxel (Jim et al., 
2010). In a study in rabbits, this device was found to avoid hypotony and elicit less 
collagen deposition and myofibroblasts differentiation than 300 μm internal diameter 
silicone tubes (Acosta et al., 2006). It is inserted through a scleral tunnel 3 mm from the 
limbus into the anterior chamber, leaving its distal end lying directly under the conjunctiva. 
It has two external fins to prevent migration into the anterior chamber (Figure 2.9). In one 
small study of 28 human eyes, IOP fell from a baseline of 24.0 +/- 5.4 mmHg to 10.5 +/- 
2.8 mmHg at 12 months and maintained at 10.2 +/- 2.0 mmHg at 2 years. Complete and 
modified success rates were 91% and 96% at one year. Two subjects developed transient 
hypotony after day one but there were no cases of chronic hypotony or maculopathy 
(Palmberg et al., 2013). 
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Figure 2.8 a) Photograph of 6 mm long AqueSys tube beside an Ahmed Glaucoma Valve. 
b) Cross section of AqueSys tube on scanning electron micrograph (1000 × magnification). 
The lumen diameter is 50 μm. 
  
a 
b 
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Figure 2.9 Plan view of MIDI-Arrow device. The lumen diameter is 70 μm. 
 
It can be seen that the newer subconjunctival space glaucoma drainage devices i.e. 
the ExPress, AqueSys and MIDI-Arrow have non-valved, smaller inner diameter tube-
without-explant designs. The main idea behind them seems to be to simplify the method of 
insertion, reduce the amount of tissue manipulation needed during insertion, and reduce 
surgery time. However, data on their (the AqueSys and MIDI-Arrow devices in particular) 
control of IOP is still limited. A study on this design of tube devices and its control of IOP 
is presented in Chapter 5 of this thesis.  
5.0 mm 
1.2 mm 
0.35 mm 
 
Anterior chamber end 
8.5 mm 
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Certain devices appear to have fallen out of favour with current glaucoma surgeons. 
This is indicated by the substantial lack of peer-reviewed articles within the last 10-15 
years. Among others, they include the Schocket, Krupin and OptiMed implants. Problems 
with inferior success rates and higher complication rates seem to have made them less 
popular, as discussed below. These following devices are either rarely used nowadays or 
not in production anymore. 
The Schocket or anterior chamber tube shunt to encircling band (ACTSEB) procedure 
involves 2 silastic tubes normally used for nasolacrimal intubation (Figure 2.10a). The first 
tube is inserted in a globe-encircling manner under the recti muscles. The other tube, with 
one end in the anterior chamber, is tucked under this encircling band. Aqueous humour 
would drain into the capsule which forms and surrounds the band. In a modified Schocket 
procedure, a tube is inserted to connect the anterior chamber with a pre-existing retinal 
encircling band (Suh, Park, Kim, & Kim, 2007). Even though the procedure is lengthy, it is 
less expensive and its materials can be assembled in most operating rooms. Unfortunately, 
the success rate appeared less than that of other devices (Smith, Sherwood, & McGorray, 
1992; Wilson et al., 1992). The two-piece nature of its construction made it prone to fail 
due to blockage at the distal end of the tube. 
The Krupin device (Figure 2.10b) consisted of a silicone explant and tube. The 
explant plate incorporated a slit valve which was reported to open at 11 mmHg and close at 
8 mmHg (Krupin, 1976). The reported success rate for this device was less than with the 
Molteno device and it was also more likely to lead to hypotony compared to the Ahmed 
Glaucoma Valve (Taglia, Perkins, Gangnon, Heatley, & Kaufman, 2002). This was likely 
to be due to its poor valve performance (Prata, Jr. et al., 1995; Francis, 1998; Eisenberg, 
Koo, Hafner, & Schuman, 1999). 
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The Optimed device had a 3 mm x 2 mm x 2 mm polymethylmethacrylate (PMMA) 
box section (Figure 2.10c) which contained 180-200 microtubules, each with an internal 
diameter of 60 µm for aqueous humour flow (Prata, Jr. et al., 1995). The microtubules 
made up the flow-restricting unit and provided a pressure gradient governed by Poiseuille’s 
formula. Aqueous humour outflow occurred when IOP exceeded 10 mmHg and capillary 
action would draw fluid through the matrix as IOP increased. A cover over the box 
prevented fibrous tissue growth from blocking the holes. In laboratory tests, this device had 
minimal flow resistance, comparable to a unrestricted Baerveldt device in one report 
(Francis, 1998; Eisenberg et al., 1999). In a small study involving 7 eyes, the failure rate 
was around 40% after 3 years (Romaniuk, 1999). 
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b) 
 
c)  
 
Figure 2.10 a) Schocket device. b) Krupin device. c) OptiMed device. 
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2.5 Schlemm’s canal and suprachoroidal space drainage 
In general, the devices here have been introduced after the subconjunctival space 
devices. These include the iStent, Hydrus, Gold Micro Shunt, CyPass and Aquashunt. The 
iStent and Hydrus are designed to facilitate aqueous humour drainage from the anterior 
chamber into the Schlemm’s canal (Figure 2.2). The Gold Micro Shunt, CyPass and 
Aquashunt devices divert aqueous humour from the anterior chamber into the 
suprachoroidal space (Figure 2.2). 
 
2.5.1 Schlemm’s canal GDD 
The iStent (trabecular micro-stent) GTS100 is an L-shaped, open half-pipe titanium 
tube (Figure 2.11a). The short snorkel inlet is designed to sit in the anterior chamber while 
the tube traverses the trabecular meshwork to end in Schlemm’s canal. This device has its 
open side placed against the outer wall of Schlemm’s canal and the closed side against its 
inner wall to prevent occlusion of the collector channels. Retention arches on the inner 
aspect prevent extrusion of the whole device. Surgery to insert the iStent is done through an 
ab interno approach without cutting any conjunctival tissue. The first benefit is that it can 
be performed through the same wound as that of phacoemulsification. If done together, the 
amount of inflammation and time for recovery is similar to that of phacoemulsification 
alone. The second benefit is that the conjunctiva is preserved in case further and more 
invasive glaucoma surgery e.g. trabeculectomy is needed. There is no bleb formation with 
this procedure (Samuelson, Katz, Wells, Duh, & Giamporcaro, 2011). 
In a randomised controlled trial, patients had phacoemulsification with iStent 
implantation or phacoemulsification alone (Fea, 2010). After 15 months, IOP in the device 
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group (12 eyes) reduced from 17.9 mmHg to 14.8 mmHg (17.3%) while IOP in the control 
group (24 eyes) reduced from 17.3 mmHg to 15.7 mmHg (9%). In another study involving 
patients with open-angle glaucoma or ocular hypertension who were undergoing cataract 
surgery (Fernandez-Barrientos et al., 2010), 33 eyes of 33 patients were randomised to 
either two stents and cataract surgery (17 eyes) or cataract surgery alone (16 eyes). Mean 
IOP reduced from 24.2 to 17.6 mmHg (27.3%) in the device group and from 23.6 to 19.8 
mmHg (16.1%) in the cataract surgery only group. In another randomised control trial, 240 
eyes with mild to moderate open-angle glaucoma with IOP ≤ 24 mmHg controlled on 1 to 3 
medications were randomised to undergo cataract surgery with iStent implantation or 
cataract surgery only (Samuelson et al., 2011). At 1 year, reduction from the pre-operative, 
un-medicated IOP in both treatment groups were similar (8.4 mmHg vs 8.5 mmHg) and 
both significantly lower by ≥ 30% from baseline values, although the reduction in number 
of medications was higher in the device group (1.4 vs 1.0). The number of ≥ 20% IOP 
reduction without medication was higher in the device group (66% vs 48%), as was the 
number of ≤ 21 mmHg (72% vs 50%). Stent obstruction occurred in 4% but there were no 
cases of hypotony. In a prospective case series (Arriola-Villalobos et al., 2012), 19 subjects 
with mild or moderate open-angle glaucoma (including pseudoexfoliative and pigmentary 
types) and cataract underwent phacoemulsification and intraocular lens implantation along 
with implantation of one iStent. IOP was reduced from 19.4 mmHg to 16.2 mmHg at the 
end of follow up (53.7 months), a 16.3% decrease in IOP. There was no incidence of 
hypotony, choroidal effusion or shallow anterior chambers. 
The newer iStent Inject or GTS400 has a flanged anterior chamber end, a narrow 
thorax portion, and a head with 4 outflow orifices (Figure 2.11b). It is 360 μm in length, 
230 μm in external diameter and is also made of titanium. In a study using human anterior 
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segments placed in perfusion organ culture, one or 2 iStent Inject devices were inserted into 
the trabecular meshwork (Bahler et al., 2012). Insertion of 1 device increased outflow 
facility from 0.16 µl/min/mmHg to 0.38 µl/min/mm Hg, with concurrent pressure reduction 
from 16.7 mmHg to 8.6 mmHg. Addition of a second device increased outflow facility to 
0.78 µl/min/mm Hg. In humans, these devices have been implanted in conjunction with 
phacoemulsification. In one report, 25 subjects who had received cataract surgery and 
stents were followed up for 2 years (Bacharach, 2012). 68% had an IOP of 18 mmHg or 
less and > 20% reduction without medication, compared to 24% in cataract surgery only 
controls. 
The Hydrus device is a Schlemm’s canal scaffold with an open structure to facilitate 
aqueous humour movement into the collector channels (Figure 2.11c). It is 15 mm long, 
curved to fit inside the canal and increases the canal’s cross-sectional area by 4-5 times for 
up to 5 clock hours. It is made of Nitinol or nickel titanium alloy (Camras et al., 2012). In 
one study, 40 patients received the Hydrus without cataract extraction and their IOP 
reduced by 21.8% from 21.6 mmHg on an average of 1.7 medications to 16.9 mmHg on 0.6 
medications after 6 months (Samuelson, Pfeiffer, & Lorenz, 2012). Minor complications 
were reported, including mild iris damage and transient hyphaema lasting less than one 
week. 
From the clinical evidence, we can see that the IOP reduction with Schlemm’s canal 
devices is less than 20% after deducting the reduction from cataract removal alone, and 
lower than that with subconjunctival space devices. They are however associated with 
minimal risks of hypotony. 
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Figure 2.11 a) iStent GTS100 device. b) iStent Inject (GTS 400) device. c) Hydrus device. 
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2.5.2 Suprachoroidal space GDD 
The suprachoroidal space is a potential space between the inner surface of the sclera 
and the outer surface of the choroid. It is not present under normal physiological conditions. 
The theoretical advantages of draining aqueous humour into this space is its natural 
counter-pressure helps to prevent severe post-operative hypotony, the potential capacity of 
transport afforded by the excellent blood supply of the metabolically active choroid, and the 
negative hydrostatic pressure gradient which facilitates drainage (Emi, Pederson, & Toris, 
1989; Jordan et al., 2006). From this space, there are 2 possible drainage pathways, one 
through scleral pores and to the episcleral venous plexus, and the other through choroidal 
resorption. 
The Gold Micro Shunt (GMS) is a flat device designed to connect the anterior 
chamber with the suprachoroidal space (Figure 2.12a). Its anterior and posterior ends have 
multiple inlet and exit holes 100 μm in diameter and these are connected by microchannels. 
Additionally, there are lateral channels 50 μm in diameter for increased aqueous humour 
movement and fin-like tabs posteriorly for anchoring the device in the suprachoroidal 
space. To reduce hypotony, only half of the microchannels are initially open. If further IOP 
reduction is needed after implantation, the rest can be opened by using a titanium-sapphire 
790 nm wavelength laser (Melamed, Ben Simon, Goldenfeld, & Simon, 2009). Clinical 
outcomes with this device are discussed subsequently.  
The CyPass (Figure 2.12b) is a 6.35 mm long, 300 μm ID hollow polyimide tube with 
microchannels along its side. It is inserted via an ab interno approach and usually 
performed along with phacoemulsification. The aim is to create a controlled cyclodialysis 
with a stented outflow conduit to the suprachoroidal space. In a prospective case-series, 81 
patients were implanted with this device and followed-up for 6 months (Ianchulev, Ahmed, 
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Hoeh, Rau, & DeJuan, 2010). There was a 29% decrease in IOP from 22.9 mmHg to 16.2 
mmHg and a similar reduction in medication requirements. There were two cases of 
transient hyphaema which resolved by one week and one case of a shallow anterior 
chamber which resolved by 1 month. 
The iStent Supra is the third model in the iStent family and has an insertion method 
similar to that of the CyPass. It is made of non-magnetic, heparin-coated polyethersulphone 
and has a titanium sleeve. The interim results of one on-going study have been reported 
(Junemann, 2013). However, it is being tested along with the use of travoprost so its 
individual effect cannot be ascertained. In the study, open angle glaucoma patients with 
IOP not controlled with 2 medications were implanted with the device and started on 
travoprost post-operatively. The IOP reduction in the 42 subjects was from 24.8 mmHg to 
13.2 mmHg (46.8%) after 1 year. 98% of cases had a reduction in IOP of 20%. 
The Aquashunt is another suprachoroidal drainage device and is made of 
polypropylene (Figure 2.12c). During insertion, a full thickness scleral incision is made 
before the device is advanced into the suprachoroidal space and then into the anterior 
chamber. The insertion tool also serves as an obturator to keep tissue from blocking the 
lumen as it is advanced. The device’s leading edge separates the adhesion between the 
ciliary body and scleral spur with a shearing effect. Excessive movement into the anterior 
chamber is limited by the shunt's shoulders, which are set 3 mm back from the leading edge 
(Rao, 2009). Data regarding this device in human use has not been reported, but one study 
did report the differences in aqueous humour dynamics, IOP and fibrosis between this 
device and the GMS in rabbits (Oatts et al., 2013). Fluorophotometric aqueous humour 
flow and both tonographic and fluorophotometric outflow facility were not changed with 
both devices without antifibrotic use. Morning IOP was decreased through 15 weeks in 
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both groups. At the end of 15 weeks, morning IOP was lower with the Aquashunt (41% 
reduction from baseline of 23.7 mmHg) than with the GMS (18% reduction from baseline). 
The reductions in evening IOP were smaller with the Aquashunt and not significant with 
the GMS. Both shunts were devoid of foreign body reaction but exhibited fibrosis, and the 
GMS showed fibrovascular invasion into its holes and microchannels. Thickness of fibrosis 
was greater in the GMS group (246 µm) than the Aquashunt group (188 µm). Antifibrotics 
reduced fibrosis around the devices but also diminished shunt performance at the end of the 
study. This latter effect was thought to be due to some aqueous humour exiting into an 
overlying bleb and thus bypassing the suprachoroidal space, which subsequently led to 
narrowing and failure of the space. The Aquashunt resulted in more cases of hyphaema 
(40% vs 10%) and was also liable to device migration (20%) and retinal detachment (10%). 
Overall, it may be that it provides better IOP control and incites less fibrosis than the GMS 
in humans. 
 
2.5.2.1 Suprachoroidal space drainage and fibrosis 
The initial report of GMS implantation showed satisfactory performance (Melamed 
et al., 2009). In the case of 38 patients with POAG, pseudoexfoliative glaucoma, pigment 
dispersion glaucoma and uveitic glaucoma on maximal medical therapy, IOP decreased by 
9 mmHg (33%) from 27.6 mmHg to 18.2 mmHg after 11.7 months. Surgical and complete 
success (IOP between 5 mmHg and 22 mmHg with and without anti-glaucoma medication) 
was achieved in 79% and 13.2% respectively. However, subsequent reports indicate how 
this device may be liable to failure due to excessive fibrosis. One report showed how 5 
correctly-placed GMS devices failed due to the presence of thick connective tissue capsules 
surrounding both their proximal and distal ends, and invading into the anterior and 
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posterior holes (Agnifili et al., 2012). Connective tissue was also observed within the inner 
microchannels although these were more loosely arranged. The mean time of failure was 
6.8 months and the mean IOP at that time was 30.4 mmHg. The suggested causes leading to 
the fibrosis were direct activation and proliferation of suprachoroidal space fibroblasts 
induced by the intra-operative manipulation of the space, and migration of Tenon’s 
fibroblasts through the scleral incision. The scleral incision was also thought to permit 
some direct subconjunctival filtration in the early post-operative period; reduced washout 
of fibroblasts from the inner microchannels by aqueous humour as a result of the bypass 
could allow proliferation of the cells. These findings are supported by another study that 
reported qualified and complete success rates (IOP < 21 mmHg and reduction > 33%) of 
67.3% and 5.5% after 2 years in 55 eyes. The change in IOP in all cases was not reported 
but in the failure cases (32.7%), the authors mentioned that thin membranes obstructed the 
anterior and posterior holes in 66.7% and 16.7% respectively (Figus et al., 2011). Another 
report described the experience of implanting the GMS into 31 eyes; after 7.3 months, 97% 
of them were classified as failures due to inadequate IOP reduction, serious complications 
or the need for additional surgery (Hueber, Roters, Jordan, & Konen, 2013). 77% needed 
further surgery due to inadequate IOP reduction, the mean IOP increased from 26.6 mmHg 
to 27.2 mmHg during the study. The overall 1-year and 2-year failure rates were 71% and 
90% respectively. However, the cause of failure could not be exactly ascertained from the 
report. 
Long term reports of the other suprachoroidal space devices are not available at the 
moment but it may be that high fibrosis rates, perhaps contributed by the excellent blood 
supply of the metabolically active choroid will downplay the role of drainage into this 
space. Further investigation and reports will help provide this important information. 
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Figure 2.12 a) Gold Micro Shunt device. b) CyPass device. c) Aquashunt device. 
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2.6 Fluid mechanics of trabeculectomy and glaucoma drainage devices 
The control of aqueous humour flow and IOP is important for successful glaucoma 
surgery. In many clinical studies, the criteria for success include IOP of between 6 and 21 
mmHg (Gedde et al., 2009; Budenz et al., 2011). As such, there is a fine balance between 
obtaining successful results, or unwanted hypotony/ hypertony. It is acknowledged that in 
the later post-operative stage, resistance and flow are determined mainly by the bleb or 
fibrous scarring beyond the device, but post-operative control by the flap or device in the 
early post-operative stage is important in limiting overfiltration and setting the stage for 
effective long-term drainage. The knowledge of how these interventions affect resistance 
and flow is then useful in making clinical decisions to obtain the best outcomes. The 
characteristics are determined by the form and function of the procedures and devices, 
which in turn depend on their drainage pathways. In this section, we will describe the fluid 
mechanical aspects related to trabeculectomy and glaucoma drainage devices. We first 
introduce some of the critical concepts in fluid mechanics. 
Aqueous humour flow through a GDD is characterised by a Reynolds number,   , 
which expresses the relative strength of inertial to viscous forces in the fluid, and is defined 
as 
   
  
 
 ,         (2.2) 
where   is a characteristic flow speed,   a characteristic length scale and   the kinematic 
viscosity (10
-6
 m
2
/s for aqueous humour). For a typical device (e.g. Ahmed or Baerveldt 
device with a 300 µm inner diameter tube),   ~ 10-4 m/s and   ~ 10-4 m, giving    ~ 10-2. 
When    is < 2000, as in this situation, the flow is viscously dominated or laminar and 
inertial forces can be completely neglected (Batchelor, 2000). 
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2.6.1 Electrical circuit analogy 
The purpose of a glaucoma drainage device is to provide an intervention strategy that, 
given an initial aqueous humour flow rate   and pre-operative pressure     , gives a post-
operative pressure      . The drainage of aqueous humour can be through routes that act in 
series or in parallel to the normal physiological route. The contrasting drainage routes put 
constraints on the resistance required of the procedure or device which can be understood 
using an electrical circuit analogy based on Ohm’s law (Akers, Gassman, & Smith, 2006). 
This approach has been used before to discuss glaucoma procedures and drainage devices 
but not to classify them in this manner (Fankhauser & Giger, 1994; Pan, 2005). The basis 
of the electrical circuit analogy is that pressure (voltage)   is equal to the product of flow 
rate (current)   and resistance   (which is the inverse of outflow facility  ). The important 
assumptions here are that aqueous humour production and trabecular outflow resistance 
remain constant after surgery (which may be more accurate in the early post-operative 
stage, before development of the changes described in section 2.4.1.1), and uveoscleral 
outflow   is similarly constant, pressure-independent and drains only 10% of total aqueous 
humour. From the Goldmann equation (Equation 2.1), the pressure difference between IOP 
and EVP,          is proportional to    . Since     ≤ 0.1, then    
 
 
 . In the 
engineering community,   is usually termed as permeability  , so 
   
 
 
 .         (2.3) 
Figure 2.13a shows the electrical circuit analogy of the physiological resistances of 
the trabecular meshwork and Schlemm’s canal operating in series. The pre-operative 
pressure is related to the flow rate by 
      
 
      
 ,        (2.4) 
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where        is the permeability of the trabecular meshwork and Schlemm’s canal. 
Intervention using a trabeculectomy/ GDD introduces an alternative subconjunctival 
route which operates in parallel to and bypassing the trabecular meshwork and Schlemm’s 
canal, as in Figure 2.13b. The effect of introducing a parallel pathway for drainage into the 
subconjunctival space, which has a permeability     , requires the conditions 
                               (2.5) 
 and conservation of mass 
             .        (2.6) 
The results can be expressed as 
       
 
           
        (2.7) 
and 
     
       
           
 .        (2.8) 
The ratio of the post-operative pressure to the pre-operative pressure is 
      
     
 
 
  
    
      
        (2.9) 
and 
    
 
 
 
    
      
 
   
    
      
 
 .        (2.10) 
Figure 2.14a shows the variation of the post-operative pressure with the ratio of the 
permeability of the device to that of the physiological route. Assuming an average EVP of 9 
mmHg, we see that for a reduction in IOP from 25-50 mmHg to 15 mmHg i.e.        
      of 0.15-0.38, the permeability of the device needs to be about 1.5-6.0 times the 
permeability of the physiological route. This correlates to around 55-85% of total flow 
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passing through the device (Figure 2.14b). For a typical   of 3 µl/min, the estimated flow 
rate through the GDD is in the range of 1.7-2.6 µl/min. 
 
a) 
 
b) 
 
c) 
 
Figure 2.13 a) Electrical circuit diagram of pre-operative outflow pathway. b) Electrical 
circuit diagram of post-operative outflow pathway (subconjunctival and suprachoroidal 
drainage). c) Electrical circuit diagram of post-operative outflow pathway (Schlemm’s 
canal drainage). 
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a) 
 
b) 
 
Figure 2.14 a) Calculated variation of post-operative pressure with ratio of permeability of 
a subconjunctival drainage device to that of the physiological route (from Equation 2.9). A 
reduction of IOP from 25-50 mmHg to 15 mmHg (             of 0.15-0.38) requires the 
permeability of the device to be about 1.5-6.0 times the permeability of the physiological 
route. b) The same permeability ratio correlates to around 55-85% of total flow passing 
through the device (from Equation 2.10).  
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From data reported in other studies, we derived   values by direct conversion of 
outflow facility or the inverse of resistance for the devices which were investigated. These 
are shown in Table 2.7. Note that in some of these in vitro studies, the flow rates involved 
were much higher than normal physiological aqueous humour flow rates. As permeability 
of valved devices depends on flow rate, the values reported may not be representative of 
one in an actual living eye with lower flow rates. Additionally, the lengths of the tube 
sections of the devices during testing were not stated. As these lengths affect resistance, the 
permeability values indicated here may be less accurate. 
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Table 2.7 Permeability ( K ) values for Ahmed Glaucoma Valve, Baerveldt, Krupin, 
Optimed and ExPress devices compared to that of normal eyes. The values in brackets are 
the flow rates used during testing. 
Device   (µl/min/mmHg) References 
Ahmed Glaucoma 
Valve 
0.4 (2 µl/min) – 20 (50 
µl/min); 0.7 (2 µl/min); 1.2 
(10.8 µl/min) 
 
(Francis, 1998; Prata, Jr. et 
al., 1995; Eisenberg et al., 
1999) 
Baerveldt (partially 
ligated) 
 
10 (2 µl/min) (Prata, Jr. et al., 1995) 
Krupin 4.0 (2 µl/min) – 11.1 (10 
µl/min); 5.0 (2 µl/min) 
 
(Francis, 1998; Prata, Jr. et 
al., 1995) 
Optimed 12.5 (2 µl/min) – 25.0 (10 
µl/min); 1.1 (2 µl/min); 6.2 
(10.8 µl/min) 
 
(Francis, 1998; Prata, Jr. et 
al., 1995; Eisenberg et al., 
1999) 
ExPress 16.4-19.6 [P50], 20.4-22.7 
[R50] (97 - 512 µl/min); 
90.9-142.9 [P200] (664 - 
2241 µl/min) 
 
(Estermann, Yuttitham, 
Chen, Lee, & Stamper, 2012) 
Normal eye 
 
0.2-0.4 (Toris et al., 2008; Gulati et 
al., 2011; Liu et al., 2011) 
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If we take   as being ≤ 0.2 µl/min/mmHg in a glaucomatous eye, we see at the 
relatively low flow rate of 2 µl/min,   of the Ahmed Glaucoma Valve is only 2-3 times that 
of the eye. This is advantageous as the reduction in IOP is lower and there is a reduced 
likelihood of hypotony. At higher flow rates,   increases as the valve opens to allow more 
aqueous humour flow. The other devices have permeabilities at least 10 times higher which 
may lead to overdrainage and hypotony. To avoid this, in the early post-operative stage 
before the development of resistance by the bleb or fibrous scarring, flow restricting 
measures need to be employed. These include temporary internal or external occlusion of 
tubes such as with the Baerveldt and Molteno devices and implantation under the scleral 
flap in the case of the ExPress device. 
When drainage is into the Schlemm’s canal, the route is in parallel with the trabecular 
meshwork and in series with the canal (Figure 2.13c). Placing a GDD in parallel with the 
meshwork leads to a post-operative pressure of 
       
 
               
              
 
 .       (2.11) 
The ratio of the post-operative pressure to the pre-operative pressure, 
      
     
 
      
               
              
 
 ,       (2.12) 
can also be expressed as 
      
     
  
   
      
 
    
      
   
   
 
      
   
 
    
      
   
    .      (2.13) 
In this case, since the highest resistance is encountered at the juxtacanalicular trabecular 
meshwork and inner wall of Schlemm’s canal, we estimate that         ~ 1. Figure 2.15 
shows the variation of the post-operative pressure with the ratio of the permeability of the 
device to that of the physiological route. Here we see that the pressure drop is always less 
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than 50%, which is in keeping with the more modest IOP reductions seen clinically (Fea, 
2010; Fernandez-Barrientos et al., 2010; Arriola-Villalobos et al., 2012). The permeabilities 
of these devices need also be higher than those for subconjunctival drainage devices. For 
example, a reduction of IOP from 24 mmHg to 18 mmHg (             of 0.6) requires 
the permeability of the device to be around 8 times the permeability of the physiological 
route. 
 
 
Figure 2.15 Calculated variation of post-operative pressure with ratio of permeability of a 
Schlemm’s canal device to that of the physiological route (from Equation 2.13). The 
pressure drop is less than 50% and a reduction of IOP from 24 mmHg to 18 mmHg 
(             of 0.6) requires the permeability of the device to be around 8 times the 
permeability of the physiological route. 
 
In the absence of data on actual devices, we can estimate their   using scaling 
analysis. Defining   as flow rate,   as internal diameter,   as length,   as dynamic 
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viscosity, and   and    as characteristic velocity and pressure scales, the conservation of 
mass requires that 
              (2.14) 
while the balance between resistance caused by viscous forces and the driving pressure 
gradient, 
  
  
 
  
 
.         (2.15) 
Combining both, 
    
  
  
     
  
  
 .        (2.16) 
For circular sections of tubing, Poiseuille’s Law is applicable. This law gives 
the pressure drop in a fluid flowing through a long cylindrical pipe (Batchelor, 2000). Its 
assumptions are that the flow is laminar through a pipe of constant circular cross-section 
substantially longer than its diameter; the fluid is incompressible and Newtonian; and there 
is no acceleration of fluid in the pipe. This law gives 
  
   
     
.         (2.17)  
In Figure 2.16, the black shaded area indicates the range for an ideal device based 
on our calculations, the red shaded area the range of reported experimental values for the 
ExPress P50 and R50 (data in Table 2.7), and the blue shaded area the range of reported 
experimental values for the ExPress P200. The expected value for the ExPress P200 (200 
μm ID, 2.64 mm length) is within the range found experimentally. The expected value for 
the ExPress R50 (50 μm ID, 2.64 mm length) is lower than its experimental value. One 
possible explanation for this is the actual device having a larger internal diameter than the 
stated 50 µm, and this will be explored in Chapter 5 of this thesis. As     , small changes 
in diameter will affect the permeability significantly. For comparison, we have also 
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superimposed the expected values for the MIDI-Arrow, AqueSys and CyPass devices. We 
can see that the first two devices have dimensions which are comparable to our ideal 
device. 
 
 
Figure 2.16 Normogram for assessing K  values (in µl/min/mmHg). The black shaded area 
indicates the range for an ideal device while the red and blue shaded areas indicate the 
range of experimental values for the ExPress P50/ R50 and ExPress P200 respectively. The 
values for the MIDI-Arrow (*), AqueSys (x) and CyPass (o) devices are superimposed. 
 
When drainage is into the suprachoroidal space, the electrical circuit analogy is 
similar to that of drainage into the subconjunctival space (Figure 2.13b). The calculated   
value of the CyPass device is much larger in comparison to the subconjunctival space 
o 
x 
* 
95 
 
devices. This may potentially lead to excessive aqueous humour outflow and hypotony, 
although a degree of restriction may be afforded by the natural counter-pressure of the 
space (Jordan et al., 2006). 
 
2.6.2 Pressure-flow response of GDD 
To characterise a GDD, it is important to be able to estimate the relationship 
between the pressure across the device and the flow rate through it. GDD can be divided 
into non-valved and valved categories, with different pressure-flow responses between 
them (Francis, 1998; Stay, Pan, Brown, Ziaie, & Barocas, 2005). For non-valved or fixed 
resistance devices, 
    .         (2.18) 
At low flow rates, resistances of these devices are lower than with valved devices (Figure 
2.17a), which may lead to problems with hypotony. Pressure is also sensitive to small 
variations in flow rate through the device (Figure 2.17b). These characteristics may be 
more suitable for devices which drain into areas such as the Schlemm’s canal (with 
resistance from the EVP distally) and the suprachoroidal space (with its natural counter-
pressure) to maintain IOP over a certain level. 
With valved devices, resistance is a function of flow rate, where it is initially high 
but falls with increasing flow rate (Figure 2.17a). At low flow rates, it is higher than with 
fixed resistance devices, which may help to reduce hypotony. Pressure is weakly dependent 
on flow rate, and is maintained at a relatively stable level over a wider range of flow rates 
(Figure 2.17b). These characteristics are advantageous for devices which drain into areas 
with less resistance such as the subconjunctival space. 
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a) 
 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
 
 
Figure 2.17 a) Expected resistance-flow rate response curves of a fixed resistance device 
(dashed line) and a valved device (solid line). b) Expected pressure-flow rate response 
curves of a fixed resistance device (dashed line) and a valved device (solid line). (  – 
resistance,   – pressure,   – flow rate). 
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For a valved device, the dependence of pressure on flow rate is based on its material 
properties (Young’s modulus  , Poisson’s ratio  ) and sheet thickness  . From the bending 
equation (Landau & Lifshitz, 1986; described in more detail in Chapter 3), 
      
        
   ,         (2.19) 
where   is the gap separation. The scaling for flow rate, 
   
  
 
 .         (2.20) 
From Equation 2.19, the scaling for deformation, 
    
  
   .         (2.21) 
Combining the scaling for flow rate with the scaling for deformation, we obtain 
   
  
   
 
 
  
 
 
 
 
  .        (2.22) 
The response of Ahmed Glaucoma Valves to flow rate has been analysed using 
finite element analysis and experiments on actual devices (Stay et al., 2005). The authors 
inferred that the valve material had a Young’s modulus   of 4.2 MPa and the pressure 
across the valve varied as       . Along with Equation 2.22, we see that pressure has a 
stronger dependence on the physical dimensions of the valve (  and  ) than it does on the 
flow rate and material properties. This may explain the reported difficulty in reproducing its 
pressure-flow characteristics (Prata, Jr. et al., 1995; Moss, 2008) as it may occur due to 
manufacturing issues related to the sensitivity of pressure to  , which has a  
 
  dependence. 
In the case of a trabeculectomy, it is essentially another flap valve formed from the 
superficial scleral flap and sutures. Therefore, the pressure-flow response should be similar 
to that of the Ahmed Glaucoma Valve, where       . In one recent study, the response 
was found to be similar to that of a fixed resistance device, with a linear increase in 
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pressure with increasing flow rate (Tse et al., 2012). In the study, which also utilised finite 
element analysis, the scleral flap was modelled as having a fixed initial gap separation. This 
assumption may be inaccurate and would explain the different pressure-flow response that 
the authors found. In this thesis, we will explore the pressure-flow response of a 
trabeculectomy. 
 
2.7 Conclusion and Research Questions 
An understanding of fluid mechanics principles may be useful in making clinical 
decisions or improving upon the procedures and devices used in glaucoma surgery. 
Hypothetically, the designs depend on where the aqueous humour drains into. Devices 
which drain into the subconjunctival space, in parallel to the trabecular outflow pathway, 
should be slightly more permeable (1.5-6.0 times) than the glaucomatous eye or weakly 
dependent on the flow rate for adequate pressure reduction while still maintaining low 
incidences of hypotony. Valved devices satisfy this latter constraint as pressures have a 
weak dependence on flow rate (      ). Devices which drain into the Schlemm’s canal 
work partially in series with the trabecular outflow pathway, and the operative conditions 
are different. As flow is limited by the resistance of the distal outflow structures and EVP, 
the devices should have higher permeabilities and can be of fixed geometry with a stronger 
dependence on flow rate (    ). Suprachoroidal drainage devices operate similarly to the 
subconjunctival space devices and thus need similar constraints. Current devices have the 
highest permeabilities and fixed geometry which may be disadvantageous but this may be 
partially accommodated by the natural counter-pressure restricting excessive aqueous 
humour outflow. 
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At the moment, trabeculectomy and subconjunctival space drainage devices still 
offer the most reductions in IOP and are likely to be continued in use for the treatment of 
glaucoma refractory to medical and laser therapy. However, they are still associated with 
large numbers of complications, of which the majority in the early post-operative period are 
related to hypotony. The findings of this review and analysis have prompted that a better 
understanding of the trabeculectomy and glaucoma drainage devices is needed to improve 
the outcome of glaucoma surgery. One of the main research questions in this thesis is how 
the trabeculectomy scleral flap performs as a valve, from a fluid mechanical perspective; 
and how it affects flow of aqueous humour and the pressure outcome. The other research 
question is whether small inner diameter fixed resistance tubes with permeabilities 1.5-6.0 
times more than a glaucomatous eye are able to provide controlled aqueous humour flow 
into the subconjunctival space with avoidance of overfiltration and hypotony. The approach 
taken in testing these hypotheses is described in the following chapters. 
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Chapter 3 
3 Fluid-structure characteristics of the scleral flap and the influence of the 
scleral flap and sutures on intraocular pressure (IOP) and aqueous humour flow 
direction 
 
3.1 Introduction 
 
Fluid mechanics is based on a combination of physical analysis and experimental 
observations (Binder, 1973). The general objective is to provide dependable practical 
results and a thorough understanding of fundamental flow features. To aid this effect, 
scaling (dimensional) analysis is useful for checking equations, changing units, determining 
a convenient arrangement of variables of a physical relationship, and planning systematic 
experiments. It frequently aids in making an easier description of the phenomena. However, 
reference to experimental data need to be made to obtain the necessary constants or 
coefficients for a complete numerical expression. 
In the brief analysis of trabeculectomy at the end of Chapter 2, we suggested that 
the procedure creates a flap valve, formed by the partial thickness scleral flap and sutures. 
As such, both the resistance-flow and pressure-flow relationships would be non-linear. In 
this chapter, we describe the fluid-structure characteristics of the scleral flap as determined 
through scaling analysis, and then compare them with experimental results with a large 
scale trabeculectomy model. With the scaling analysis, the characteristics of interest were 
the dependences of both flap displacement   and pressure   on flap dimensions   and  , 
and aqueous humour flow rate  . We then use the physical model to objectively measure 
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the influence of flap thickness, shape, suture number and position on the pressure under the 
model scleral flap. In the final part of the experiment, we perform a qualitative assessment 
of how the variables determine aqueous humour flow under the scleral flap. The intended 
outcome was an enhanced understanding of how the different variables could affect the 
outcome of surgery. As far as we know, there has never been an approach such as this to 
understand the trabeculectomy procedure. 
 
3.2 Methods 
 
3.2.1 Scaling analysis 
The scleral flaps are characterised by the geometrical dimensions length  , width 
  and thickness   (Figure 3.1). The aqueous humour is characterised by flow rate   and 
dynamic viscosity  . The flaps are subjected to small amounts of strain so a linearly elastic 
model is appropriate, where for a small strain, they are characterised by Poisson’s ratio 
  and Young’s modulus  . 
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Figure 3.1 Schematic diagram of scleral flap from above and a cross section view. In the 
physical model, the silicone sheet (scleral flap) is indicated in grey and the back plate 
(limbus) and ‘sutures’ in red. The inlet hole (sclerostomy) is indicated in blue and the 
bottom plate in white.  – width,   - length,   - sheet thickness,   - fluid height. 
 
Aqueous humour flow below the scleral flap is characterised by low Reynolds 
numbers (~ 10
-2
, this calculation is explained in the following section) and can be described 
by lubrication theory where the flow of fluids is in a thin layer over a wide area. The depth-
averaged velocity, 
   
   
 
            (3.1) 
where   is a coefficient for the boundary conditions. This is solved subject to the constraint 
that the flux of aqueous humour through the sheet is  . The characteristic size of the flap is 
  (since     ~ 1), so we have 
 
  
     and 
 
  
    . The integral form of mass 
conservation requires that flow rate out of the rectangular flap, 
L 
W 
T 
H 
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        (3.2) 
where the integral is taken over the exit from the flap (the order of magnitude estimates of 
the terms are indicated below the underbrace). The characteristics of the flaps depend on 
whether they are bending (the initial deflection perpendicular to the mid-surface of the flap) 
or stretching (when further deformation from transverse loads results in a change in the area 
of the mid-surface) (Ribe, 2001).   is the Airy stress function. The coupled equations for 
bending and stretching (Landau & Lifshitz, 1986) are 
      
        
    
  
   
   
   
   
   
 
   
   
   
   
  
   
    
   
    
 
         
   
  
       (3.3) 
and 
   
 
  
   
   
   
   
   
  
   
    
 
 
 
      
   
  
          (3.4) 
The following is a modification of the coupled equations. For low flow rates, balancing 
pressure against bending forces from Equation 3.3 gives 
    
  
   
  
  
           (3.5) 
or 
 
 
  
    
   
 
 
 .          (3.6) 
For high flow rates, stretching is important and      . Balancing stretching and pressure 
gives 
    
  
 
  
  
,          (3.7) 
or 
104 
 
 
 
  
    
   
 
 
 .          (3.8) 
The transition from bending to stretching occurs when 
 
 
 ~ 1, which occurs when the critical 
flow rate, 
   
   
   
.          (3.9) 
The pressure can be related to the flap displacement. Below the critical flow rate, the 
pressure is 
 
 
  
  
   
 
 
 
 
 
 
 
 
 
.         (3.10) 
At higher flow rates, in the stretching state, the pressure shows a weaker dependence on 
flow rate, i.e. 
 
 
  
  
   
 
 
 
 
 
 
 
  
 
.         (3.11) 
This tells us what the pressure response of a flap is and how it depends on flow rate, flap 
thickness, flap size and elastic modulus. 
The flap is typically characterised by a length   = 3 mm in the sclera which has a 
Young’s modulus   ~ 1×106 Pa. At the limbus, the sclera is approximately 0.5 mm thick, 
and the flap formed is typically half thickness   = 0.25 mm. Such flaps are sutured in 
position so that aqueous humour (  ~ 10-3 Pa.s) can leak from 3 sides. The critical flow rate 
   (from Equation 3.9) is 7.5×10
−7
 m
3
/s, which is significantly higher than that of normal 
aqueous humour flow rate (1.5-3 μl/min or 2.5-5.0×10−11 m3/s). Therefore, this flap also 
works in the bending regime. 
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3.2.2 Physical model 
The physical model exploits the principle of geometric and dynamic similarity or 
similitude which is commonly used in the area of engineering to test fluid flow conditions 
with scaled models (Binder, 1973). In order to obtain information regarding the flow 
phenomena in or around a structure, called the original or prototype, it is often convenient, 
economical and sound engineering to experiment with a copy or model of the prototype. 
The model may be geometrically smaller than, equal to, or larger than the prototype in size. 
These provide an advantage in research, design and performance-prediction work which 
cannot be obtained from theoretical calculations alone. Certain laws of similarity need to be 
observed in order to ensure that the model test data can be applied to the prototype. These 
laws in turn provide means for correlating and interpreting the test data. In addition to 
geometric similarity, dynamic (i.e. forces acting on the flow) similarity need also be 
considered, where the velocity and streamlines of flow are matched. The dimensionless 
Reynolds number (  ) determines the ratio of viscous versus inertial forces acting on the 
body. Dynamic similarity between a prototype and its model is realised when the    for the 
model equals that of the prototype. The    can be determined from 
                 (3.12) 
or 
        ,          (3.13) 
where   is velocity,   is a characteristic length or hydraulic diameter,   is kinematic 
viscosity,   is volumetric flow rate and   is cross-sectional area. For example, taking a 
simple case where a model is tested in the same fluid as that of the prototype flow (i.e. with 
the same kinematic viscosity), a larger model than the prototype will need a higher 
associated velocity. Another application of the principle is to replace the operating fluid 
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with a different test fluid, which can be for convenience, cost or safety reasons. However, it 
is often impossible to achieve strict similitude during a model test (Heller, 2011). The 
greater the departure from the application's operating conditions, the more difficult 
achieving similitude is. In these cases, some aspects of similitude may be neglected, 
focusing on only the most important parameters. For aqueous humour flow under a scleral 
flap, with typical values of   ~ 3µl/min,  ~ 4 mm,   ~ 3 mm,   ~ 0.5 mm and   ~ 10-6 
m
2
/s (see Figure 3.1), the    is ~ 2.5 × 10-2. In our model, with typical values of   ~ 
400ml/h,   ~ 12 cm,   ~ 9 cm,   ~ 2 mm and   ~ 10-3 m2/s, the    is ~ 1.9 × 10-2. As 
such, while the model is much larger than a scleral flap, the flow properties are similar. 
The main assembly consisted of 9 mm thick transparent acrylic upper and lower 
plates separated by an intermediate section. The intermediate section comprised of a back 
plate (to represent the limbus) and 1 cm x 1 cm x 1 cm cuboidal ‘sutures’ to adequately 
restrain the silicone sheets at their edges but allow space for their deformation (Figure 3.1). 
The lower plate had a 10 mm inlet hole through which the working fluid flowed in 
underneath the sheet, injected using a syringe driver (Cole-Parmer, IL, USA). The upper 
plate applied uniform pressure on the intermediate section and lower plate. This assembly 
was then mounted on top of a light box to enhance visualisation of flow (Figure 3.2). 
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Figure 3.2 Elevated view photograph of the main assembly with a triangular sheet in 
position. 
 
In our experiment, transparent silicone sheets (HT-6240; Rogers Corporation, CT, 
USA) of 0.3, 0.5, 0.8, 1.6 and 3.2 mm thicknesses were used to model the scleral flap; in 
relation to a typical actual scleral flap thickness of 250 µm, they were up to 12 × thicker. 
The range of thicknesses allowed us to test pressure and flow as a function of flap 
thickness. Prior to the experiment, the material properties of the silicone sheets were 
determined using a materials tester (model H5KS; Hounsfield Test Equipment, Surrey, 
UK). A 1.6 mm thick sheet was mounted and incrementally loaded with up to 75 N of 
force. High resolution images were taken, which showed the axial extension and transverse 
contraction of the sheet. The Young’s (elastic) modulus   was determined from the initial 
slope of the stress-strain curve and the Poisson’s ratio   from the transverse contraction 
strain to axial extension strain ratio. We found   = 1.0 MPa (which is comparable to 
108 
 
reported scleral values of 1.2-1.3 MPa (Asejczyk-Widlicka, Srodka, Kasprzak, & 
Pierscionek, 2007) and 1.8-2.9 MPa (Friberg & Lace, 1988)) and   = 0.495 (which is close 
to the 0.5 expected for an incompressible material). 
These sheets were cut into 12 cm x 12 cm squares, 12 cm x 9 cm rectangles and 12 
cm equilateral triangles. In relation to typical actual scleral flap dimensions, they were 
around 30 × larger. They were fixed at the ‘limbus’ end using the back plate of the 
intermediate section (Figure 3.1). Additionally, they were also fixed in various suture 
configurations including 2 sutures, 4 sutures or 5 sutures for rectangular and square flaps; 
and 1 suture or 3 sutures for triangular flaps (Figure 3.3). These configurations are the ones 
commonly seen in experimental and clinical practice (Birchall et al., 2006; Tse et al., 2012; 
de Barros et al., 2008; Kobayashi & Kobayashi, 2011). 
For the working fluid, we used 100% glycerine (VWR International Limited, UK) 
and undiluted Parker black ink (as a dye) in a ratio of 100:1. The dye was necessary for 
visualising fluid flow underneath the sheet. The kinematic viscosity of the glycerine and 
dye fluid,   was ~ 1.15×10-3 m2/s which enabled us to maintain dynamic similarity to 
aqueous humour flow under a scleral flap. The solution was homogenously mixed and the 
whole system ensured to be free of air bubbles before each run. 
Before placement of each silicone sheet, a thin layer of glycerine was spread out on 
the bottom plate to aid subsequent removal of air bubbles. The sheet was then placed and 
restrained with the back plate and ‘sutures’. Next, the glycerine was squeezed out to create 
an air tight seal between the sheet and the lower plate. The upper plate was then placed on 
top of the back plate and ‘sutures’ and tightened down with wing nuts (Figure 3.2). To 
prevent air from getting under the sheets again, the nuts were not over-tightened. The 
assembly was also checked to be level before the start of the experiment. 
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Figure 3.3 Configurations of sheets and sutures. Top row shows rectangles and squares 
with 2 sutures (left), 4 sutures (middle) and 5 sutures (right). Bottom row shows triangles 
with 1 suture (left) and 3 sutures (right). 
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Our model utilised separate pressure measurement and image recording circuits 
(Figure 3.4). These circuits are described separately in the following sections. 
 
 
Figure 3.4 Photograph of complete setup. The syringe driver pumped dyed fluid and the 
pressure transducer measured pressure under the transparent sheet on the main assembly. 
The black and white camera recorded images for analysis of the direction of flow. 
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3.2.2.1 Pressure measurement 
For the pressure measurement circuit, we used a pressure transducer (model 
26PCAFA6D, 15V excitation; Honeywell International, NJ, USA) connected to a signal 
conditioner/ amplifier (Mantracourt Electronics Ltd, Exeter, UK) and personal computer. 
Non-expansile tubing (outer diameter 6 mm, internal diameter 4 mm) was used throughout 
the system. This setup was connected to the inlet hole of the main assembly and syringe 
driver with a 3-way connector. The level of the pressure inlet port on the pressure 
transducer was the same as the level of the lower plate and the syringe driver. Prior to the 
actual experiment, calibration of the pressure transducer was performed using a water 
manometer which was a 1 m long hollow glass rod with an outer diameter of 6 mm and 
internal diameter of 3 mm. The voltage readings for various levels from 0 – 70 cm H2O 
(and the equivalent values in mmHg, 1 cm H2O = 0.7355 mmHg) were noted and plotted in 
a graph. A least squares linear fit to the relationship between voltage and pressure was 
calculated (Figure 3.5). The equation derived was then used to convert voltage into pressure 
readings. 
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Figure 3.5 Calibration of pressure transducer showing linear response to change in 
pressure. The pressure transducer provided a ‘base’ voltage reading even with 0 mmHg 
pressure. 
 
Measurement of the resistance of the tubing and connections was also performed. 
We infused the working fluid through the system at 100, 200, 300 and 400 ml/h without a 
silicone sheet in place and measured the voltage changes. From a simplified version of 
Poiseuille’s equation, 
               (3.14) 
the resistance was determined from the slope of the pressure versus flow rate graph and it 
was 0.004 mmHg/ml/h. This baseline resistance was deducted from the pressure readings 
from each run. 
In the actual experiment with silicone sheets in place, the syringe driver was started 
and the pressure recorded and plotted. The flap, suture and flow rate combinations used are 
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stated in section 3.2.2.3. A typical pressure curve obtained is shown in Figure 3.6, the 
outcome of interest was the equilibrium pressure. 
 
 
Figure 3.6 Typical pressure curve showing an initial spike, before equilibration after the 
silicone sheet flap valve opened. 
 
3.2.2.2 Image recording and processing 
Images were recorded using a black and white camera (Dolphin F145B; Allied Vision 
Technologies GmbH, Germany) connected to a personal computer. Experiments were 
carried out in a darkened room to enhance contrast for the image analysis.  
Prior to the actual experiment, calibration was performed by adding dyed glycerine 
into an empty beaker in increments of 0.5 ml up to a total of 20 ml, with serial images 
being taken (Figure 3.7). With a known beaker diameter (59.0 mm), the average height of 
the fluid as the volume increased could be calculated. MATLAB was used to measure the 
average intensity of each pixel in each image and correlated this with the average height of 
the fluid. As the intensity increased with fluid height, a corresponding fluid height could be 
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attributed to all areas in an image (Cenedese & Dalziel, 1998). The calibration curve 
indicated a linear relationship between the change in intensity (I0/I) and the height of fluid 
(thickness) up to around 4 mm (Figure 3.8). The curve levelled out after that as the intensity 
became saturated and the program could not register any further change. From this 
information, the maximum reading of the fluid height in the MATLAB script was set to 4 
mm. 
 
 
Figure 3.7 Calibration using dyed glycerine increments. Serial images are taken after each 
addition and analysed using MATLAB. 
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Figure 3.8 Calibration curve for image processing. The curve levelled out after around 4 
mm thickness. 
 
In the actual experiment, an initial image was recorded before flow was started, and 
then at pre-determined intervals of between 1 to 4 seconds after the start of flow. With 
these images, MATLAB measured the average intensity of each pixel in the individual 
images. The difference in intensity was then converted into fluid height under the sheet. For 
the comparison with the scaling analysis, a     versus          plot was produced (see 
Results section) while for the assessment of fluid flow under the flap, the final image was 
processed as a false-colour image (Figure 3.9). 
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Figure 3.9 Method of processing false colour image by MATLAB. The initial image is 
compared with the final image and the difference in intensity converted into fluid height in 
the processed image. Suture positions can just be visualised in the processed image. 
Initial image (before flow is started) 
Final image (after flow has ended) 
Processed image 
Height of fluid in mm 
Suture positions 
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3.2.2.3 Experimental combinations 
For the comparison between scaling analysis and physical model section, 0.3, 0.5, 
0.8, 1.6 and 3.2 mm thick rectangle (with 2 sutures) and triangle (with 3 sutures) sheets 
were used with flow rates of 50, 100, 200, 300 and 400 ml/h. Additional flow rates of 10 
and 20 ml/h were also used with the 1.6 and 3.2 mm thick sheets. This was to test a wide 
range of   and   values. 
For the pressure under the scleral flap and flow of fluid flow under the scleral flap 
sections, we utilised 0.8 and 1.6 mm thick sheets in all the configurations shown in Figure 
3.3. This was to test a wide range of configurations which may exist in clinical practice. 
However, only flow rates of 100, 200 and 400 ml/h were used, to maintain dynamic 
similarity to aqueous humour flow. 
For all experimental runs, we ran 50 ml of fluid for the rectangle and square flaps 
and 35 ml for the triangle ones. This was pre-determined through pilot runs to be sufficient 
for the pressure and flow to reach equilibrium. 
 
3.2.2.4 Statistical analysis 
 Statistical analysis was performed using Prism 4 software (GraphPad Software, Inc., 
CA, USA). The paired t-test was used when comparing 2 groups while repeated measures 
ANOVA with Bonferroni’s multiple comparison post-test was used when comparing 3 
groups. P < 0.05 was considered statistically significant. 
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3.3 Results 
 
3.3.1 Comparison between scaling analysis and physical model 
 The experimental variation of 
 
 
 with 
    
   
 is shown in Figure 3.10. The experiments 
cover a significant range of 
    
   
 (over 10 decades) because of the sensitivity of the results 
to  . The experimental results support the scaling analysis, with a 1/4 gradient for 
 
 
 < 1 
(bending state) and 1/6 gradient for 
 
 
 > 1 (stretching state), confirming the predictions of 
Equations 3.6 and 3.8 respectively. The experimental variation of 
 
 
 with 
  
   
 is shown in 
Figure 3.11. There was a wide scattering of the data points, indicating a poor correlation 
between the analysis and the measured pressure values. 
 
 
Figure 3.10 Experimental variation of 
 
 
 with 
    
   
 (see Equations 3.6 and 3.8), showing 1/4 
and 1/6 gradients corresponding to the bending and stretching states. 
bending 
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stretching 
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Figure 3.11 Experimental variation of 
 
 
 with 
  
   
 (see Equations 3.10 and 3.11), showing 
the wide scattering of data points. 
 
3.3.2 Pressure under the scleral flap 
Note that the pressure readings do not correlate with actual IOP. They are however 
indicative of the relative differences in IOP with different scleral flap configurations in the 
actual trabeculectomy procedure. 
The pressure readings were heavily influenced by flow rate and sheet thickness. 
With our setup, the lowest flow rate of 100 ml/h generally gave small pressure changes (< 
0.1 mmHg) which were affected more by experimental errors. When the rate of 200 ml/h 
was used, this problem was reduced. The thinner 0.8 mm sheet also tended to provide low 
readings. The biggest differences were seen with the thicker 1.6 mm sheet and rate of 400 
ml/h. 
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A total of six experimental runs were performed for each setting. In the following 
graphs, pressure drops are inversely related to the pressure values shown. Error bars 
indicate 1 standard deviation (SD) and asterisks (*) indicate where differences are 
statistically significant (p < 0.05). 
 
Influence of flap thickness 
Pressures under the thicker sheets were higher than those under the thinner sheets 
i.e. the pressure drops were smaller. When there were 3 sutures for triangles and 2 sutures 
for rectangles and squares (Figure 3.12), pressures under the thinner sheets were between 
35.6-48.9% of pressures under the thicker sheets. When there were 3 sutures for triangles 
and 5 sutures for rectangles and squares (Figure 3.13), pressures under the thinner sheets 
were between 27.2-42.8% of pressures under the thicker sheets. 
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Figure 3.12 Comparison between thicknesses when there were 3 sutures for triangles and 2 
sutures for rectangles and squares. With all 3 shapes, pressures were higher with the thicker 
sheet. 
 
 
Figure 3.13 Comparison between thicknesses when there were 3 sutures for triangles and 5 
sutures for rectangles and squares. With all 3 shapes, pressures were higher with the thicker 
sheet. 
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Influence of flap shape 
When there were 3 sutures for triangles and 2 sutures for rectangles and squares, we 
found that triangles maintained higher pressures, followed by rectangles and squares 
(Figure 3.14). The pressures under the rectangular sheets were between 48.6-80.3% of 
pressures under the triangular sheets and pressures under the square sheets were 29.7-
40.2% of pressures under the triangular sheets. When there were 3 sutures for triangles and 
5 sutures for rectangles and squares, a similar pattern was seen but the differences were all 
not statistically significant (Figure 3.15). Pressures under the rectangular sheets were 
between 61.8-108.9% of pressures under the triangular sheets and pressures under the 
square sheets were 61.4-88.5% of pressures under the triangular sheets. 
 
 
 
Figure 3.14 Comparison between shapes when there were 3 sutures for triangles and 2 
sutures for rectangles and squares. Triangles maintained higher pressures, followed by 
rectangles and squares. 
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Figure 3.15 Comparison between shapes when there were 3 sutures for triangles and 5 
sutures for rectangles and squares. There were no statistically significant differences 
between the shapes. 
 
Influence of suture numbers and positions 
With increasing numbers of sutures, the pressure drop became smaller (Figures 
3.16-3.18). With the rectangular sheets, 4 sutures provided between 58.7-84.2% of the 
pressures with 5 sutures and 2 sutures provided between 44.6-130% of the pressures with 5 
sutures. With the square sheets, 4 sutures provided between 45.3-98.4% of the pressures 
with 5 sutures and 2 sutures provided between 49.9-54.5% of the pressures with 5 sutures. 
With the triangular sheets, 1 suture provided between 52.5-81.0% of the pressures with 3 
sutures. 
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Figure 3.16 Comparison between number of sutures in the rectangle group. Generally, 
higher pressures were maintained with more sutures. 
 
 
 
Figure 3.17 Comparison between number of sutures in the square group. Generally, higher 
pressures were maintained with more sutures. 
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Figure 3.18 Comparison between number of sutures in the triangle group. Higher pressures 
were maintained with more sutures. 
 
3.3.3 Fluid flow under the scleral flap 
For this part of the experiment, we determine the flow under the flap using the height and 
spread of fluid in the final image. There may be differences between our findings and actual 
aqueous humour flow under the scleral flap due to other differences between the silicone 
sheet used in our model and actual sclera such as wettability characteristics. 
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Influence of flap thickness 
When comparing between the different thicknesses, we found fluid height under the 
thinner sheets to be higher and wider for all three sheet shapes (Figure 3.19). The difference 
was small with the rectangle and square sheets but larger with the triangle sheet. The 
direction of flow was similar between thicknesses. 
 
Influence of flap shape 
Our results were inconclusive when considering rectangles and squares with 5 
sutures (see next section). With the 4-suture rectangle and square sheets, we found that the 
direction of flow was away from the limbus towards the opposite edge (Figures 3.20a and 
b). With the 2-suture rectangle sheet (Figure 3.20c), the direction of flow was away from 
the limbus and also to the sides. With the 2-suture square sheet (Figure 3.20d), the direction 
of flow was to the sides. With 3-suture triangles, the flow was also away from the limbus 
(Figure 3.20e) but when there was only 1 suture then the flow was to the sides (Figure 
3.20f). 
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Figure 3.19 False colour final images showing fluid height under a) rectangle (b) square 
and (c) triangle sheets. Suture positions (grey boxes) are superimposed on the images. The 
images on the left are for 1.6 mm thickness while those on the right are for 0.8 mm 
thickness. Fluid heights under the thinner sheets were higher and wider for all three sheet 
shapes. 
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Figure 3.20 False colour final images showing fluid movement under a (a) rectangle with 4 
sutures, (b) square with 4 sutures, c) rectangle with 2 sutures,  d) square with 2 sutures, e) 
triangle with 3 sutures and (f) triangle with 1 suture. Suture positions (grey boxes) are 
superimposed on the images. With 4-suture rectangle and square sheets, the direction of 
flow was away from the limbus towards the opposite edge. With the 2-suture rectangle 
sheet the flow was away from the limbus and also to the sides. With the  
b) a) 
c) d) 
e) f) 
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(Continued) Figure 3.20 
2-suture square sheet, the direction of flow was to the sides. With 3-suture triangles, the 
flow was also away from the limbus but when there was only 1 suture then the flow was to 
the sides. 
 
Influence of suture numbers and positions 
With the 5-suture rectangle and square configurations, fluid tended to accumulate 
under the sheets as they were well constrained. With 4 sutures, the flow was directed more 
posteriorly while with 2 sutures the flow was directed mainly to the sides (Figures 3.21 and 
3.22). With 3-suture triangles, the flow was away from the limbus but when there was only 
1 suture then the flow was to the sides (Figure 3.23). 
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Figure 3.21 False colour final images showing fluid movement under a rectangular sheet 
with (a) 5, (b) 4 and (c) 2 sutures. Suture positions (grey boxes) are superimposed on the 
images. With 5 sutures, fluid accumulated under the sheet as it was well constrained. With 
4 sutures, the flow was directed posteriorly while with 2 sutures the flow was directed 
posteriorly and to the sides. 
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Figure 3.22 False colour final images showing fluid movement under a square sheet with 
(a) 5, (b) 4 and (c) 2 sutures. Suture positions (grey boxes) are superimposed on the images. 
With 5 sutures, fluid accumulated under the sheet as it was well constrained. With 4 
sutures, the flow was directed posteriorly while with 2 sutures the flow was directed to the 
sides. 
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Figure 3.23 False colour final images showing fluid movement under a triangular sheet 
with (a) 3 sutures and (b) 1 suture. Suture positions (grey boxes) are superimposed on the 
images. With 3 sutures, the flow was away from the limbus but with 1 suture it was to the 
sides. 
 
3.4 Discussion 
 
3.4.1  Comparison between scaling analysis and physical model 
 The scaling analysis showed that the displacement generated by fluid flow scaled as 
 
 
  
    
   
 
 
 
 when the elastic sheet was bending and 
 
 
  
    
   
 
 
 
 when it was stretching, 
which was the same as that of the Ahmed Glaucoma Valve in our previous study 
(Appendix A). We were able to confirm this non-linear, valvular relationship (Oosterbroek 
et al., 1998) between scleral flap displacement and flow rate with our experimental 
findings. Stay et al. (2005) reported that pressure scaled as    
 
  with Ahmed 
Glaucoma Valves. From our theoretical calculations, we also expected the trabeculectomy 
scleral flap to have the same dependence, with 
 
 
  
  
   
 
 
 
 
 
 
 
 
 
 in the bending state and 
a) b) 
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 in the stretching state. However, we could not confirm this relationship 
due to the poor correlation between the calculations and the experimental data, and believe 
this to be due mainly to a weakness with our recording equipment. With the flow rates 
used, most of the net pressure changes were low (≤ 1 mmHg) and this was at the lower 
limit of sensitivity and precision of the pressure transducer. The lack of precision was 
especially significant as very small differences in   were expected from the experiment 
(between 10
-4
 and 10
-5
 [dimensionless quantities], as can be seen in Figure 3.11). 
 
3.4.2 Pressure and fluid flow under the scleral flap 
A trabeculectomy involves the creation of a guarded drainage channel in the sclera, 
through which aqueous humour can flow out of the eye in a controlled manner into a 
subconjunctival bleb, thereby reducing the IOP. In the early post-operative period, the 
scleral flap serves as the principal resistance to aqueous humour outflow (Birchall et al., 
2006; Birchall et al., 2007; Tse et al., 2012). This makes it important as a regulator to 
reduce the risk of overfiltration and hypotony, and conversely it may also result in 
inadequate reduction in IOP. In addition, this flap may also have an important role in the 
posterior diversion of aqueous humour flow, which is desirable (Jones et al., 2005; Birchall 
et al., 2006; Dhingra et al., 2009). All these factors provided the motivation to look at 
pressure changes and aqueous humour flow direction afforded by this flap after the 
procedure. 
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Influence of flap thickness 
As flap thickness increases, its rigidity and resistance to lifting also increases 
(Birchall et al., 2007). This is seen in our case, with thinner flaps there is more fluid flow 
below it and to the outside thus creating a larger pressure drop (50-70% lower pressures 
with the thinner 0.8 mm sheets). In a recent computational study, trabeculectomy surgery 
was modelled using finite element simulation to compare the effect of various scleral flap 
and sclerostomy shapes and sizes on aqueous humour outflow rate in an objective manner 
(Tse et al., 2012). Computations were performed based on fluid-solid interaction involving 
theoretical flap deformation caused by the flow of aqueous humour under it. In their 
comparison with 250 μm thick flaps, the authors found a marginal reduction (-4.8%) in 
aqueous humour outflow rate with 300 μm thick flaps but a much larger increase 
(+188.4%) with 200 μm thick flaps. 
The results indicate that the thickness of the scleral flap created during 
trabeculectomy may be tailored according to the desired IOP outcome. In clinical practice, 
half thickness (around 250 μm) flaps are recommended (Jones et al., 2005; Stalmans, 2006; 
Salim, 2012). To facilitate more aqueous humour flow, thinner flaps can be created, and 
vice versa. However, only very small changes should be made as when scleral flap 
thickness gets closer to 200 μm there may not be sufficient tension to control aqueous 
humour flow and also a higher risk of dehiscence or cheese-wiring of the flap (Tse et al., 
2012; Dhingra et al., 2009; Khaw et al., 2012). 
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Influence of flap shape 
In the 3-suture triangle versus 2-suture rectangle and square comparison, there were 
statistically significant higher pressures with the triangles, by around 20-70%. The 
differences were not statistically significant in the 3-suture triangle versus 5-suture 
rectangle and square comparison. This discrepancy could be due to the 3-suture triangle 
flaps having more sutures and thus more resistance to flow than the 2-suture rectangle and 
square flaps. However, in this same configuration group, there were also statistically 
significant differences between the rectangle and square flaps, so the effect of sutures 
cannot completely account for the results. We believe that triangular flaps of the same 
width and length result in lower pressure drops than rectangular or square ones. This is due 
to the smaller surface area of the triangular flap, being half of that of a rectangle or square 
with similar dimensions. Although not statistically significant, the rectangles in our 
experiment also had lower pressure drops compared to squares, a difference likely to be due 
to the smaller surface area (108 cm
2
 versus 144 cm
2
). 
Our pressure findings support the findings reported by Tse et al. which showed that 
triangular flaps led to lower aqueous humour outflow rates and higher pressures when 
compared to square ones. For example, the rate for a 4 mm × 4 mm triangle flap was 57.6% 
lower than that of a 4 mm × 4 mm square flap. They also found that smaller scleral flaps 
result in lower aqueous humour outflow rates. For example, the rate for a 3 mm × 2 mm 
rectangle flap was 32.7% lower than that of a 4 mm × 4 mm square flap. Interestingly, 
when they compared a 4 mm × 4 mm square flap with a 5.65 mm × 5.65 mm triangle flap 
which had the same surface area, the aqueous humour outflow rate was 26.6% lower with 
the triangle flap. However, the triangles in their study all had 3 sutures compared to 2 
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sutures for the squares and rectangles, the difference which could explain the lower flow 
rates with the triangles. This effect of sutures will be discussed in the next section. 
The evidence points to that if larger reductions in IOP are needed, then the scleral 
flap should be made square or larger. However, this effect does not seem to be reflected in 
clinical findings. In a study to compare a triangular flap in one eye versus a square-shaped 
one in the other eye of the same patient, there was no long-term difference in the post-
operative IOP and complication rates (Kimbrough, Stewart, Decker, & Praeger, 
1982). Another study comparing triangular and square scleral flaps found that there was a 
pressure difference (2.5 mmHg lower for triangular flaps) for the first two post-operative 
days although this difference became non-significant after that. Additionally, in this study 
the triangular flaps only had one suture for ‘high flow’ of aqueous humour, compared to 
four sutures for the square flaps for ‘low flow’ conditions (Batterbury & Wishart, 1993). 
The exact dimensions of the flaps could not be ascertained in these reports for us to 
examine the effect of size. 
Other studies considered the effect of varying the size of the scleral flap. In a 
laboratory study modelling trabeculectomy on cadaver eyes with real time monitoring of 
the IOP, there was no significant effect of changing flap sizes from 4 mm × 4 mm to 3 mm 
× 2 mm on the eventual IOP (Birchall et al., 2007). Two clinical studies showed no clear 
advantage or disadvantage of 4 mm × 4 mm scleral flaps compared to 2 mm × 2 mm ones 
(Starita, Fellman, Spaeth, & Poryzees, 1984; Vernon et al., 1998). However, there are 
potential advantages of smaller flaps, there being a larger area of undisturbed tissue (which 
might be important in reducing overall bleb scarring or if repeat surgery is required) and a 
reduced astigmatic effect on the cornea (Vernon et al., 1998; Vernon, Zambarakji, 
Potgieter, Evans, & Chell, 1999). 
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We found that the direction of flow was influenced less by shape but more by the 
number and position of sutures, which will be discussed in the next section. With different 
shapes, the small difference between them could be due to the similarity in their 
width:length aspect ratios, which in our experiment were 1.33 for rectangles, 1.00 for 
squares and 1.15 for triangles. In a previous computational and experimental study by our 
group (unpublished data), we found that the width:length aspect ratio of a scleral flap was 
important in determining the direction of aqueous humour flow. Changing the shape of the 
flap from a square (aspect ratio 1.0) to wide rectangle (aspect ratio 2.5) would increase the 
fraction of fluid moving posteriorly by a factor of 6. Additionally, with width:length aspect 
ratios of < 2, triangular flaps created more posterior flow. When this aspect ratio increased 
to > 2, the effect was reversed. However, as far as we know, there have not been any 
clinical studies to compare these theoretical and experimental results with. 
 
Influence of suture numbers and positions 
Our results show that the pressure drop becomes smaller when more sutures are 
inserted. With more sutures, there is more resistance under the scleral flap, leading to less 
aqueous humour escape through the flap gap and thus a higher pressure is maintained. 
Careful control of the pressure drop is important, especially to avoid hypotony after 
trabeculectomy. In certain cases such as in inflammatory glaucoma where there may be 
postoperative ciliary body shutdown and increased uveoscleral outflow (Rahman et al., 
2000; Schubert, 1996; Toris et al., 1987), the number of sutures may need to be increased to 
allow for the higher risk of hypotony. 
We were unable to determine flow direction with the 5-suture configuration as the 
fluid accumulated under the well-constrained sheets. With 4 sutures, the flow was directed 
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more posteriorly while with 2 sutures the flow was directed more to the sides. In the 
triangle group, this pattern was also seen with 3 sutures and 1 suture respectively. The 
direction of flow naturally avoids the suture positions due to the higher resistance 
encountered. In the case of 2 sutures (for rectangles and squares) or 1 suture (for triangles), 
it is also affected by the distance to the closest edge of the sheet. A larger portion of fluid 
flows to the sides as they are closer to the sclerostomy as compared to the opposite edge. 
From our results, we support the intra-operative use of an anterior chamber infusion 
via a paracentesis to titrate flow during scleral flap closure (Jones et al., 2005; Dhingra et 
al., 2009; Khaw et al., 2012). The number and position of sutures can be varied by 
observing fluid flow, of which amount and direction can be a good estimate of the post-
operative outcome. However, it is also important to note that if there is too little flow 
underneath the scleral flap, such as when having too many sutures, there might be increased 
scarring and resistance underneath it and this will lead to even less aqueous humour 
outflow and high IOP (Haynes & Alward, 1999; Bettin, 2012). A good strategy around this 
is to use adjustable or releasable sutures to titrate pressure postoperatively (Wells et al., 
2004; Jones et al., 2005; de Barros et al., 2008; Kobayashi et al., 2011). With this strategy, 
a slightly higher initial post-operative IOP is still acceptable as this can be lowered by 
adjusting or removing sutures a few days to a few weeks after the initial surgery. 
 
There was a number of limitations in our experiment. Suture tension can be an 
influential factor in determining pressure and direction of flow (Wells et al., 2004; Birchall 
& Wells, 2008). However, in clinical practice the exact amounts of tension applied are 
variable among surgeons, and indeed many surgeons put in adjustable or releasable sutures. 
We therefore did not look into this effect and designed our experiment such that there was 
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standardised and adequate but not tight suture tension at the edges of the scleral flap in our 
model. The effect of the sclerostomy size was also not considered. Tse at al. (2012) looked 
into this and reported that smaller sclerostomy surface areas, and thus larger flap-to-
sclerostomy surface area ratios increased aqueous humour outflow rate. 
Additionally, our experimental setup also did not include a fluid capacitor, as used 
in flow experiments with actual glaucoma drainage devices on their own i.e. not mounted 
into eyes (Eisenberg et al., 1999; Lim, Wells, & Khaw, 2002). In retrospect, compliance 
provided by this capacitor could eliminate the initial spike in pressure before the valve 
opened (Figure 3.6). However, we do not think we were significantly disadvantaged as we 
were looking at the subsequent steady state equilibrium pressures and not valve opening or 
closing pressures (Gilbert & Bond, 2007). Finally, we also acknowledge that in the actual 
procedure, numerous other variables come into play, especially in the longer term e.g. 
wound healing and scarring under the conjunctival bleb (Azuara-Blanco & Katz, 1998; 
Khaw et al., 2001). As such, our study only provides information on the early post-
operative control of IOP and aqueous humour flow. 
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3.5 Conclusion 
 
The scaling analysis and experimental data show that the trabeculectomy scleral 
flap has a valve-like, non-linear dependence of displacement as a function of flow rate. The 
dependence of pressure as a function of flow rate could not be determined. Flap thickness, 
shape and the number and position of sutures can affect pressure and aqueous humour flow 
under the scleral flap. Thinner and larger scleral flaps, as well as lower number of sutures 
provide higher pressure drops, with the effect of the sutures being clinically more 
significant. Similarly, flow direction is affected mainly by suture number and position, 
aqueous humour moves away from areas of the flap under tension from the sutures and 
more towards the nearest free edge of the flap. Posterior flow of aqueous humour is 
promoted by placing sutures along the sides while leaving the posterior edge free. 
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Chapter 4 
4 The effect of scleral flap shapes, suture numbers and aqueous humour protein 
content and viscosity on equilibrium pressure under the trabeculectomy scleral flap in 
a porcine model 
 
4.1 Introduction 
 
This experiment was designed to compare and validate the equilibrium pressure 
findings from our physical model in Chapter 3 to that of a porcine scleral flap model. A 
trabeculectomy scleral flap is created on mounted porcine sclera and the resulting 
equilibrium pressures with different scleral flap shapes and suture numbers are measured. 
Porcine eyes have been used as trabeculectomy and non-penetrating glaucoma surgery 
models, and in other glaucoma-related experiments such as to assess uveoscleral outflow 
and to investigate the change in IOP during LASIK surgery (Jacobi, Dietlein, Colling, & 
Krieglstein, 2000; Lee, Chiang, & Shah, 2006; Shaarawy, Wu, Mermoud, Flammer, & 
Haefliger, 2004; Xu, Yao, Wu, Li, & Ye, 2010; Wagner, Edwards, & Schuman, 2004; 
Hernandez-Verdejo, Teus, Roman, & Bolivar, 2007). This is in view of their low cost, easy 
availability and the fact that their size and volume, particularly of the anterior chamber (0.3 
ml), are closer to the human than any other species reported (Sanchez, Martin, Ussa, & 
Fernandez-Bueno, 2011).
 
The sclera is 2 × thicker than human sclera but both have similar 
histology and collagen bundle arrangement (Nicoli et al., 2009). The particular model that 
we employed was based on that of the AGFID project team (2001) which used porcine 
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corneoscleral buttons mounted on an artificial anterior chamber to assess fluid leakage and 
pressure control after making stab incisions through the sclera. 
Additionally, we also used this model to look at the influence of aqueous humour 
protein content and viscosity on equilibrium pressures under the scleral flap, to see if higher 
IOP could be expected soon after trabeculectomies for example in eyes affected by 
secondary glaucoma due to inflammation (Panek, Holland, Lee, & Christensen, 1990; 
Herbert, Viswanathan, Jackson, & Lightman, 2004; Siddique, Suelves, Baheti, & Foster, 
2013). Changes in aqueous humour protein content may occur in inflammation, due to the 
breakdown of the blood-aqueous barrier, leading to increased levels of albumin, globulin 
and fibrinogen. In normal aqueous humour the protein content is around 10-20 mg/ 100 ml, 
and in cases of uveitis this can increase to 1000-2000 mg/ 100 ml (Krause & Raunio, 1969; 
Krause & Raunio, 1970; Tripathi, Millard, & Tripathi, 1989). For comparison, the protein 
content of plasma is 6000-7000 mg/ 100 ml (Gornall, Bardawill, & David, 1949). Previous 
studies have reported that increased aqueous humour protein content and its subsequent 
aggregation and precipitation can increase the resistance of the trabecular meshwork and 
reduce outflow facility (Epstein, Hashimoto, & Grant, 1978; Johnson et al., 1986; Ladas et 
al., 2001). As such, we can see how this is a possible mechanism of raised IOP and 
glaucoma. 
Another potential determinant of outflow facility is aqueous humour viscosity or its 
resistance to flow, which is increased by higher protein contents. Viscosity is a measure of 
the friction between layers in a fluid which are travelling at different velocities, with 
velocity being highest in the centre and lowest in the periphery. With higher viscosity, more 
stress i.e. pressure is needed to overcome this friction to maintain movement of the fluid 
with the same velocity pattern. Although there have been reports of aqueous humour 
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viscosity not changing significantly in the presence of excess protein in inflammation 
(McEwen, 1958) or in POAG (Vass et al., 2004), one study found that it affected outflow 
facility in cadaveric eyes more than expected when measured differences between infusion 
fluids were analysed (Epstein et al., 1978). The authors reported that diluted serum had less 
viscosity than undiluted, but interfered with outflow facility more than anticipated on the 
basis of viscosity alone. They concluded that serum proteins interfere with outflow in a 
more complex way than through abnormal viscosity alone. As far as we know, there are no 
repeat or similar studies that have been subsequently reported. 
When there is a breakdown of the blood-aqueous barrier, the trabecular meshwork 
may also be blocked by inflammatory cells. As the trabecular meshwork pore size goes 
down to < 15 μm in diameter (Bill & Svedbergh, 1972), 10 μm diameter red blood cells and 
10-20 μm diameter white blood cells (Young, Lowe, Stevens, & Heath, 2006) may cause 
blockage and a reduction in aqueous humour outflow. However, in a clinical study by 
Ladas et al. (2001), there was no correlation between outflow facility as determined by 
Schiotz tonography and the amount of anterior chamber cells as determined by slit-lamp 
microscopy. The authors did however find a correlation between outflow facility and 
aqueous humour protein levels inferred from laser flare photometry. They suggested that 
the effect of cells on aqueous humour outflow facility was smaller than the effect of its 
protein content. 
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4.2 Methods 
 
Eyes from 6-12 month old mixed breed pigs were used. Whole pig heads were 
obtained from an abattoir and the eyes enucleated and used within 36 hours of slaughter 
(Johnson, 2005). The eyes were discarded if they had any discernible damage on them. 
These eyes were sectioned horizontally and the iris, lens, vitreous and choroid removed 
(Figure 4.1). The scleral segments were then cut into 18 mm diameter asymmetrical discs, 
to include a small section of limbus and cornea. These discs were then mounted on a 
Barron artificial anterior chamber, normally used in corneal transplant surgery (Katena 
Products, Inc., NJ, USA) [Figure 4.2]. Room temperature was maintained around 21 
o
C. 
One inlet port of the artificial anterior chamber was attached to the infusion pump 
(Cole-Parmer, IL, USA) and pressure transducer (model 162PC01D, 8V excitation; 
Honeywell International, NJ, USA). This pressure transducer was connected to an interface 
board/ voltmeter (model VM110; Velleman NV, Gavere, Belgium) and personal computer 
(PC) [Figure 4.3]. The other inlet port of the artificial anterior chamber was closed. Non-
expansile, low compliance silicone tubing (outer diameter 6 mm, internal diameter 3 mm) 
was used throughout the system. The working fluid used to mimic aqueous humour was 
Balanced Salt Solution (BSS; Alcon Laboratories, Inc., Texas, USA) unless stated 
otherwise. BSS is used in ophthalmic surgery for irrigation and to replace aqueous humour 
(Edelhauser & Macrae, 1995). It has similar pH, osmolality and concentrations 
of sodium, potassium, calcium, magnesium and chloride to aqueous humour. 
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Figure 4.1 Enucleated porcine eye before sectioning (left), after sectioning and removal of 
iris, lens, vitreous and choroid (right). 
 
 
Figure 4.2 Barron artificial anterior chamber used to mount corneoscleral segments. 
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Figure 4.3 Experimental setup. The artificial anterior chamber was connected to the 
infusion pump and pressure transducer using non-expansile tubing and a 3-way tap. 
 
 Before the actual experiment, we calibrated the pressure transducer (see Chapter 3) 
and measured the resistance of the Barron artificial anterior chamber and silicone tubing. 
This was done by infusing BSS at 50, 100, 200, 300 and 400 ml/h through the system with 
the two tissue pedestal openings open to the atmosphere. The tissue pedestal openings and 
the pressure transducer inlet port were positioned at the same level. The resistance was 
determined from the slope of the pressure vs. flow rate line. Compliance of the silicone 
tubing was also measured. We infused 10, 20, 30 and 40 µl of BSS into the system with the 
pinch clamps closed and measured the resulting pressure changes. The compliance was 
derived from the slope of the volume infused vs. pressure line. 
At the start of each experimental run, the infusion rate was set at 3 μl/min (0.18 ml/h) 
to mimic normal aqueous humour production rate. When the pressure was around 20 
mmHg, a scleral flap was fashioned on the mounted sclera (Figure 4.4). A 250 μm Accurate 
Depth blade (BD, NJ, USA) was used to outline either 4 mm x 3 mm rectangles, 4 mm x 4 
mm squares or 4 mm x 4 mm triangles (Figure 4.5). A crescent knife was then used to 
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dissect below the flap up to the limbus. This flap was then reflected and a stab incision with 
an MVR blade performed at the limbus. After this step, a 0.75 mm in diameter sclerostomy 
was performed with a Kelly Descemet’s membrane punch. Any remaining air in the 
anterior chamber was removed through the sclerostomy by a gentle bolus of BSS. The flap 
was then repositioned and sutured down with 2 10/0 nylon sutures. In Chapter 3, we found 
that sutures played the most important role in determining pressure, so an equal number of 
sutures for all 3 shapes was chosen to prevent spurious results due to discrepancy in suture 
numbers. For the rectangular and square flaps, the sutures were positioned at the 2 far 
corners while for the triangular flaps these were midway along the 2 free edges. The sutures 
were tied to achieve adequate tightness while avoiding creasing or stretching of the scleral 
flap. Time was then reset to zero and the equilibrium pressure in the chamber recorded. 
This was defined as a steady pressure with fluctuations within 0.5 mmHg of each other for 
> 5 minutes (Figure 4.6). The tracing was expected to typify the rise in IOP after the scleral 
flap was sutured in a trabeculectomy. 
For the comparison between different fluids, to standardise the shape we only used 4 
mm wide x 3 mm long rectangular scleral flaps. However, these rectangular flaps had either 
4 or 2 sutures each (Figure 4.5) and the groups were compared separately. 
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Figure 4.4 a) Porcine eye mounted on artificial anterior chamber, b) scleral flap margin 
demarcated, c) scleral flap created and reflected, d) after sclerostomy, e) after resuturing (2 
sutures), f) after resuturing (4 sutures). 
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Figure 4.5 Configurations of scleral flaps and sutures. Top row shows 2 sutures each in the 
comparison between different scleral flap shapes. Bottom row shows rectangles with 2 and 
4 sutures each, used in the comparison between different fluids. 
  
150 
 
 
Figure 4.6 Typical pressure curve after resuturing the scleral flap, showing equilibrium as 
fluid flows out under the scleral flap. Due to compliance of the sclera and chamber space, 
there was no spike in the increase in pressure. 
 
 We used three different infusion fluids in this part of the experiment. The first was 
plain BSS as a control, the second was albumin in BSS in a concentration of 300 mg/ 100 
ml to model a moderate amount of abnormal aqueous humour protein (Shah, Spalton, & 
Taylor, 1992). For this, 1 ml of 30% Bovine Serum Albumin (BSA) was added to 99 ml of 
BSS. The third solution contained albumin in BSS at a concentration of 3000 mg/ 100 ml to 
simulate a maximal amount of abnormal aqueous humour protein (Krause et al., 1970). For 
this, 10 ml of 30% Bovine Serum Albumin (BSA) was added to 90 ml of BSS. We chose 
albumin as the source of protein because it constitutes the majority (55% by mass fraction) 
of aqueous humour protein (Krause et al., 1969; Shah et al., 1992). 
The viscosities of these fluids were measured with a U-tube viscometer (size A; 
VWR International Limited, UK). This was to enable us to directly compare our viscosity 
results with those of Epstein et al. (1978). The following steps were taken according to the 
manufacturer’s guidelines and that in the European Pharmacopoeia 5.0 (European 
0 
2 
4 
6 
8 
10 
12 
14 
16 
18 
20 
0 5 10 15 20 
P
 (
m
m
H
g)
 
t (min) 
151 
 
Directorate for the Quality of Medicines, 2005a). The viscometer was partially immersed 
and kept upright in a water bath at 21 °C. 12 ml of the fluid to be tested was pipetted into 
the viscometer and left for 30 minutes for temperature equilibration. Suction was applied to 
the other limb to raise the fluid level beyond the upper mark, and then released. The time 
required for the level of the fluid to drop from the upper mark to the lower one was 
measured with a digital stopwatch to the nearest tenth of a second. 5 readings were taken 
for each fluid and compared to that of distilled water, to get the relative viscosity. The 
viscometer was rinsed with distilled water and acetone before drying in air between fluids. 
 In all groups, n = 8. Statistical analysis was performed using Prism 4 software 
(GraphPad Software, Inc., CA, USA). The unpaired t-test was used when comparing 2 
groups while one-way ANOVA with Bonferroni’s multiple comparison post-test was used 
when comparing 3 groups. P < 0.05 was considered statistically significant. 
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4.3 Results 
 
The resistance of the Barron artificial anterior chamber and silicone tubing was 
0.0002 mmHg/μl/min and this was taken into consideration when calculating the actual 
pressure. The compliance of the silicone tubing was 1.60 µl/mmHg. The relative viscosities 
of the various working fluids (compared to distilled water at 21
 o
C) were 1.02 +/- 0.002 
(mean +/- SD) for plain BSS, 1.04 +/- 0.001 for albumin in BSS (300 mg/ 100 ml) and 1.12 
+/- 0.001 for albumin in BSS (3000 mg/ 100 ml) [p < 0.001]. 
As our model here is still quite dissimilar from an actual eye (e.g. not having the 
same ocular compliance in the absence of the majority of the sclera and cornea, and other 
eye structures such as the iris and trabecular meshwork), the pressure readings may not 
correlate exactly with actual IOP. Instead this model gives an indication of the relative 
difference in IOP. The advantage of this model is that we are able to isolate the effect of the 
variables solely on the scleral flap. 
In the following bar charts, error bars indicate 1 SD and * indicates a statistically 
significant difference. When comparing the different shapes (Figure 4.7), the mean for 
triangles was 19.6 +/- 7.3 mmHg, for rectangles was 18.7 +/- 5.1 mmHg and for squares 
was 16.5 +/- 5.3 mmHg. The differences between them were not statistically significant (p 
= 0.755). 
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Figure 4.7 Comparison between different shapes, using BSS as the working fluid. There 
was no statistically significant difference between the shapes. 
 
When comparing the different fluids, in the 4 suture group (Figure 4.8), the mean 
equilibrium pressure with plain BSS was 31.9 +/- 5.0 mmHg, for albumin in BSS (300 mg/ 
100 ml) was 31.6 +/- 5.5 mmHg and for albumin in BSS (3000 mg/ 100 ml) was 33.1 +/- 
6.2 mmHg. There was no statistically significant difference between the fluids (p = 0.859). 
In the 2 suture group (Figure 4.9), the mean equilibrium pressure with plain BSS was 18.7 
+/- 5.1 mmHg, for albumin in BSS (300 mg/ 100 ml) was 19.4 +/- 5.0 mmHg and for 
albumin in BSS (3000 mg/ 100 ml) was 20.4 +/- 4.7 mmHg. Again, there was no 
statistically significant difference between the fluids (p = 0.841). 
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Figure 4.8 Comparison between fluids in the 4-suture group. There was no statistically 
significant difference between the fluids. 
 
 
Figure 4.9 Comparison between fluids in the 2-suture group. There was no statistically 
significant difference between the fluids. 
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When comparing the same fluid with 4 or 2 sutures (Figure 4.10), all groups showed 
statistically significant differences. In the BSS group, 4 sutures yielded 31.9 +/- 5.0 mmHg 
while 2 sutures yielded 18.7 +/- 5.1 (p = 0.002). In the albumin in BSS (300 mg/ 100 ml) 
group, 4 sutures yielded 31.6 +/- 5.5 mmHg while 2 sutures yielded 19.4 +/- 5.0 mmHg (p 
< 0.001). Finally, in the albumin in BSS (3000 mg/ 100 ml) group, 4 sutures yielded 33.1 
+/- 6.2 mmHg while 2 sutures yielded 20.4 +/- 4.7 mmHg (p = 0.002). 
 
 
Figure 4.10 Comparisons between same fluids with 4 or 2 sutures. When considering the 
same fluid, 4 sutures always maintained higher pressures. 
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4.4 Discussion 
 
In this experiment, we looked at the influence of scleral flap shapes and suture 
numbers on equilibrium pressure under the scleral flap in trabeculectomies. This was to 
enable a comparison with some findings from our physical model experiment in Chapter 3. 
As this porcine scleral flap model more closely resembles an actual eye as compared to the 
previous physical model, we also employed it to look at the influence of aqueous humour 
protein content and viscosity, which may increase in anterior chamber inflammation. 
In contrast to our findings in Chapter 3 and that of Tse et al. (2012), with this 
porcine model we found no differences in equilibrium pressures with the different shaped 
scleral flaps. This finding is in keeping with the clinical findings reported by Kimbrough et 
al. (1982) and Batterbury et al. (1993) as discussed in Chapter 3.There was also no 
statistically significant difference between the different sizes and surface areas. In this 
study, the surface areas of our porcine flaps were 8 mm
2 
(triangle), 12 mm
2 
(rectangle) and 
16 mm
2
 (square).
 
Birchall et al. (2007) found no difference in IOP between 16 mm
2
 and 6 
mm
2
 flaps made in enucleated human eyes. Starita et al. (1984) and Vernon et al. (1998) 
found no difference between 16 mm
2
 flaps and 4 mm
2
 microtrabeculectomy flaps in actual 
patients. 
The discrepancy between physical/ computational models and actual eye tissue 
could be due to factors such as ocular rigidity or compliance (Pallikaris, Dastiridou, 
Tsilimbaris, Karyotakis, & Ginis, 2010) and sclerocorneal elasticity (Johnson et al., 2007). 
These are measures of tissue distensibility and indicate how much volume can be 
introduced before a change in pressure occurs. With the porcine sclera and artificial anterior 
chamber in place, there is more compliance in the system which results in less change in 
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pressure with change in volume. As such, statistically significant differences with the 
physical model might not translate similarly in the porcine model. 
Additionally, surface tension of aqueous humour may affect trabecular outflow, 
such as with the vacuolation of aqueous humour into Schlemm’s canal (Ross, Blake, & 
Ayyala, 2010). In a liquid, attractive forces exist between the molecules. The majority of 
molecules are surrounded by other molecules and there is no net force acting on each of 
them. Molecules on the surface, however, are pulled inwards with little or no opposite 
force. The surface layer thus acts as a tense membrane resisting external force. The surface 
tension of glycerine is 63 mN/m at 20 
o
C (National Physical Laboratory, 2013), lower than 
that of BSS which is 71 mN/m (Ross et al., 2010); this difference in character between the 
fluids could also affect flap function and pressures between our models. In summary, there 
is a more complex interaction between the actual eye tissue, ‘aqueous humour’ and sutures 
in the porcine model which most likely explains the differences between it and the physical 
model. 
In this porcine model, when comparing the number of sutures, equilibrium pressures 
with 4 sutures were around 40% higher than with 2 sutures. This is because of the increased 
resistance of the scleral flap, needing a higher pressure for aqueous humour to lift and open 
it. This supports our finding in Chapter 3 and strengthens our belief that sutures play the 
most important role in determining pressure outcomes after trabeculectomy. 
We found no differences in equilibrium pressures between the different fluids, in both 
the 4-suture and 2-suture groups. Although they did not perform trabeculectomies, we 
compare our results with that of Epstein et al. (1978) which showed significant reduction 
(36-42%) in outflow facility in enucleated human eyes when using diluted human serum as 
the infusion fluid. The obvious difference between our model and theirs is they used whole 
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eyes with intact trabecular meshwork. As juxtacanalicular trabecular meshwork pore size 
goes down to < 15 μm in diameter (Bill et al., 1972), these structures are more likely to be 
blocked by precipitation of excess protein, as compared to the larger sclerostomy and space 
under the scleral flap, especially in the initial period before fibrosis and wound healing 
develop. 
In their study, Epstein et al. obtained relative viscosities of 1.12 for diluted 25% 
human serum, 1.29 for diluted 50% human serum and 1.70 for whole human serum, while 
we obtained values of 1.02 for BSS, 1.04 for albumin in BSS (300 mg/ 100 ml) [which is 
expected to be approximately equivalent to diluted 5% human serum] and 1.12 for albumin 
in BSS (3000 mg/ 100 ml) [approximately equivalent to diluted 50% human serum]. The 
relative viscosity values for Epstein et al.’s whole human serum and our BSS were similar 
to that found in another study looking at the viscosity of normal aqueous humour (Beswick 
& McCulloch, 1956). The discrepancy between relative viscosity values of Epstein et al.’s 
diluted 50% human serum and its equivalent in our experiment may be due to differences 
between using serum or albumin. Knowing the relative viscosity of actual uveitic aqueous 
humour could help determine the better model of it, but this has not been reported. This 
knowledge would be helpful for future studies exploring the link between aqueous humour 
protein content, viscosity and subsequent pressure outcomes. 
Taking into account all the evidence, it does not appear that increased aqueous 
humour protein levels and viscosities affect the control of pressure by the scleral flap in the 
initial stages after trabeculectomy before wound healing has developed. However, their 
effect in the long term, or on the trabeculectomy procedure in a whole eye is still 
inconclusive and further studies in this area are indicated. 
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We would like to discuss some features of this model. We were unable to assess the 
effect of scleral flap thickness, due to the technical difficulty in ensuring a precise and 
consistent flap thickness across the whole scleral flap. An attempt to minimise this problem 
was made with the usage of 250 µm Accurate Depth and crescent knives to create the flap. 
Perhaps one way of ensuring a consistent thickness is with the use of a femtosecond laser, 
as has been utilised in a previous laboratory study (Bahar, Kaiserman, Trope, & Rootman, 
2007). However, at the present time, there would likely be cost and availability issues with 
this modality. Our model also does not incorporate the trabecular meshwork or the 
conjunctival bleb. Some authors have previously modelled the trabecular meshwork using 
in-line membrane filters with 0.2 μm and 1.0 μm pores, which are similar to the smallest 
pores of the juxtacanalicular trabecular meshwork (Johnson et al., 1986). However, we did 
not include this in our setup as we wanted to isolate the flow through the trabeculectomy; 
interaction between the infusion fluid and membrane filter could add to another source of 
variable resistance, which would affect our pressure findings. The conjunctival bleb is 
thought to form the main resistance to aqueous humour outflow a few weeks after surgery 
(Azuara-Blanco et al., 1998; Khaw et al., 2001). However, fibrosis and wound healing 
below the bleb are difficult to predict and model accurately (Tse et al., 2012) so we also left 
this feature absent. As such, our model is more suitable for examining the results of 
intervention in the early post-operative stage, when the subconjunctival space is not yet the 
main barrier to flow.  
Our experimental setup here did not include a fluid capacitor, as discussed in the 
preceding chapter. We think this additional component was superfluous as there was 
sufficient compliance in the system and we were measuring equilibrium values for 
pressure, and not valve opening pressures when any surges in pressure can affect 
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measurements (Gilbert et al., 2007). As seen in Figure 4.6, there was no spike in the 
pressure curves we obtained. Finally, the effect of anterior chamber inflammation on the 
aqueous outflow channels may be masked by associated hyposecretion of aqueous humour 
(Sen et al., 2012; Toris et al., 1987) and the IOP may vary depending on the predominance 
of outflow obstruction or hyposecretion. Aqueous humour production may also be similarly 
affected by the surgery itself (Schubert, 1996). These make it difficult to predict the 
outcome after trabeculectomy surgery. With our model, we set the aqueous humour 
‘production’ rate constant at 3 µl/min. We predict that the pressure differences when using 
lower flow rates would be even smaller. 
 
4.5 Conclusion 
 
Equilibrium pressures under the scleral flap are affected by the number of sutures 
but not by typical scleral flap shapes and sizes. Differences between the physical and actual 
eye tissue models are due to a more complex interaction between the scleral flap, aqueous 
humour and sutures. The control of pressure by the scleral flap in the initial stage after 
trabeculectomy is not affected by the different aqueous humour protein contents and 
viscosities encountered in anterior chamber inflammation. 
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Chapter 5 
5 An evaluation of fixed resistance tubes for drainage into the subconjunctival 
space 
 
5.1 Introduction 
 
In Chapter 2 (section 2.6.1), we calculated that subconjunctival space devices with 
permeabilities 1.5-6.0 × more than the glaucomatous eye could provide reductions in IOP 
from 25-50 mmHg to 15 mmHg. Figure 5.1 shows permeability,   by dimensions of tube 
devices as derived from Poiseuille’s Law (see Chapter 2), 
  
 
 
 
   
     
          (5.1) 
where   is resistance,   is internal diameter,   is dynamic viscosity and   is device length. 
The black shaded area covers the range of values for our ideal device (assuming a 
glaucomatous eye with an outflow facility of 0.2 μl/min/mmHg). From Figure 5.1, we 
predict that for a fixed resistance device of around 5 mm in length, a 50-75 µm internal 
diameter (ID) lumen could provide the required aqueous humour flow from the anterior 
chamber to the subconjunctival space. However, with diameters such as these, it is 
conceivable that there is an increased risk of obstruction by protein or fibrin deposition 
post-surgery. 
The pressure drop across the device itself is shown in Figure 5.2. From Poiseuille’s 
Law, 
  
      
   
,          (5.2) 
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at a flow rate,   of 3 μl/min, a 5 mm long device with an ID of 50 µm would have a 
pressure drop of 12.2 mmHg. The relationship is such that if the flow rate is halved to 1.5 
μl/min then the pressure drop will also be halved to 6.1 mmHg as well. These pressure 
drops can also be taken as the differences between pressures in the anterior chamber and 
subconjunctival space ends (Acosta et al., 2006). It can be seen that if the pressure in the 
subconjunctival space is zero, as can be expected in the early post-operative stage before 
wound healing develops, then the pressure in the anterior chamber or the IOP will be the 
same as the pressure drop across the tube, thus hypotony is avoided. 
In this chapter, we test these predictions and also compare the results with those of 
the ExPress P50 and P200 devices. 
 
 
Figure 5.1 Permeability ( , in μl/min/mmHg). The black shaded area covers our desired 
values for an ideal device. L- length of tube, d – diameter of tube. 
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Figure 5.2 Pressure drop across a tube (in mmHg, at a flow rate of 3 μl/min). * indicates 
the value for a 5 mm long, 50 μm ID tube. If the flow rate is halved, the pressure drop is 
also halved. 
 
For the experiments, we used 50 µm and 100 µm ID tubes bought from Cole-
Parmer (IL, USA) and ExPress P50 and P200 devices (4 units each) which were provided 
by Alcon, Inc. (TX, USA). The 50 µm and 100 µm ID tubes were made from 
polytetrafluoroethylene (PTFE), a synthetic fluoropolymer of tetrafluoroethylene. We chose 
to use these extruded tubes as our model as they were readily available in the dimensions 
we wanted to test, with small tolerances in manufacture. There was limited availability in 
manufacturing our own tubes to the exacting dimensions and tolerances; an available 
alternative was to produce tubes through a manual dip-coating process, but this is 
associated with much higher dimensional variability in the tubes produced (Siewert et al., 
2012). In the study by Siewert et al., when they used this process of dip-coating, there was 
between 19-42% deviation when trying to make tubes with 60-160 µm wall thicknesses. As 
* 
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such, we were unable to test using other materials such as silicone which is used in current 
glaucoma drainage devices such as the Ahmed and Baerveldt devices. 
PTFE is a high-molecular-weight compound consisting wholly 
of carbon and fluorine atoms covalently bonded to each other (The Merck Index, 1976). 
PTFE molecules at the surface also repel other molecules that come close to them. Its 
contact angle or measure of surface wettability/ surface tension is the lowest among 
polymers, including silicone, which may make it less prone to protein adsorption (Butt, 
Graf, & Kappl, 2006). As such, PTFE is hydrophobic, stable, non-reactive and non-toxic. 
Because of its chemical inertness, PTFE cannot be cross-linked like an elastomer. It has one 
of the lowest coefficients of friction and is used medically to make vascular stents and 
artificial heart valves (Sayers, Raptis, Berce, & Miller, 1998; Quintessenza, Jacobs, Chai, 
Morell, & Lindberg, 2010). Although the use of a PTFE tube on its own as a glaucoma 
drainage device has not been reported, a heat-stretched, semi-permeable membrane version 
of PTFE (expanded-PTFE) has been tested as a material to make subconjunctival space 
glaucoma drainage explants attached to silicone tubes leading into the anterior chamber 
(Boswell, Noecker, Mac, Snyder, & Williams, 1999; Kim, Kim, Choi, Lee, & Ahn, 2003). 
Although Boswell et al. found that the resulting post-implantation fibrosis in their rabbit 
model was thinner and more vascularised with the expanded-PTFE explants than with 
silicone Baerveldt devices, Kim et al. subsequently reported that the IOP control and 
complications seen in their human study were similar to those reported from using Ahmed, 
Baerveldt and Molteno implants. 
We started off with material testing of the PTFE tubes. This was done to look at the 
Young’s Modulus or stiffness of the PTFE, for a brief comparison with other materials used 
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to make subconjunctival space glaucoma drainage devices. Scanning electron microscopy 
was performed next to look at the dimensions and details of the tubes and ExPress devices. 
This was followed by flow studies to look at resistance of the tubes and devices. Resistance 
is the inverse of facility, and we looked at these values to enable a comparison with other 
published studies. The effect of higher protein and fibrin content in the fluid flowing 
through the lumens was also investigated, to see how they may affect flow and pressure. 
We then incorporated the tubes and devices into our porcine sclera model from Chapter 4 to 
test and compare their control of pressure, with and without overlying scleral flaps. Finally, 
we looked at the most suitable stab incision sizes for their insertion, as a measure to 
minimise external leakage which could lead to additional drops in pressure. 
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5.2 Methods 
 
5.2.1 Material testing 
Samples of the 100 μm ID PTFE tubes were subjected to uni-axial tensile testing 
using a H5KS materials tester (Hounsfield Test Equipment, Surrey, UK) with a 250N load 
cell. The 50 μm ID tubes are assumed to have the same material properties since they are 
made of the same material. 38 mm lengths of the 100 μm ID tube were attached to the 
upper and lower grips, with care taken to avoid slippage. The cross-sectional area of each 
tube was calculated to be 0.118 mm
2
. Force was applied at a strain rate of 1 mm/min and 
the elongation noted. The machine produced a force-elongation curve, and a stress-strain 
curve was then plotted. The Young’s modulus of the PTFE material was determined from 
the gradient of the secant between 0 and 1% strain. At these limits, we assumed a linear 
stress-strain relationship for the polymer as the load applied was small. 
 
5.2.2 Electron microscopy 
Samples of the PTFE tubes and ExPress devices were imaged using a scanning 
electron microscope (Quanta 200F; FEI, OR, USA). We had an AqueSys glaucoma 
drainage device available, which we also imaged. The PTFE tubes and collagen AqueSys 
device were coated with an ultrathin 20nm layer of gold prior to scanning while the 
stainless steel ExPress tubes were uncoated. We selected the most perpendicular images to 
minimise parallax errors when measuring the relevant dimensions using ImageJ software 
(US National Institutes of Health, MA, USA). At least 6 measurements in different 
orientations or positions were taken for each dimension and the mean and SD obtained. 
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5.2.3 Flow studies 
The following experiments were all performed at room temperature (20-21°C). 
 
5.2.3.1 Fixed flow rate method 
We measured the resistance of the 50 μm and 100 μm tubes by first cutting 5 mm 
long segments using a microtome, to avoid luminal deformation. The first 2.5 mm of these 
segments were then glued on the outside with cyanoacrylate glue before mounting in the 
lumen of 21G needles (0.51 mm inner diameter; BD, NJ, USA) [Figure 5.3]. To minimise 
the amount of resistance in the needles themselves, they were cut down to 5 mm in length 
from the hilt before the tubes were glued to them. Water-tightness was checked by injecting 
BSS through the mounted tubes while looking for leaks around the attachment site. 
Based on the setup in Chapter 4, using a 3-way tap and non-expansile, low 
compliance silicone tubing, the mounted tubes were attached to a 1 ml syringe (BD, NJ, 
USA) on a syringe driver (Cole-Parmer, IL, USA) and a pressure transducer (162PC01D; 
Honeywell International, NJ, USA). This pressure transducer was connected to an interface 
board/ voltmeter (VM110; Velleman NV, Gavere, Belgium) and personal computer. 
Balanced Salt Solution (BSS) [Alcon Laboratories, Inc., TX, USA] was used with this 
method unless stated otherwise, and all air bubbles were removed from the system prior to 
the start of each run. 
Prior to the actual runs, the resistance of the 21G needle itself was measured. This 
was done by infusing BSS at 10, 20, 30, 40 and 50 μl/min through a needle without a tube 
and recording the pressure. Resistance was deduced from the slope of a pressure versus 
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flow rate graph. There was no discernible pressure increase with flow rates up to 50 μl/min, 
so we took the resistance to be negligible. In the actual runs with the tubes mounted to the 
needles, flow rate was increased from 0 to 35 μl/min (50 μm tubes) or 40 μl/min (100 μm 
tubes) in steps of 5-10 μl/min. Each flow rate was maintained for 5 minutes and the 
stabilised pressure recorded (Figure 5.4). Again, resistance was derived from the slope of 
the pressure against flow rate graph. 
 
 
Figure 5.3 Setup for fixed flow rate method. 
 
 
21G needle 
Tube 
3-way tap 
Pressure 
transducer 
 
  
Syringe driver 
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Figure 5.4 Typical steps in pressure when flow rates were increased. 
 
5.2.3.2 Fixed pressure method 
This method was used primarily to compare the resistance of ExPress devices in our 
study with those reported in another study (Estermann, Yuttitham, Chen, Lee, & Stamper, 
2013). We also used this method to test our 50 μm and 100 μm tubes, to compare with the 
results with the fixed flow rate method. 
Manometers or standpipes are attached to the system without a syringe driver in 
place, the pressure from the head of water would provide flow through the tube or device 
tested. The amount of fluid collected enabled calculation of flow rate and resistance values. 
The manometers were constructed from three 60 ml syringe barrels which were cut and 
glued together. For the tubes, the 21G needle mountings (from the previous section) were 
attached to the syringe tip at the bottom of the manometer (Figure 5.5). 
As for the ExPress devices, we slightly modified the method described by 
Estermann et al. We implanted the devices using their pre-loaded injectors onto 0.8 mm 
0 
5 
10 
15 
20 
25 
30 
0 5 10 15 20 25 30 35 
P
 (
m
m
H
g)
 
t (min) 
170 
 
thick silicone sheets (HT-6240; Rogers Corporation, CT, USA). These sheets were then 
bound with rubber bands to a similar manometer as described before but which had the 
bottom end removed (Figure 5.6). In initial tests, we found that there were more incidences 
of leakage around the ExPress devices when using laboratory film, as used by Estermann et 
al. 
After attaching the tubes or ExPress devices, the manometer was filled with BSS, 
which was then allowed to flow and flush the system for 15 minutes. Water-tightness 
around the ExPress devices were checked with a microscope during this time, if in doubt 
the devices were implanted in new silicone sheets and re-mounted to the manometer. The 
height of BSS was then set at 6.8, 13.6, 20.4, 27.2 and 34.0 cm (equivalent to 5, 10, 15, 20 
and 25 mmHg) and the dripping fluid was collected in a beaker on a precision scale (GF-
300; A&D Instruments Ltd., Abingdon, UK) over a period of 15 minutes for each level. 
During the test, the level of BSS in the manometer, and thus pressure was kept constant by 
addition from a BSS bottle and tube. From the amount of BSS collected, we derived the 
flow rate, which in turn enabled us to derive resistance. 
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Figure 5.5 Setup for fixed pressure method (tubes). The manometer level was kept constant 
by addition from a BSS bottle and tube (not shown). 
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Figure 5.6 Setup for fixed pressure method (ExPress devices). The manometer level was 
kept constant by addition from a BSS bottle and tube (not shown). 
 
5.2.3.3 Effect of higher protein and fibrin content 
Resistance values of the tubes and devices when using BSS, albumin in BSS (300 
mg/ 100 ml), albumin in BSS (3000 mg/ 100 ml), fibrin in BSS (0.5 mg/ ml) and fibrin in 
BSS (1.0 mg/ ml) were determined. The concentrations of albumin used in this experiment 
were to model moderate and maximal amounts of abnormal aqueous humour protein, as in 
Chapter 4, and the method for preparing them was described in that chapter. The 
concentrations of fibrin in BSS were chosen based on estimation, as we could not find in 
the literature typical values for the concentration of fibrin in aqueous humour during 
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inflammation. These concentrations provided cloudy solution appearances similar to that 
seen in fibrinoid aqueous humour, with sedimentation much like that seen in hypopyon 
formation. The fibrin in BSS solutions were prepared by adding 25 mg and 50 mg of fibrin 
(insoluble powder from human plasma; Sigma Aldrich, Dorset, UK) with BSS to make up 
volumes of 50 ml. Separate syringes were used for the different fluids. 
As the insoluble fibrin tended to sink down in the gravity-dependant fixed pressure 
experimental setups (Figures 5.5 and 5.6) and could easily block the tubes and devices, we 
employed the fixed flow rate method as in Figure 5.3. The only difference was when testing 
the ExPress devices; to enable water-tight attachment to the 3-way tap, they were glued to 
the lumens of 24G (0.51 mm inner diameter; BD, NJ, USA) IV cannulas which were also 
cut down to 5 mm in length. These cannulas on their own also had negligible resistances 
when tested. 
With the tubes and ExPress devices in situ, flow rate was increased from 0 to 35 
μl/min (50 μm tubes) or 40 μl/min (100 μm tubes) in steps of 5-10 μl/min, or 0 to 166.7 
μl/min (ExPress devices) in steps of 33.3 μl/min. The higher flow rates were necessary with 
the ExPress devices as they had lower resistances and thus produced lower pressure 
readings with the lower flow rates. Each flow rate was maintained for 5 minutes and the 
stabilised pressure recorded. The resistance was deduced from the slope of a pressure 
versus flow rate graph. 
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5.2.4 Porcine sclera model 
We incorporated the tubes and ExPress devices into our porcine sclera model as 
described in chapter 4. With this model, with the corneoscleral disc mounted on the Barron 
artificial anterior chamber and physiological flow rates of 1.5-3.0 μl/min, we were unable 
to obtain a stable pressure as it continually increased as the infusion progressed; pressure 
was only released when stab incisions were performed. In contrast, the AGFID project team 
(2001) found that stable pressures of between 15-28 mmHg could be maintained with a 
similar setup. Their flow rates were not reported, but besides this, the difference could also 
be due to less water-tightness in their different artificial anterior chamber. We also created 
4 mm wide × 3 mm long, 250 µm thick scleral flaps before proceeding to apply the relevant 
interventions. This was to obtain closer scleral bed thickness to human eyes (Chapter 4) and 
improve the fit of the ExPress devices. Any air remaining in the anterior chamber was 
removed after each stab incision by a gentle bolus of BSS. 
 
5.2.4.1 Equilibrium pressure without an overlying scleral flap 
This was to compare the control of pressures by the different tubes and devices on 
their own, without the effect of an overlying flap. Patent 50 µm tubes or ExPress devices 
were inserted after a 27G stab incision while 100 µm tubes were inserted after a 26G stab 
incision (Figures 5.7 and 5.8). Scleral flaps were not repositioned or sutured after device 
insertion. The flow rate was set at 3µl/min and the pressure tracing reset. The resulting 
equilibrium pressures were observed. Each ExPress device was used for two runs. 
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Figure 5.7 Setup for equilibrium pressure without a flap experiment. The scleral flap was 
not repositioned or sutured after device insertion. 
 
 
Figure 5.8 Photograph of ExPress device in situ (arrow) and reflected scleral flap. 
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5.2.4.2 Equilibrium pressure with an overlying scleral flap 
Here we compared equilibrium pressures between ExPress devices and a 
trabeculectomy. The 50 µm (and 100 µm) tubes were not tested as they are aimed for 
insertion without scleral flaps. For the ExPress devices, a 27G stab incision through the 
scleral bed was performed after which they were inserted using their injector. Each device 
was used for two runs. For the trabeculectomy, after creating a scleral flap, a sclerostomy 
was performed using a 0.75 mm diameter scleral punch. In all cases, the scleral flaps were 
sutured down adequately with 2 10/0 nylon sutures, as in Figure 5.9. The flow rate was set 
at 3µl/min and the pressure tracing reset. A typical trace is shown in Figure 5.10, showing a 
gradual increase in pressure until the flap opened to allow flow. 
 
 
Figure 5.9 Diagram of ExPress device under a sutured flap. 
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Figure 5.10 Typical pressure curve in equilibrium pressure with an overlying flap 
experiment. The pressure levelled out after the flap opened to allow flow. 
 
5.2.4.3 Index of external leakage with different stab incision sizes 
Occluded tubes or ExPress devices were inserted after making stab incisions in the 
scleral bed with 27G (50 µm tubes and ExPress devices), 26G (100 µm tubes) or 25G 
(ExPress devices) needle stabs (Figure 5.11). The nominal outer diameters (OD) of these 
needles were as follows – 27G 0.41 mm, 26G 0.46 mm and 25G 0.51 mm. The tubes were 
occluded with cyanoacrylate glue at their tips. The ExPress P50 and P200 devices (1 each) 
were occluded with short segments of broken-off introducer wire in their lumens. The 
occlusions were supplemented by using cyanoacrylate glue to cover the flanged external 
(subconjunctival space) ends. Each of these devices was used twice for each subgroup. 
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After the devices were inserted through the incisions, pressure in the manometer 
was increased to 20 mmHg. Scleral flaps were not repositioned or sutured after device 
insertion. This time, no BSS was added to the manometer during the test. The whole 
apparatus was left for 1 hour for pressure to stabilise, after which the pressure was noted. 
 
 
Figure 5.11 Setup for index of external leakage experiment. Scleral flaps were not 
repositioned or sutured, and no BSS was added to the manometer during the test. 
 
 Statistical analysis was performed using Prism 4 software (GraphPad Software, Inc., 
CA, USA). The unpaired t-test was used when comparing 2 groups while one-way 
ANOVA +/- Bonferroni’s multiple comparison post-test was used when comparing 3 
groups. P < 0.05 was considered statistically significant. 
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5.3 Results 
 
5.3.1 Material testing 
From the stress-strain curve that was produced, the gradient of the secant between 0 
and 1% strain showed that the Young’s modulus of the PTFE material was 663 +/- 38 MPa 
(n = 3). 
 
5.3.2 Electron microscopy 
A summary of dimensions of the tubes and devices is shown in Table 5.1. Some 
actual images are shown in Figures 5.12-5.16. 
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Table 5.1 Summary of tube and device dimensions. 
PTFE tubes 
 50 µm 100 µm Notes 
Internal diameter (µm) 56.3 +/- 2.3 106.8 +/- 1.4 Examples in Figure 5.12 
External diameter (µm) 354.2 +/- 4.6 397.0 +/- 7.0 
ExPress devices 
 P50 P200  
Length, whole (mm) 2.56 +/- 0.01 Example in Figure 5.13 
Width, tube section (µm) 377.0 +/- 8.5 
Length, complete tube section (mm) 1.36 +/-0.02 
Internal diameter, subconjunctival space 
end (µm) 
205.0 +/- 5.8 206.4 +/- 3.3 P = 0.564 
Examples in Figure 5.14 
Internal diameter, anterior chamber end 
(µm) 
206.9 +/- 3.7 204.5+/- 0.9 P = 0.434 
Examples in Figure 5.15 
AqueSys device 
Internal diameter (µm) 55.9 +/- 2.6  Example in Figure 5.16 
External diameter (µm) 147.7 +/- 1.9  
Note: For the electron microscope we used, the manufacturer quotes an error in magnification (and measurement) of +/- 1.5%. 
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Figure 5.12 Cross-sections of (a) 50 µm and (b) 100 µm tubes (500 × magnification). 
 
 
Figure 5.13 Profile of two ExPress P200 devices (78 × magnification). 
 
a b 
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Figure 5.14 Subconjunctival space ends of (a) P50 and (b) P200 devices (100 × 
magnification). The external dimensions and lumens are similarly sized. 
 
 
Figure 5.15 Anterior chamber ends of (a) P50 (160 × magnification) and (b) P200 
devices (200 × magnification). The external dimensions and lumens are similarly sized. 
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Figure 5.16 AqueSys device (1000 × magnification). 
 
5.3.3 Flow studies 
5.3.3.1 Resistance of 50 µm and 100 µm tubes 
With the fixed flow rate method (Figure 5.17a), resistance of the 50 µm tubes 
was 1.52 +/- 0.12 mmHg/μl/min and for the 100 µm tubes was 0.17 +/- 0.02 
mmHg/μl/min (mean +/- SD, n = 6 each). Comparatively, with the fixed pressure 
method (Figure 5.17b), resistance of the 50 µm tubes was 1.48 +/- 0.15 mmHg/μl/min 
and for the 100 µm tubes was 0.19 +/- 0.01 mmHg/μl/min (n = 6 each). There was no 
statistically significant difference in resistance values between fixed flow rate and fixed 
pressure methods (P = 0.659 for 50 µm, P = 0.334 for 100 µm). 
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Figure 5.17 (a) Pressure-flow rate relationship with fixed flow rate method. Resistance 
is calculated from the gradient of the best-fit line. (b) Flow rate-pressure relationship 
with fixed pressure method. The gradient reflects the facility i.e. the inverse of 
resistance. 
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5.3.3.2 Resistance of ExPress devices 
Resistance of the P50 devices was 0.054 +/- 0.002 mmHg/μl/min and for the 
P200 devices was 0.010 +/- 0.001 mmHg/μl/min (n = 4 each) [Figure 5.18]. 
 
 
 
 
Figure 5.18 (a) Flow rate and (b) resistance of ExPress devices with fixed pressure 
method. The devices demonstrated fixed resistance characteristics. 
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5.3.3.3 Comparison between experimental and predicted permeability values 
Differences between experimental and predicted permeability values from the 
fixed pressure method are shown in Table 5.2 below. 
 
Table 5.2 Experimental and predicted permeability of devices. 
 Permeability, experimental 
(μl/min/mmHg) 
Permeability, predicted 
(μl/min/mmHg) 
50 µm tube 
 
0.66 +/- 0.05 0.40 
100 µm tube 
 
5.44 +/- 0.17 5.11 
P50 
 
18.57 +/- 0.76 Poiseuille’s Law not applicable 
as lumens do not have constant 
circular cross-section. P200 104.71 +/- 14.68 
 
5.3.3.4 Effect of higher protein and fibrin content 
With the 50 µm tube (Figure 5.19), there was a significant difference in 
resistance between BSS and albumin in BSS (3000 mg/ 100 ml). With that level of 
albumin, resistance was increased by 26.1%. Fibrin in BSS (0.5 mg/ ml and 1.0 mg/ ml) 
did not affect resistance in this experiment. With the 100 µm tube and both ExPress 
devices (Figures 5.19 and 5.20), there were no statistically significant differences in 
resistance values between all the different fluids. 
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Figure 5.19 Resistance of PTFE tubes with different fluids (n = 6 each). * indicates a 
statistically significant difference compared to BSS. In the 50 µm tubes, only albumin in 
BSS (3000 mg/ 100 ml) resulted in higher tube resistance than BSS. In the 100 µm 
tubes, there were no statistically significant differences between fluids. 
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Figure 5.20 Resistance of ExPress devices with different fluids (n = 4 each). There 
were no statistically significant differences between fluids in both devices. 
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5.3.4 Porcine sclera model 
5.3.4.1 Equilibrium pressure without an overlying scleral flap 
Equilibrium pressures were 6.71 +/- 0.34 mmHg for the 50 µm tube, 4.54 +/- 
0.89 mmHg for the 100 µm tube, 0.63 +/- 0.59 mmHg for the ExPress P50 and 0.25 +/- 
0.38 mmHg for the ExPress P200 (n = 8 each). There were statistically significant 
differences between all devices, apart from that between the ExPress P50 and ExPress 
P200. 
 
5.3.4.2 Equilibrium pressure with an overlying scleral flap 
Equilibrium pressures were 17.81 +/- 3.30 mmHg for the ExPress P50, 17.31 +/- 
4.24 mmHg for the ExPress P200 and 16.28 +/- 6.67 mmHg for the trabeculectomy (n = 
8 each, P = 0.850) [Figure 5.21]. 
 
5.3.4.3 Index of external leakage with different stab incision sizes 
Pre and post-insertion pressure values with the different combinations of tubes 
and devices are shown in Table 5.3. 
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Figure 5.21 There was no statistically significant difference in equilibrium pressures 
between the ExPress devices and a trabeculectomy. However, the standard deviation 
with a trabeculectomy was larger, indicating a wider variability in readings. This may 
be due to lumen size variations in the trabeculectomy. 
 
Table 5.3 Pre and post insertion pressures in index of external leakage experiment. 
Tube/ device, 
size of stab 
incision 
Pre insertion 
pressure, 
mmHg 
Post insertion (60 
mins) pressure,  
mmHg 
Difference, 
mmHg 
P  
value 
50 µm tube, 
27G 
20.24 +/- 0.25 19.82 +/- 0.26 0.43 +/- 0.15 # < 0.001 
100 µm tube, 
26G 
20.22 +/- 0.12 20.04 +/- 0.12 0.19 +/- 0.01 # < 0.001 
ExPress, 27G 20.26 +/- 0.16 19.22 +/- 0.21 1.03 +/- 0.26 * < 0.001 
ExPress, 25G 20.20 +/- 0.22 19.17 +/- 0.59 1.03 +/- 0.58 * 0.008 
N = 6 (tubes), 4 (ExPress). No statistically significant difference between pre insertion 
pressures. 
Statistically significant differences between # and *.  
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5.4 Discussion 
 
5.4.1 Material testing 
 We compared our findings with data from MATBASE 
(http://www.matbase.com). On the database, Young’s moduli are given as 1-5 MPa for 
silicone, 410-750 MPa for PTFE, 1.5-2.0 GPa for polypropylene and 200 GPa for 
stainless steel. The Young’s modulus of our PTFE tubes was thus consistent with that 
listed and is more stiff than silicone (which is used to make many current glaucoma 
drainage devices) but less so than polypropylene (earlier Ahmed and Molteno devices) 
and stainless steel (ExPress devices). 
 Material stiffness should be considered in the design of glaucoma drainage 
devices. It has been suggested that the more rigid polypropylene undergoes micro-
movement which increases inflammation (Ayyala, Michelini-Norris, Flores, Haller, & 
Margo, 2000). Clinical studies have shown that silicone Ahmed Glaucoma Valves have 
lower rates of the hypertensive phase (24% vs 32%) as well as failure (4-6% vs 13-
18%) compared to polypropylene ones (Ishida et al., 2006). Another study also found 
differences in encapsulation rate (0% vs 20%) between silicone and polypropylene 
Ahmed Glaucoma Valves in their paediatric glaucoma population (Sayed & Awadein, 
2013). Along the same lines of reasoning, PTFE being stiffer than silicone may also 
cause more inflammation and thus be less suitable as glaucoma drainage device 
material. 
Stainless steel, as used in ExPress devices is the stiffest among the materials 
mentioned above. As such, it may also cause more inflammation than silicone. This 
may be the reason why in the initial period when ExPress devices were implanted 
without cover under a scleral flap, a significant number of conjunctival erosions (11-
12%) were reported, particularly if they were malpositioned (Traverso et al., 2005; 
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Rivier et al., 2007; Stewart, Diamond, Ashmore, & Ayyala, 2005). Following this, 
implantation of the devices under the scleral flap was recommended (Dahan et al., 2005; 
Maris et al., 2007), and is the current practice today (de Jong, Lafuma, Aguade, & 
Berdeaux, 2011; Good & Kahook, 2011; Dahan et al., 2012). Long term results may 
show whether this effect of stiffness is important for implantation under the scleral flap 
too, although in one study which has reported 5-year outcomes, no cases of conjunctival 
erosion were reported (de Jong et al., 2011). 
 
5.4.2 Electron microscopy 
For the PTFE tubes we used, the SEM measurements were consistent with the 
nominal dimensions supplied by the manufacturer, which were 50 µm ID/ 350 µm OD 
for 50 µm tubes and 100 µm ID/ 400 µm OD for 100 µm tubes. For the ExPress 
devices, the external dimensions of the P50 and P200 devices were similar to each other 
and consistent with the nominal dimensions supplied by the manufacturer. Most 
strikingly, we found that the lumens of both models also had the same dimensions, at 
both subconjunctival space and anterior chamber ends. We subsequently approached 
Alcon, Inc. to enquire about this finding. They confirmed our findings and showed how 
the P50 differs from the P200 only in having a 150 µm diameter bar lying across its 
lumen in the middle of the device, as in Figure 5.22. This design has interesting 
implications on fluid flow and pressure, as will be discussed in the next section. 
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Figure 5.22 Inner bar (in grey) in the lumen of the P50 device. This bar is located 
centrally in the device. 
 
5.4.3 Flow studies 
Studies on flow in glaucoma drainage devices have employed both fixed flow 
rate (Prata, Jr. et al., 1995; Eisenberg et al., 1999; Lim et al., 2002; Pan, 2002) and fixed 
pressure methods (Breckenridge, Bartholomew, Crosson, & Kent, 2004; Estermann et 
al., 2013). We compared the different methods and found no statistically significant 
difference in the resistance values they produced. One article suggested that while the 
fixed flow rate method was useful for assessing device performance and validation, the 
gravity-dependant fixed pressure method usually took less time and could be useful as a 
manufacturing line test (Porter, Krawczyk, & Carey, 1997). However, we would like to 
point out that the fixed pressure method generated flow rates of up to 3000 μl/min in the 
case of the ExPress P200 devices. This high flow rate is an unlikely representation of 
actual conditions in the eye and may also lead to erroneous results when testing flow-
rate sensitive devices such as valves, due to the more turbulent flow generating larger 
resistance values (Batchelor, 2000). 
150 µm 
200 µm 
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The resistances and flow rates of the two ExPress models were consistent with 
fixed resistance characteristics, and similar to that reported by Estermann et al. (2013) 
which were 0.056 mmHg/μl/min for the P50 and 0.009 mmHg/μl/min for the P200. We 
too found that the difference in resistance values between the P50 and P200 could not 
be explained just on the basis of their descriptions, where from Poiseuille’s Law a four-
fold decrease in inner diameter from 200 μm to 50 μm would increase resistance by 256 
times. In our experiment, the P50 device resistance was only around five times more 
than that of the P200 device, and around 28 times more than that of the 50 μm ID tube. 
However, we now know that the P50 device has 200 μm diameter circular lumens at 
both ends and 2 smaller half-circle shaped ones centrally (Figure 5.22), thus making 
Poiseuille’s Law inapplicable to its case. In fact, this law is also not applicable for 
ExPress devices in general as the side orifice disrupts the constant circular cross section 
assumption. Instead, there is no single law to calculate the resistance of these more 
complex devices and experimental determination is indicated. 
Experimental permeability values of the tubes were higher than those predicted 
from Poiseuille’s Law. The difference was marked with the 50 μm ID tube (65%) but 
small with the 100 μm ID tube (6%). The error could be due to small unnoticed leakage 
around the smaller tube, or in determining its internal diameter (by a difference of up to 
8 μm) as permeability has a dependence on diameter to the fourth power, as compared 
to linear dependences on the other dimensions i.e. viscosity, length and flow rate. 
Despite the higher experimental permeability values, the one for the 50 μm ID tube 
(0.66 μl/min/mmHg) still meets the requirement we predict for reduction in IOP from 
25-50 mmHg to 15 mmHg. 
The MIDI-Arrow device has an ID of 70 μm and length of 8.5 mm, thus making 
its calculated permeability 0.55 μl/min/mmHg. In a small study in 23 humans, IOP fell 
from a baseline of 24.0 +/- 5.4 mmHg to 10.5 +/- 2.8 mmHg at 12 months and 
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maintained at 10.2 +/- 2.0 mmHg at 2 years (Palmberg et al., 2013). Complete and 
modified success rates were 91% and 96% at one year. Two subjects developed 
transient hypotony after day one but there were no cases of chronic hypotony or 
maculopathy. Another device, the AqueSys has a 50 µm ID and a 6 mm length, making 
its calculated permeability value 0.32 μl/min/mmHg. In a study where AqueSys devices 
were inserted into 15 patients, the mean pre-operative IOP of 21.3 mmHg reduced to 
12.2 mmHg at 1 week. It was subsequently maintained at 15.0 mmHg at 1 month, 15.2 
mmHg at 6 months and 15.3 mmHg at 12 months. No cases of hypotony were reported 
(Kersten-Gomez et al., 2012). The favourable clinical data with the two devices can be 
taken as an encouraging sign that fixed resistance devices with permeability values in 
the region we predicted are able to provide adequate reductions in IOP whilst 
minimising hypotony. If we consider the 5 mm long and 50 μm ID tube we tested, with 
its calculated permeability of 0.40 μl/min/mmHg, the IOP drop would be intermediate 
between that with the MIDI-Arrow (~ 14 mmHg at 12 months) and that with the 
AqueSys (~ 6 mmHg at 12 months). The hypotony rate would also be intermediate 
between those reported in the 2 studies. These predictions will need to be tested in 
actual living eyes. 
 
5.4.3.1 Effect of higher protein and fibrin content 
With the 50µm tube, resistance was higher with albumin in BSS (3000 mg/ 100 
ml) than with plain BSS. The increase of 26.1% is an indicator of potential blockage of 
the smaller diameter tube by fluids with high protein concentrations, and could be due 
to increased viscosity [relative viscosity of 1.12 for albumin in BSS (3000 mg/ 100 ml) 
as found in Chapter 4] or protein deposition. Although PTFE has features that promote 
stability and non-reactivity, in a previous study which compared fibrinogen, fibrin and 
cellular adhesion on polymers, PTFE was found to be less resistant than 
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phosphorylcholine-coated polymethylmethacrylate [PC-PMMA] (Lim, 1999). As such, 
besides the potential problem with its stiffness, this is another which may make it less 
suitable for use to make glaucoma drainage devices. 
There was no statistically significant difference in generated resistance between 
BSS and 0.5 or 1.0 mg/ ml fibrin in BSS solutions. However, in an earlier pilot study 
where we used a constant pressure setup (Figures 5.5 and 5.6), we found that the 
insoluble fibrin tended to sink to the bottom of the apparatus and could block both 50 
µm and 100 µm tubes. Even with the constant flow rate setup (Figure 5.3), we could see 
most of the fibrin gravitating below the level of the syringe hub (outlet), thus it was 
mostly ‘clear’ BSS that flowed through the mountings and devices. However, since 
most glaucoma drainage devices are inserted in the superior half of the eye, we felt that 
our constant flow rate model was still a good representative. In future, a more refined 
model incorporating a convection effect in the anterior chamber (Siggers & Ethier, 
2011) to allow a more realistic movement of fibrin should enable us to understand 
fibrin’s effect better. Additionally, improvement on this model we used may be realised 
with the use of in situ polymerised fibrin (produced by mixing fibrinogen and thrombin 
solutions) in lieu of the insoluble powder, as it is a more realistic representation of fibrin 
in the anterior chamber. 
At this moment, the evidence suggests that caution is appropriate with the use of 
devices with internal diameters less than 100 µm for cases such as inflammatory 
glaucoma where aqueous humour protein concentrations are frequently raised (Herbert 
et al., 2004; Siddique et al., 2013). 
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5.4.4 Porcine sclera model 
5.4.4.1 Equilibrium pressure without an overlying scleral flap 
The 50 μm tubes maintained pressure above 6 mmHg without overlying scleral 
flaps. At the lower physiological aqueous humour flow rate of 1.5 µl/min, this pressure 
is expected to be around 3 mmHg. This suggests that the tubes may offer a degree of 
protection against hypotony after insertion in actual eyes. Contrarily, the ExPress 
devices offered virtually no resistance to flow. This is in keeping with the results of our 
flow studies and initial clinical ExPress device implantations without cover under a 
scleral flap, when significant numbers of hypotony (up to 91%) occurred (Wamsley et 
al., 2004; Rivier et al., 2007). Following the findings, implantation of the devices under 
the scleral flap was recommended (Dahan et al., 2005; Maris et al., 2007). 
 
5.4.4.2 Equilibrium pressure with an overlying scleral flap 
We found that pressures did not differ between the ExPress devices and a typical 
trabeculectomy. This finding is consistent with those of many clinical studies (Maris et 
al., 2007; de Jong et al., 2011; Dahan et al., 2012). However, we can say that ExPress 
device implantations result in less variability in pressure readings. This may be due to 
lumen size variations (Buys, 2013); ExPress devices have lumen size measurements 
with small tolerances (Table 5.1), as compared to making a sclerostomy with a 
punching device or knife. In practice, even with same-sized punching devices, 
variations in sclerostomy sizes occur due to differences in scleral tissue tension or 
sharpness of the instruments (for example, if the cutting process is performed more than 
once). 
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5.4.4.3 Index of external leakage with different stab incision sizes 
We looked at the amount of para-tubal leakage which occurs after insertion of 
the devices. In the case of the ExPress devices, we also compared the amounts after 27G 
and 25G stab incisions (sizes stated in the packaging leaflet). The least amount of 
leakage occurred with the 100 μm tube (397 μm OD) after a 26G (0.46 mm nominal 
OD) needle stab, followed by the 50 μm tube (354 μm OD) after a 27G (0.41 mm 
nominal OD) needle stab. When we tried to insert a 100 μm tube after a 27G needle stab 
(to try to improve the fit), a significant amount of manipulation was needed which could 
deform the tube. 
There was more para-tubal leakage with the ExPress devices than with the tubes, 
but the amounts were similar after either 27G or 25G (0.50 mm nominal OD) needle 
stabs. It is likely that the spur enlarges the scleral opening during insertion, which leads 
to a poorer fit around the body and increased leakage. However, we found that 
subjectively more manipulation was needed to insert the device after the smaller 27G 
needle stab, which could traumatise surrounding local tissue. We therefore think that 
25G needle stabs are better for inserting ExPress devices. 
 
Overall, this experiment has provided insight into some issues related to material 
selection, dimensions and shapes of potential and current glaucoma drainage devices, 
and their control of flow and pressure. These need to be taken into consideration when 
designing new devices. One next step is to identify potentially better materials in 
respect to biocompatibility for the production of prototypes, to be used for insertion into 
living eyes. Such materials may be those with fibrosis-modifying (Lobler et al., 2011) 
or drug elution (Sahiner et al., 2009; Ponnusamy, Yu, John, Ayyala, & Blake, 2013) 
capabilities. Other physical designs can also be explored, such as a device with multiple 
channels, some with removable occlusions which can be removed post-operatively to 
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titrate flow and pressure; and larger diameter but longer tubes (to have the same 
permeability values) which can deposit aqueous humour more posteriorly in the 
subconjunctival space. 
The knowledge of the actual pressure drops with the tubes in the porcine sclera 
model could support our theoretical prediction. However, we were unable to measure 
them due to the inability to maintain stable pressures before intervention i.e. making 
stab incisions and inserting the tubes. Additionally, the resistance of the overlying 
conjunctiva and bleb are not considered, making our findings realistic only for the early 
post-operative stage of surgery before wound healing has developed. Finally, another 
limitation of this study is that the in vitro findings may not correlate exactly with results 
in actual living eyes, where other issues such as total ocular compliance and tissue 
hydration come into play. As such, the findings from this experiment need to be 
corroborated by those from experiments with actual living eyes. 
 
5.5 Conclusion 
 
The 50 μm ID tubes we used have resistance and permeability values that we 
predict can provide the required aqueous humour flow and IOP reduction, while still 
preventing low IOP without insertion under a scleral flap. However, they may be 
blocked by fluids with high protein content. Poiseuille’s Law is not applicable for 
estimating resistance in ExPress devices. Their low resistance values make them 
unlikely to prevent hypotony on their own and they lead to similar equilibrium pressure 
as the trabeculectomy procedure when inserted under the scleral flap. Insertion of these 
devices after a 25G stab incision allows less tissue manipulation. Finally, the stiffness of 
PTFE may be disadvantageous for its use as a material for glaucoma drainage devices. 
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Chapter 6 
6 General discussion, conclusion and future work 
 
There are a number of surgical methods for treating glaucoma, including the 
trabeculectomy and the insertion of glaucoma drainage devices. At the current time, 
these procedures are still associated with post-operative complications for a significant 
number of patients, particularly related to the control of aqueous humour flow in the 
early post-operative period. In this thesis, a fluid mechanics approach was taken to 
understand better some aspects of the surgery and devices with the aim to improve their 
outcomes. 
The trabeculectomy scleral flap acts as a valve or guard to control aqueous 
humour outflow, particularly in the early post-operative period before resistance 
develops in the subconjunctival bleb through the process of wound healing (Birchall et 
al., 2006; Birchall et al., 2007; Tse et al., 2012). This is important for the prevention of 
overfiltration and subsequent hypotony, of which significant numbers were shown after 
non-guarded filtrating procedures such as iridencleisis, trephination and Scheie’s 
procedure (Elliot, 1909; Scheie, 1958; Spaeth et al., 1975; Razeghinejad et al., 2011). 
Sutures, and to a lesser extent, scleral flap geometry affect aqueous humour outflow and 
the change in pressure. Less overfiltration and higher IOP can be achieved with a higher 
number of sutures, thicker scleral flaps, and flaps with smaller surface areas. Tight 
scleral flap closure at the end of surgery is preferable as the sutures can be adjusted or 
removed by the surgeon in the post-operative period to titrate aqueous humour outflow 
and IOP (Wells et al., 2004; Jones et al., 2005; de Barros et al., 2008; Kobayashi et al., 
2011). Additionally, diversion of aqueous humour flow more posteriorly into the 
subconjunctival space can encourage the formation of larger and more diffuse blebs, 
less scarring and inflammation, and less hypotony (Jones et al., 2005; Birchall et al., 
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2006; Dhingra et al., 2009); thoughtful positioning of the sutures, such as putting them 
along the sides of the flap while avoiding the posterior free margin can facilitate this 
diversion. 
With glaucoma drainage devices, single fixed-resistance tubes with inner 
diameters in the range of 50-75 µm can potentially improve the control of aqueous 
humour flow into the subconjunctival space with adequate reduction of IOP and less 
risk of overfiltration and hypotony, without needing additional flow-restricting 
measures such as temporary internal or external sutures, or insertion under scleral flaps. 
The 50 μm internal diameter tubes that were tested in Chapter 5 showed particular 
promise as a basis of new glaucoma drainage devices as they maintained pressure > 5 
mmHg in the porcine sclera model, although the actual drop in pressure was not tested. 
This will need further investigation by means of in vivo experiments which have the 
added benefit of being able to measure pressure drops in the short and longer terms after 
device implantation. Additional results from implantation of similar devices such as the 
MIDI-Arrow and AqueSys in human eyes are expected to corroborate the findings in 
this thesis. 
One potential problem with smaller inner diameter tubes is that their resistance 
may be increased by higher aqueous humour protein or fibrin content, and viscosities 
such as when there is significant anterior chamber inflammation. While the larger space 
under scleral flap in the early post-operative period may not be affected as much, the 
smaller lumens within the tubes may get obstructed by protein or fibrin deposition. 
Additionally, the effect of protein and fibrin on the trabecular meshwork (Johnson et al., 
1986) may add to even more aqueous humour outflow resistance and this will add to a 
bigger effect on the overall outcome. It may be prudent to consider this potential 
weakness if the smaller diameter devices are to be inserted in inflamed eyes. Additional 
testing in living eyes will be needed to confirm or refute the observation that was found. 
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When considering the experimental approach in this thesis, the large scale 
physical analogue and ex vivo porcine corneoscleral models allowed a cost-effective, 
efficient and convenient way to assess the effect of variables on the isolated scleral flap, 
as well as performance of model and actual drainage devices. The experimental setups 
enabled the control of parameters such as aqueous humour flow rates and viscosity to 
simplify and standardise conditions to find general principles about the investigated 
procedure and devices. This approach is analogous to recognised methods such as those 
used in tablet dissolution or drug release studies, which are conducted in glass 
containers with paddle wheels or baskets, or flow-through chambers (European 
Directorate for the Quality of Medicines, 2005b). While the apparatus are dissimilar to 
the stomach or gastrointestinal tract, they can provide important information in the 
evaluation and development of new therapies and medicines. 
While the experimental setups in this thesis provided a physical understanding 
of flow and pressure control in idealised situations, they were unable to assess the more 
complex, global in vivo effect, which is affected by other variables such as ocular 
compliance, wound healing and resistance of the overlying conjunctiva and bleb. There 
were differences even between the two setups that were used, which supports the notion 
that there is less relevance of findings to clinical outcomes when utilising models that 
are distinctly dissimilar to the actual tissues and conditions (Weinreb et al., 2005; 
Johnson, 2005). As such, the findings in this thesis still need testing for reproducibility 
in real eyes, of animals or preferably humans. 
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Conclusion 
 
The trabeculectomy scleral flap acts as a valve to guard from excessive aqueous 
humour outflow and hypotony, and parameters such as the number and position of 
sutures and scleral flap geometry can be tailored to alter aqueous humour outflow and 
IOP outcomes. Tubes with internal diameters around 50 μm show promise for 
controlled aqueous humour flow into the subconjunctival space with avoidance of low 
IOP. However, their performance may be limited by obstruction of the small lumens by 
particles such as protein and fibrin. 
Applying engineering principles to glaucoma surgical procedures and drainage 
devices have provided novel insight into their function. The analyses and models used 
in this thesis mimic trabeculectomies and glaucoma drainage devices, and can be used 
to assess aqueous humour flow in the development of new treatments or devices. The 
advantages include efficiency, cost-effectiveness and the ability to test many variables. 
However, their main limitation is that the results may not translate exactly into the more 
complex living eye. 
 
Future work 
 
There is a need to improve the outcome of surgical procedures for glaucoma. 
The process of developing new procedures or devices can start with physical analysis 
and Computational Fluid Dynamics (CFD). These may help to predict the resultant 
outcomes in an efficient way as they enable the control of many variables which can 
otherwise be difficult in in vivo settings. These techniques simplify and standardise 
conditions to tell us general principles about the procedures and devices, to guide their 
evolution. Their analyses can be followed up by using experimental models with similar 
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physical and geometrical properties to the procedures and devices. With the 
experimental models, more realistic specifications and conditions enable the results to 
be closer to those in the actual clinical situation. 
Although not explored in this thesis, CFD is another technique to analyse fluid 
flow with the procedures and devices (Gardiner et al., 2010; Villamarin et al., 2012). 
With this technique, numerical methods and algorithms are employed to analyse 
situations. The calculations required to simulate the interaction of fluids with surfaces 
are performed using advanced and high-speed computers, resulting in software which 
may predict the results in complex scenarios with reasonable accuracy. In the case of 
this research project, CFD could possibly simulate the flow of aqueous humour under 
the scleral flap in a 3-dimensional manner, and the flow of aqueous humour along the 
channels of devices with more complicated designs such as the ExPress. However, the 
main difficulty with this technique is in characterising the geometry and structural 
interactions of the procedures and devices; these are intrinsically complex and 
challenging, and may affect the validity of the predicted outcomes. 
In the process of designing a new glaucoma drainage device, consideration 
should also be given to the types of materials used in their manufacture. The ideal 
glaucoma drainage device should be made of materials which can be integrated into the 
surgical site without causing significant inflammation, foreign body reaction or other 
damage to the surrounding tissue. At the same time, they should also have a degree of 
resistance to adhesion and blockage from the fluid and cellular material flowing through 
the device. Biodegradable forms could provide the alternative outflow pathway initially, 
and then degrade to leave a fistula or tract behind, and they may also be used as drug 
delivery vehicles providing pressure-lowering or anti-scarring pharmacological support. 
Current and new research into biocompatibility is expected to produce materials which 
have these capabilities. Polymer and biomaterial technology is advancing rapidly and 
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have been used, among others, as scaffolds for tissue engineering and regeneration as 
well as controlled release drug delivery vehicles (Nair & Laurencin, 2007). It is 
conceivable then, that a suitable material derived from this polymer group could be used 
in the manufacture of glaucoma drainage devices. 
Once a potential material is found, suitable designs and dimensions need to be 
investigated further. These may involve experimenting with different physical designs 
such as combinations of inner diameters and lengths of channels, for better control of 
resistance, aqueous humour flow and subsequent pressure. Adjustable valve openings 
which can be modified post-operatively to titrate aqueous humour flow and pressure can 
also be explored. Alternatively, tubes with multiple channels may also provide 
controlled aqueous humour flow, some of the channels could be occluded at the time of 
surgery but then opened in the post-operative stage to titrate flow and pressure 
according to the initial outcome. The external design of these devices may also be 
investigated, for example having different appendages such as those to prevent 
excessive external movement or leakage; or to ease their insertion techniques. 
 Finally, a prototype incorporating all these desirable characteristics can be 
manufactured and tested in in vivo animal studies. The animal model could be the 
rabbit; it has a large eye relative to its body, is easy to handle and breed, and more 
economical than with using dogs or primates (Gwon, 2008). It is already used to assess 
procedures such as cataract surgery, corneal transplantation, laser refractive surgery, 
retinal detachment surgery and intravitreal drug delivery. However, young rabbits have 
a more robust post-operative inflammatory response, greater than that seen in adult 
human eyes. This needs to be taken into account when assessing the post-operative 
stage. 
If the results prove to be favourable, then the final stage would be to introduce 
the device in humans to see if the translation from ‘bench-to-bedside’ is successful. 
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